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Background: Neuroendocrine-immune (NEI) regulation is essential for maintaining health. 
Through repeated activation of the stress response, early-life adversity may lead to dysregulation 
of the NEI network and increase risk of inflammatory-related disease. Studying NEI functioning 
during childhood, however, has been limited by the need for biologic data, which has been largely 
restricted to blood-based measures.   
Objectives: Using salivary biomeasures of immune activity (cytokines) this study examined: 1) 
the nature and correlates of salivary cytokines in children; and 2) the role of early-life adversity in 
moderating child NEI functioning.  
Methods:  Data were drawn from the Fetus to Five study, a laboratory-based study of mother-
child pairs. Children participated in stress-inducing tasks and provided four saliva samples. 
Mothers completed a survey about child health, family sociodemographics, and maternal mental 
health. Saliva was assayed for four inflammatory cytokines (IL-1β, IL-6, IL-8, TNFα) and 
markers of autonomic nervous system (ANS) and hypothalamic-pituitary-adrenal (HPA) activity 
(alpha-amylase (sAA), cortisol).  Multilevel mixed models examined relations between cytokines 
and child health and demographic factors, and associations with sAA and cortisol. Composite 
scores reflecting socioeconomic status (SES) and maternal distress were created for each child 
using factor analysis of SES and maternal psychological (depressive symptoms, anxiety, stress) 
variables.  Multilevel mixed models for cortisol examined child cortisol-cytokine relations and 
interactions between maternal distress and cytokines on cortisol, adjusting for SES. 
Results: Cytokines were largely unrelated to health and demographic factors, but were associated 
with oral health measures. Among boys, cytokines were positively associated with sAA and 
inversely associated with cortisol.  In the full sample, positive maternal distress-cytokine 
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interactions on cortisol for IL-1β, IL-6 and TNFα indicated that as maternal distress increased, 
inverse cytokine-cortisol relations became weaker. These interactions were driven by significant 
interactions among girls.   
Conclusions:  Salivary cytokines in children reflect oral immune processes.  Relations between 
cytokines and markers of ANS and HPA activity in saliva, however, mirror those in serum, 
suggesting NEI functioning may be studied using salivary biomeasures.  Among girls, regardless 
of SES, maternal distress was associated with less efficient regulation of child inflammatory 
activity by cortisol.  This desensitization may increase inflammatory-related disease risk and 
contribute to health disparities. 
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Introduction, Study Aims, and Significance 
 
1.1. Introduction 
Eliminating health disparities in the United States has been a national priority for 
decades.  However, efforts toward this goal have made limited progress (1–3).  Disadvantaged 
populations still suffer higher morbidity and mortality rates of diabetes, obesity, depression, 
stroke, and cardiovascular and respiratory disease (1). In addition to exhibiting similar 
socioeconomic disparities, these diseases also share a common underlying pathophysiology 
involving dysfunctional inflammatory processes of the immune system (4–6).  Understanding 
how these inflammatory processes are altered by socioeconomic factors and the health risks 
associated with these changes is fundamental to understanding and addressing health disparities 
in the US. Of particular importance is the critical role of the early-life environment in shaping the 
development and regulation of these inflammatory processes (7).   
The goal of this study was to further our understanding of the biologic mechanisms 
linking low socioeconomic status (SES) and increased disease risk through use of new salivary 
immune biomeasures. The study focused on the role of early-life adversity in shaping the 
development of two biologic systems involved in inflammatory processes– the central nervous 
system (CNS) and the immune system. There were three specific aims, to: 1) explore current 
salivary analyte data analysis methods and their implications for data quality, and the validity and 
reliability of study findings; 2) examine the nature and correlates of salivary immune markers 
(cytokines) in five-year old children, and examine relations between cytokines and demographic 
and health characteristics, as well as relations with activation of the CNS; 3) examine the role of 
early-life adversity in moderating the relation between CNS and immune system activity in five-
year old children.   
2 
 
1.2.  Study Aims and Hypotheses 
Aim 1: Explore current salivary analyte data analysis methods, with a focus on pre-analytic data 
processing techniques, and their implications for data quality, and the validity and reliability of 
study findings. 
Biomeasure data are increasingly important and popular in child health and development 
research (8).  As a cost-effective, socially acceptable, and minimally-invasive method for 
obtaining biologic data, saliva is well-suited for large-scale public health studies of child health 
and development.  This aim advances the field of salivary bioscience by addressing the 
challenges inherent in salivary biomeasure data analysis and by proposing standard methods and 
reporting for salivary biomeasure studies.  Despite the wide-spread use of salivary biomeasure 
data, there is limited information regarding the best practices of salivary data processing and 
analysis. In particular, differences in pre-analytic data processing methods are important, because 
these early steps of data processing are largely unreported in published manuscripts.  
Furthermore, differences in pre-analytic data processing methods between studies limit the 
validity and reliability of salivary biomeasure results and may underlie inconsistencies in findings 
throughout the literature.  
Aim 2: Examine the nature and correlates of salivary immune markers (cytokines) in five-year 
old children, and relations between cytokines and demographic and health characteristics, as well 
as relations with activation of the CNS (including autonomic nervous system (ANS) and 
hypothalamic-pituitary adrenal (HPA) axis activity).  
Hypothesis 2.1. Salivary cytokine activity is positively intercorrelated across a series of cognitive 
and emotional challenge tasks. 
The four salivary cytokines examined in this study are proinflammatory and share 
regulatory mechanisms (6).  Findings from studies examining salivary cytokines in older 
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participants suggest a coordinated immune response in the oral cavity and strong inter-cytokine 
correlations; however, to date, studies in young children are lacking (9). It was hypothesized that 
the inter-cytokine associations in young children are similar to those observed in older 
participants.  Although no studies were identified that examined inter-cytokine correlations after a 
stressor task, the cytokines examined in this study have common regulatory mechanisms 
mediated by the activation of the ANS and HPA axis (6).  Therefore, the cytokines’ response to 
stress was hypothesized to be related to the stress response of the ANS and HPA axis and to be 
highly intercorrelated.   
Hypothesis 2.2. Salivary cytokine activity is positively associated with oral health issues and 
unrelated to demographic and systemic health factors. 
Immune processes are highly specific to the tissues and immunological threats of the 
region.  Salivary cytokines are produced within the oral cavity to respond to local immunological 
threats (10).  Previous studies show consistent positive associations between oral health problems 
and baseline salivary cytokine levels in adolescents and adults (11–17). Systemic health factors, 
however, are largely unrelated to baseline levels of salivary cytokines in healthy adolescents and 
adults (9,18–20). It was hypothesized that similar relations exist in young children.   
Hypothesis 2.3. Salivary cytokines are positively associated with ANS activity and negatively 
associated with HPA activity in five-year old children. 
Systemically, the immune system and the ANS and HPA axis are reciprocally regulated 
(21). Activation of the ANS by acute stress stimulates the release of proinflammatory cytokines 
(21).  Inflammatory cytokines stimulate the HPA axis to release cortisol, and cortisol inhibits 
proinflammatory cytokine production (21).  The nature of these neuroendocrine-immune 
interactions in saliva are hypothesized to be similar to those systemically. Although not widely 
studied, this hypothesis is supported by two investigations that examined associations between 
one proinflammatory cytokine (interleukin-6) and HPA activity in saliva (22,23).  These studies 
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show that inflammatory activity was inversely related to HPA activity and positively related to 
ANS activity (22,23). If interactions between salivary ANS, HPA, and inflammatory activity 
mirror systemic interactions, this finding would support the use of these minimally-invasive 
biomeasures for the study of systemic neuroendocrine-immune functioning and inflammatory 
regulation.  
Aim 3: Examine the role of early-life adversity in moderating the relation between HPA and 
immune system activity in five-year old children.   
Hypothesis 3.1. Maternal psychological well-being moderates HPA-immune system relations in 
five-year old children regardless of family socioeconomic status. 
Early-life adversity and stress impact the development and calibration of the HPA axis 
and the immune system (24,25). Caregivers, in particular, play a significant role in both the 
child’s exposure to stress and the impact the exposure has on the developing child’s physiology. 
A supportive caregiver can buffer the child from the negative effects of early-life stressors (26), 
while children raised by mothers with poor psychosocial health are more likely to experience 
cognitive, behavioral and physical health problems during childhood and later in life (27). It was 
hypothesized that coordination between the HPA axis and immune system is altered by maternal 
psychological well-being and that these changes are measurable using salivary biomeasures of the 
HPA axis (cortisol) and inflammatory activity (cytokines).  Furthermore, it was hypothesized that 
maternal psychological well-being moderates the relation between salivary cytokines and cortisol 
regardless of family SES.    
1.3.  Significance 
The financial and societal costs of health disparities in the US are substantial.  Over a 
three year period, the national cost of health disparities climbed to nearly $1.25 trillion, with over 
$200 billion in direct medical costs (28).  Annually, an estimated $1 trillion of forgone economic 
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value, including wages and years working, is attributed to health disparities in low-SES adult 
populations (29).  Disproportionate disease burden also leads to large disparities in mortality. One 
study found a 35-year gap between the highest and lowest life expectancies in the US (30), and a 
high school education alone has been associated with nearly 13 years of additional life 
expectancy (31).   
Advancing efforts to stem health disparities requires an increased understanding of the 
mechanisms and risk factors of diseases disproportionately affecting low-SES populations 
(32,33). This dissertation furthers these goals by examining relations between psychosocial and 
socioeconomic aspects of the early-life environment and neuroendocrine-immune coordination- a 
critical regulatory mechanism of the inflammatory processes underlying many of the diseases that 
cluster in low-SES populations. This study recognizes the importance of early-life environments 
in calibrating these regulatory processes.  It focuses on identifying mechanisms and risk factors 
for health disparities early in life when prevention, intervention, and treatment efforts can have 
the largest impact.  
Findings from this study could inform policies and programs aimed at reducing the 
burden of inflammation-related diseases.  Evidence of biologic changes related to psychosocial 
stressors early in life would have significant implications for shaping policy and programmatic 
interventions that focus on early childhood as a critical intervention point for fostering healthy 
development and future health and well-being.  By demonstrating the role of family factors on 
physiologic functioning, the results from this study can help increase focus on policy and 
programmatic interventions for parents and families, an area of domestic policy that has 
traditionally been  overlooked (34) but has recently received increasing investments (e.g., home 
visiting programs).  The results can also highlight the integral role of the psychosocial 
environment in child health, and be used to support community and family interventions to 
reduce health disparities (35). 
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Finally, the study’s methodology is an important contribution to the field of public health 
and child development. Biomarkers play an increasingly important role in research and in 
supporting evidence-based policies and programs (36).  However, the collection of blood-based 
biomeasures is subject to strict regulations and requires considerable financial and personnel 
resources (36).  In addition, obtaining consent for blood collection can be difficult and social 
acceptability is low, particularly for children (36).  Saliva collection is a minimally-invasive, low-
cost and socially acceptable method of obtaining biomeasure data (36,37). Little research has 
focused on immune system salivary analytes, and only two studies were identified that examined 
these biomeasures in children (38,39).  Findings from this study will advance the field of salivary 
immunologic analyte research and demonstrate the feasibility and value of salivary biomeasure 
research in public health.  Furthermore, study aim 1 will contribute to the field of salivary 
bioscience by discussing the challenges and best practices of salivary biomeasure data analysis 
and calling for standardization and disclosure of methodology.  This approach will improve the 
validity, reliability and replicability of study findings in this new and growing area of public 
health research.  
1.4.   Organization of the Dissertation 
 This dissertation includes three independent manuscripts, as well as four chapters that 
introduce the dissertation, present the overarching theoretical framework and existing knowledge, 
describe the study methods and design, and discuss the conclusions and implications of the study 
findings.  This chapter presents the study aims, hypotheses and public health significance of the 
dissertation. The second chapter discusses the theoretical framework underlying the study aims. It 
also provides basic background information about the biologic and psychosocial concepts 
examined in the studies, as well as key findings from the literature that informed the study aims 
and hypotheses.  Chapter three presents a detailed description of the study design and methods, 
including information about the study from which the data used in the dissertation were drawn, as 
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well as sample selection and statistical analysis details.  Chapters four, five and six each contain 
manuscripts associated with each study aim (aim 1 is addressed in chapter four, aim 2 in chapter 
five, and aim 3 in chapter six).  The final chapter synthesizes the results from the three 
manuscripts and discusses the conclusions of the studies.  This chapter also discusses the 
implications of the study findings as an integrated work with a focus on public health research, 


















1.5.   References 
1.  Centers for Disease Control and Prevention. CDC Health Disparities and Inequalities 
Report - United States, 2013. Morb Mortal Wkly report Surveill Summ [Internet]. 2013 
Nov 22;62 Suppl 3(3):3–5. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24264513 
2.  US Department of Health and Human Services. The Vision, Mission, and Goals of 
Healthy People 2020. Washington, D.C.; 2011.  
3.  Bleich S, Jarlenski M, Bell C, LaVeist T. Health Inequalities: Trends, Progress, and 
Policy. Annu Rev Public Heal Public Heal. 2012;33:7–40.  
4.  McDade TW. Early environments and the ecology of inflammation. Proc Natl Acad Sci U 
S A. 2012;(PNAS Early Edition):1–8.  
5.  Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating 
inflammatory factors in humans: A review and meta-analysis. Brain Behav Immun. 2007 
Oct;21(7):901–12.  
6.  Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common 
human diseases and well-being. Neurochem Int [Internet]. 2008 Jan [cited 2014 Mar 
26];52(1-2):40–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17716784 
7.  Johnson SB, Riley AW, Granger DA, Riis J. The science of early life toxic stress for 
pediatric practice and advocacy. Pediatrics. 2013;131(2):319–27.  
8.  Eunice Kennedy Shriver National Institute of Child Health and Human Development. 
Scientific Vision: The next decade [Internet]. 2012. Available from: 
http://www.nichd.nih.gov/vision 
9.  Riis JL, Out D, Dorn LD, Beal SJ, Denson L, Pabst S, et al. Salivary cytokines in healthy 
adolescent girls: Intercorrelations, stability, and associations with serum cytokines, age, 
and pubertal stage. Dev Psychobiol [Internet]. 2013 Jul 19 [cited 2013 Dec 20];(June). 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23868603 
10.  Gröschl M. The physiological role of hormones in saliva. BioEssays: [Internet]. 2009 Aug 
[cited 2013 Dec 16];31(8):843–52. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19554609 
11.  Gümüş P, Nizam N, Lappin DF, Buduneli N. Saliva and Serum Levels of B-cell 
Activating Factors and Tumor Necrosis Factor-Alpha in Periodontitis Patients. J 
Periodontol [Internet]. 2013 May 23 [cited 2013 Dec 18];0:1–14. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23701482 
12.  Gursoy UK, Könönen E, Uitto V-J, Pussinen PJ, Hyvärinen K, Suominen-Taipale L, et al. 
Salivary interleukin-1beta concentration and the presence of multiple pathogens in 
9 
 
periodontitis. J Clin Periodontol [Internet]. 2009 Nov [cited 2013 Dec 18];36(11):922–7. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19799718 
13.  Nibali L, Fedele S, D’Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Dis 
[Internet]. 2012 Apr [cited 2013 Nov 11];18:236–43. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22050374 
14.  Rathnayake N, Akerman S, Klinge B, Lundegren N, Jansson H, Tryselius Y, et al. 
Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol [Internet]. 
2013 Feb [cited 2013 Dec 18];40(2):140–7. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23174014 
15.  Gornowicz A, Bielawska A, Bielawski K, Grabowska SZ, Wójcicka A, Zalewska M, et al. 
Pro-in ammatory cytokines in saliva of adolescents with dental caries disease. 
2012;19(4):711–6.  
16.  Nishida N, Yamamoto Y, Tanaka M, Maeda K, Kataoka K, Nakayama K, et al. 
Association between passive smoking and salivary markers related to periodontitis. J Clin 
Periodontol [Internet]. 2006 Oct [cited 2013 Dec 18];33(10):717–23. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/16889628 
17.  Heikkinen AM, Sorsa T, Pitkäniemi J, Tervahartiala T, Kari K, Broms U, et al. Smoking 
affects diagnostic salivary periodontal disease biomarker levels in adolescents. J 
Periodontol [Internet]. 2010 Sep [cited 2013 Dec 18];81(9):1299–307. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20450405 
18.  Nishanian P, Aziz N, Chung J, Detels R, Fahey J. Oral fluids as an alternative to serum for 
measurement of immune activation. Clin Diagn Lab Immunol. 1998;5(4):507–12.  
19.  Sjögren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to 
psychosocial factors: studies on serum, saliva, and in vitro production by blood 
mononuclear cells. Brain Behav Immun [Internet]. 2006 May [cited 2013 Nov 
11];20(3):270–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16183246 
20.  Williamson S, Munro C, Pickler R, Grap MJ, Elswick RKJ. Comparison of biomarkers in 
blood and saliva in health adults. Nurs Res Pract. 2012;2012:1–4.  
21.  Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nat 
Rev Immunol [Internet]. Nature Publishing Group; 2011 Sep [cited 2013 Dec 
18];11(9):625–32. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3597082&tool=pmcentrez&re
ndertype=abstract 
22.  Izawa S, Sugaya N, Kimura K, Ogawa N, Yamada KC, Shirotsuki K, et al. An increase in 
salivary interleukin-6 level following acute psychosocial stress and its biological 
correlates in healthy young adults. Biol Psychol [Internet]. Elsevier B.V.; 2013 Oct [cited 




23.  Moons WG, Eisenberger NI, Taylor SE. Anger and fear responses to stress have different 
biological profiles. Brain Behav Immun [Internet]. Elsevier Inc.; 2010 Feb [cited 2014 
May 13];24(2):215–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19732822 
24.  Miller GE, Chen E, Zhou ES. If It Goes Up, Must It Come Down? Chronic Stress and the 
Hypothalamic-Pituitary-Adrenocortical Axis in Humans. Psychol Bull. 2007;133(1):25–
45.  
25.  Coe CL, Lubach GR. Critical periods of special health relevance for 
psychoneuroimmunology. Brain Behav Immun. 2003;17:3–12.  
26.  Gunnar MR, Donzella B. Social regulation of the cortisol levels in early human 
development. Psychoneuroendocrinology [Internet]. 2002;27(1-2):199–220. Available 
from: http://www.ncbi.nlm.nih.gov/pubmed/11750779 
27.  Earls MF, The Committee on Psychosocial Aspects of Child and Family Health. 
Incorporating recognition and management of perinatal and postpartum depression into 
pediatric practice. Pediatrics [Internet]. 2010 Nov [cited 2014 May 30];126(5):1032–9. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20974776 
28.  LaVeist TA, Gaskin DJ, Richard P. The economic burden of health inequalities in the 
United States. 2009.  
29.  Schoeni RF, Dow WH, Miller WD, Pamuk ER. The economic value of improving the 
health of disadvantaged Americans. Am J Prev Med. Elsevier Inc.; 2011 Jan;40(1 Suppl 
1):S67–72.  
30.  Murray CJL, Kulkami SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ, et al. 
Eight Americas: Investigating Mortality Disparities across Races, Counties, and Race-
Counties in the United States. PLoS Med. 2006;3(9):1513–24.  
31.  Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to 
disparities in mortality. N Engl J Med. 2002;347(20):1585–92.  
32.  Garner AS, Shonkoff JP, Siegel BS, Dobbins MI, Earls MF, McGuinn L, et al. Early 
childhood adversity, toxic stress, and the role of the pediatrician: translating 
developmental science into lifelong health. Pediatrics. 2012 Jan;129(1):e224–31.  
33.  Dankwa-Mullan I, Rhee KB, Williams K, Sanchez I, Sy FS, Stinson N, et al. The science 
of eliminating health disparities: summary and analysis of the NIH summit 
recommendations. Am J Public Health. 2010 Apr 1;100 Suppl(December 2008):S12–8.  
34.  Zedlewski S, Adams G, Dubay L, Kenney G. Is There a System Supporting Low-Income 
Working Families? 2006.  
35.  Williams DR, Costa M V, Odunlami AO, Mohammed SA. Moving upstream: How 
interventions that address the social determinants of health can improve health and reduce 
disparities. J Public Heal Manag Pract. 2008;14(Suppl):s8–17.  
11 
 
36.  Djuric Z, Bird CCE, Furumoto-Dawson A, Rauscher GHG, Ruffin MTMI, Stowe RRP, et 
al. Biomarkers of Psychological Stress in Health Disparities Research. Open Biomark J. 
2008 Jan;1(1):7–19.  
37.  Marques AH, Silverman MN, Sternberg EM. Evaluation of stress systems by applying 
noninvasive methodologies: measurements of neuroimmune biomarkers in the sweat, 
heart rate variability and salivary cortisol. Neuroimmunomodulation [Internet]. 2010 Jan 
[cited 2013 Dec 16];17:205–8. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2917732&tool=pmcentrez&re
ndertype=abstract 
38.  El-Sheikh M, Buckhalt JA, Granger DA, Erath SA, Acebo C. The association between 
children’s sleep disruption and salivary interleukin-6. J Sleep Res. 2007 Jun;16(2):188–97.  
39.  Keller PS, El-Sheikh M, Vaughn B, Granger DA. Relations between mucosal immunity 
























Theoretical Basis and Background 
 
2.1. Theoretical Basis 
 The conceptual framework for this study (Figure 2.1) is adapted from the multi-level 
society-behavior-biology framework of Glass and McAtee (2006) and the concept of biological 
embedding (1,2). Glass and McAtee organize the determinants of health within multiple levels of 
nested systems (1).  There are two sets of systems – one inside the body that ranges from the 
genetic constitution to multi-organ systems, and one outside the body that ranges from the family 
to the global context (1).  As an individual develops over the life course, the social and built 
environment influence physiologic systems via embodiment (1). Embodiment is the process by 
which external forces alter an individual's biology at each level from epigenetic changes to 
changes in multi-organ interactions (1).  Embodiment is also known as biological embedding (2).  
Like embodiment, biological embedding explains how life experiences and environments “get 
under the skin” and alter biologic functioning to affect life-long health and vulnerability to 
disease (2).  
 Glass and McAtee also discuss the importance of stable characteristics of the social and 
built environment that influence the likelihood that an individual will be exposed to or engage in 
risky behaviors (1).  These characteristics are called risk regulators (shown in Figure 2.1 as 
dashed boxes; 1).  An individual's social and built environments create opportunities and 
constraints on behavior (1).  Accordingly, an individual's health is influenced by both physiologic 
bottom-up processes, which are altered through embodiment, and by the opportunities and 





Figure 2.1. Conceptual framework for the study  
 
 Following Glass and McAtee's framework (1), this study examines the embodiment of 
micro-level (family) adversities, and whether the embodiment of these adversities is expressed as 
alterations within the neuroendocrine-immune (NEI) network.  The study considers 
socioeconomic and psychosocial family characteristics as risk regulators that affect physiologic 
regulation of the central nervous system (CNS) and immune system via symbolic inputs (e.g., 
fear, threat).  The multi-level and integrative nature of this study allows for a deeper 
understanding of the within and across-level relations between psychosocial and biologic factors. 




Early-life adversity is defined as the experience of negative life events in childhood (3).  
A wide range of events can be categorized as adverse experiences.  Events range from physical, 
sexual, and psychological abuse to a lack of parental responsiveness to the child’s needs, 
dysfunctional family relationships, and the witnessing of violence or death (3).  Negative life 
events are not under the control of the child and are capable of causing harm, suffering, and 
lasting changes in the development of the child (3).  Children in low socioeconomic status (SES) 
families experience a greater number of negative life events than children in more advantaged 
families (4–6).  Many studies, therefore, use SES as a proxy measure for adversity (e.g., 7,8).  
Adversity and Stress 
Life events that constitute early-life adversity, such as maltreatment, neglect, harsh or 
inattentive parenting and chaotic family environments, elicit negative emotional responses such 
as feelings of fear, threat, danger, and helplessness (3). These emotional responses are coupled 
with the activation of the physiologic stress response (stimulation of the CNS).  The acute 
activation of the stress response to negative life events can be protective in the short-term and 
help the child cope with the immediate danger or threat (9).  The frequency and severity of 
negative life events experienced during early-life adversity, however, triggers repeated activation 
of the stress response, which may result in physiologic damage and dysfunction (9).  Childhood 
adversity is associated with an increased risk of a wide range of childhood and adult diseases 
including heart disease, chronic respiratory diseases, and depression (10,11).  The link between 
early-life adversity and adult disease is so strong that childhood adversities have been called “the 
new morbidities of childhood” (12,13).  The CNS and immune system’s response to stress that 
accompanies these “new morbidities” (12,13) is an important part of the mechanism underlying 
the association between early-life adversity and disease.  
The Physiologic Response to Stress 
The Central Nervous System 
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Two interconnected systems within the CNS regulate the body’s response to stress – the 
sympathetic-adrenomedullary (SAM) system (in the sympathetic branch of the autonomic 
nervous system (ANS)) and the hypothalamic-pituitary-adrenal (HPA) axis.  These systems are 
activated by the brain, specifically the hypothalamus, when physiologic balance within the body 
is challenged by internal or external stimuli.  Once activated, the SAM system and HPA axis 
respond to the demands of the stimuli and work to restore balance within the body. (14) 
The SAM system:  When activated by the hypothalamus, the SAM system rapidly responds with 
an increase in heart rate, respiration, blood pressure and the release of catecholamines 
(epinephrine (adrenaline) and norepinephrine).  This quick response to challenge braces the body 
for a “fight or flight”.  The catecholamines mobilize immune cells into the blood stream and 
trigger the release of immune messengers (cytokines) to protect the body against immediate 
injury and damage.  The SAM stress response is dampened by activation of the parasympathetic 
nervous system, which decreases the immune system response via the vagus nerve. (15)   
The HPA response: Compared to the SAM response, 
the HPA response is delayed, peaking about 25 minutes 
after the stressor.  The HPA axis involves a cascade of 
chemical reactions.  It begins with the hypothalamus 
releasing corticotrophin-releasing hormone (CRH) and 
culminates with the adrenal glands releasing cortisol into 
the bloodstream.  Cortisol affects the function of cells 
throughout the body and in multiple biologic systems, 
including the nervous, cardiac, immune, digestive, and 
reproductive systems by binding to cell receptors.  Once 
bound to cell receptors, cortisol can enter cell nuclei and 
affect gene transcription (epigenetic effects).  Cortisol also crosses the blood-brain barrier.  In the 
Figure 2.2. HPA negative feedback loop  
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brain, and in the hippocampus, pituitary, and hypothalamus in particular, cortisol binding inhibits 
the production of CRH.  This response creates a negative feedback loop that is important for 
regulating the acute response to stress (see Figure 2.2).  Keeping the acute HPA response regulated 
in this manner is critical because it allows the body to establish homeostasis. (14) 
The Immune System: A Focus on Inflammation 
Like the CNS, the immune system maintains balance within the body and protects it from 
foreign threats.  The immune system is made up of two cooperative systems, the innate and 
adaptive immune systems.  When faced with an immediate threat, both systems react with a 
coordinated response called inflammation. (16) 
Inflammation is a surge in the innate and adaptive immune systems. During 
inflammation, immune cells rush to the area of infection or threat.  Specialized immune cells (B 
cells) release antibodies that tag invading bodies for destruction, and other immune cells engulf 
and kill (phagocytosize) foreign bodies and infected cells.  Inflammation is facilitated and 
regulated by chemical messengers called cytokines that are released by immune and somatic 
cells.  Proinflammatory cytokines promote the inflammatory processes by increasing the 
permeability of vascular and lymphatic endothelial walls and facilitating an influx of blood, 
immune cells, and cytokines to the site of infection or injury. (16) 
Cytokines 
Cytokines are the primary chemical messengers of the immune system (16).  In addition 
to regulating immune processes, cytokines facilitate communication between the immune system 
and the rest of the body and are critical for development, growth, healing, and tissue maintenance 
throughout the body (17). Cytokines in the interleukin family, like interleukin-1 beta (IL-1β), 
interleukin-6 (IL-6) and interleukin-8 (IL-8), act on leukocytes (17,18). Tumor necrosis factors, 
like tumor necrosis factor alpha (TNFα), are involved in initiating inflammation, maintaining 
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lymphoid organs and regulating lymphocytes (17,18). IL-1β, IL-6, IL-8 and TNFα have 
proinflammatory mechanisms; they are released during inflammation and promote inflammatory 
processes (19).  
Interaction between the CNS and Immune System: The Neuroendocrine-Immune (NEI) Network  
Both the immune system and the CNS are tasked with adapting the body’s internal 
environment to meet the demands and challenges of the external environment. Communication 
between these systems is essential for establishing homeostasis, allostasis, and overall health.  A 
set of shared chemical messengers (cytokines) and direct nerve-cell interactions allow for the 
integration and reciprocal regulation of the CNS and immune system. See Figure 2.3 for an 
illustration of NEI connections (20,21).             Figure 2.3. The neuroendocrine-immune network 
Cytokines and the neuroendocrine-
immune network   
Cytokines play a critical role in 
coordinating and regulating NEI activity, 
including stress-related activity in the ANS 
and HPA axis (20).  ANS activation in 
response to acute stress stimulates the release 
of noradrenaline which activates primary and 
secondary tissues of the immune system (e.g., 
bone marrow, spleen, lymph nodes; 20).  ANS 
activation also increases the production and 
circulation of proinflammatory cytokines and 
mobilizes immune cells (20).  The surge in 
inflammatory cytokines associated with ANS activation stimulates the HPA axis to release cortisol 
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which then inhibits inflammatory cytokine production (20,22).  This creates a negative feedback 
loop between the immune system and the CNS (20,21).   
 Damage or dysfunction within this feedback loop can cause imbalance in the immune 
system and inflammatory processes (19,20). Imbalance may result in chronic inflammation and 
excessive cytokine secretion which is associated with “sickness behaviors” (e.g., depressed mood 
and decreased appetite), autoimmune and neurologic disease, and death (19,23,24).  On the other 
hand, imbalance may also result in insufficient immune functioning and potentially increased 
susceptibility to disease (25).               
Cortisol and the neuroendocrine-immune network  
The effect of cortisol on the immune system is of particular importance for understanding 
developmental changes in the NEI network related to early-life adversity.  Cortisol binds to 
glucocorticoid receptors on immune cell membranes.  Once bound, cortisol can interfere with the 
cell’s ability to interact with other messengers such as cytokines. Cortisol can also pass through 
the cell membrane, enter the cell nucleus, and bind to specific gene promoter sites altering the 
cell’s production of cytokines.  Inside the cell, cortisol can bind to the cell mitochondria (the 
powerhouse of the cell) and cause dysregulation in cell energy and cell death.  The magnitude of 
cortisol’s effect on immune cells, however, is determined by the cells’ sensitivity to circulating 
cortisol.  The number and sensitivity of glucocorticoid receptors on CNS and immune cells, 
therefore, are critical for regulation of the NEI network.  (19,26,27)   
Markers of ANS, HPA and Immune System Activity in Saliva 
 Activity within the ANS and HPA axis can be reliably measured using salivary 
biomarkers. Salivary cytokines, however, are relatively new salivary biomeasures, and basic 
questions regarding their levels, correlations with systemic immune activity, and stress sensitivity 




Salivary cortisol is an established biomarker of HPA axis activity (28–30), and there are 
strong serum-saliva correlations for cortisol (31). The HPA response to stress can be measured in 
salivary cortisol approximately 20 to 40 minutes post-stressor (32–35).   
Salivary alpha-amylase 
ANS activity can be indexed by salivary alpha-amylase (sAA; 36,37). Specialized cells in 
the saliva glands produce sAA (37). These cells are innervated by the ANS; norepinephrine 
released in response to ANS activation stimulates secretion of sAA (37). Stress-related increases 
of sAA occur approximately five to ten minutes post-stressor and are associated with other 
indices of ANS arousal, including cardiovascular and skin conductance measures (38).  sAA is a 
byproduct of ANS activation; peaks of sAA reflect activity of the ANS acute stress response and 
should therefore correlate with a rise in proinflammatory cytokines (20).  Although research is 
limited, one study of adults participating in an acute stress task found salivary IL-6 was positively 
associated with a marker of ANS activity (heart rate; 39).  
Salivary cytokines 
Immune processes are highly localized and specific to the tissues and immunological 
threats of the immediate area (e.g., blood, mucosal tissues, intestines and airways).  Given the 
compartmentalized nature of the immune system and the local production of cytokines within the 
oral cavity, variation in salivary cytokines may largely represent oral immune processes rather 
than general immune functioning (40).  Therefore, the utility of salivary cytokines for 
understanding overall health may be limited.  Studies of adults and adolescents have found little 
evidence supporting strong serum-saliva cytokine correlations (41–44).  However, serum-saliva 
correlations for young children are not known.   
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Also, interactions between salivary cytokines and salivary measures of ANS and HPA 
activity (sAA and cortisol) have not been examined in children and may provide insight into NEI 
functioning.  Salivary cortisol and alpha-amylase provide important information regarding HPA 
and ANS activation in response to stress, therefore correlations between these biomarkers and 
salivary cytokines may provide insight into neuro-immune connections and overall NEI network 
regulation.   
Salivary cytokines and stress and emotions:  Few studies have examined associations between 
salivary cytokines and emotions and their response to stress.  While one study was identified that 
found salivary IL-1β was associated with activation of brain areas involved in emotional 
processing in adults (45), all other studies identified used salivary IL-6 to examine the relation 
between salivary immune markers and stress and emotions. In general, higher levels of salivary 
IL-6  have been associated with negative emotions and mental states, such as fear (46), 
depression, anxiety, social withdrawal and hopelessness (43,47). In response to social stressors, 
adults exhibit an increase in salivary IL-6 (48,49).  
 The stress-reactivity of IL-6 in children may vary by sex with one study finding a stress-
related increase in salivary IL-6 among girls and a decrease in boys (38).  This change in salivary 
IL-6, however, was not associated with age, body mass index (BMI), or ethnicity, and baseline 
levels of IL-6 did not vary by age, BMI, ethnicity, or sex (38).  The mechanisms underlying 
cytokine stress-reactivity in saliva are not well understood, and reactivity may reflect both 
immune system as well as ANS and HPA processes.  
Early-life Adversity, NEI Regulation and Biological Embedding  
 Infancy and early childhood, when the HPA axis and immune system are undergoing 
developmental change, represents a sensitive period during which stress may have a profound, 
and possibly lasting, impact on the functioning of the NEI network (50,51).  Animal studies have 
demonstrated the importance of early-life experience on establishing a set-point for the immune 
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system (50).  Chronic or repeated stress early in life floods the developing body with stress 
hormones.  High levels of cortisol during early-life development can alter the CNS, the immune 
system, and the regulatory mechanisms of the NEI network (2,7,8,52,53). 
 The SAM response does not habituate to stress (54).  Throughout development in 
infancy and early childhood, repeated psychological stressors elicit steady spikes in SAM 
hormones, which trigger the HPA axis to release cortisol (54).  High levels of circulating cortisol 
early in life can decrease the number and sensitivity of cortisol receptors on cells throughout the 
body, including immune and HPA cells involved in the NEI network (55,56).  Fewer or less 
sensitive receptors make the cells less responsive to cortisol, thereby making cortisol a less 
effective regulator of both inflammatory activity and the HPA response.  This response can result 
in a “defensive phenotype” characterized by an over-active inflammatory and HPA response to 
challenge (55).  In addition, cortisol early in life can shift the polarization of the immune system 
to favor the inflammatory response (57,58). The combination of a less regulated and 
inflammation-prone immune system and a less regulated HPA response could put children 
experiencing chronic early-life stress at greater risk of developing inflammation-based disorders. 
 Early-life adversity is often experienced within the family, as family is the primary 
context for early childhood development.  Family psychosocial factors, including maternal mental 
health and family SES are two areas of exposure to early-life adversity that have been linked to 
biological changes in the NEI network (2,4,8,59–62).   
Maternal mental health    
 A sensitive and attentive adult caregiver is one of the most important protective factors 
supporting child health (13,28).  Maternal mental health is critical for shaping a child’s 
development and laying the foundation for lasting health and well-being (13,28,63,64).  Animal 
studies have shown a potential link between the quality of early-life maternal care and later-life 
immune functioning (50). In rat studies, dysfunctional maternal behavior (early weaning and care 
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by humans, rather than mother rats) is associated with an inflammation-prone immune response 
in offspring (50).  Few studies, however, have examined these effects on the immune system at 
the biologic level in humans. 
 One such study examined the effect of maternal warmth experienced during childhood 
among adults who grew up in low-SES families (65).  The results showed that adults from low 
SES families who reported higher levels of maternal warmth had less expression of 
proinflammatory genes and an attenuated increase in IL-6 to an immune challenge compared to 
adults from low SES families with less warm mothers during childhood (65).  These relations 
were not mediated by current SES, health behaviors, or BMI (65).  These findings support the 
notion that more supportive and caring mothers during childhood can help buffer changes in NEI 
network regulation associated with low childhood SES and illustrate the critical importance of 
maternal factors in child development.  
 Evidence from a recent study of adults illustrates the protective influence of social 
support from stress-related physiologic changes within the NEI network.  Miller and colleagues 
found that glucocorticoids (chemicals similar to cortisol) were less effective regulators of IL-6 
activity in adults experiencing chronic stress compared to adults not experiencing chronic stress 
(chronic stress defined as having a child undergoing treatment for cancer compared to parents of 
medically healthy children) (56).  This stress-related desensitization of the IL-6 response to 
glucocorticoids was mitigated (the IL-6 response was more sensitive to the regulatory effects of 
glucocorticoids) in adults reporting high levels of support from their friends and family members 
(56).  The protective effect of social support was unique to adults experiencing high levels of 
stress and was not seen in adults with low levels of stress (56).  These findings further 
demonstrate the importance of social support in NEI network regulation particularly under high 
stress conditions.   
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 While few studies have examined the influence of maternal factors on NEI network 
regulation specifically, there is strong evidence that maternal mental health is associated with 
changes to HPA regulation in children (66–69).  The direction of these changes, however, 
remains unclear.  While some studies show a positive relation between maternal depression and 
children’s cortisol levels (69,70), maternal mental health has also been associated with decreased 
or more variable cortisol (67,70).  Furthermore, relations between maternal mental health and 
child cortisol may vary by sociodemographic factors (68,71).  Maternal mental health may also 
moderate the association between SES and child cortisol levels (66).  Observed relations between 
maternal mental health and child HPA activity may also reflect combined effects of other related 
adversities, such as low SES, family violence and instability, and poor child care practices (72).  
Furthermore, the impact of maternal mental health on child HPA regulation depends on many 
factors, including the nature and severity of mental health problems, the child’s developmental 
stage, the presence of other buffering factors (e.g., fathers and other caregivers), and the timing of 
the mental health problems (69,72).  Given the range of factors that influence the relation 
between maternal mental health and child HPA regulation, it is not surprising that the effects of 
maternal mental health on child cortisol remains unclear.   
Family socioeconomic status 
 Socioeconomic disadvantage is associated with an increased number of negative life 
events, such as increased residential mobility and instability, disruptive family relationships, and 
witnessing community violence (66-68).  Family SES is often used as a proxy for childhood 
adversity, and studies have found evidence of the biologic embedding of early-life adversities 
related to low family SES in the regulatory pathways of the HPA axis and immune system 
(4,6,55,62,73). 
  Miller and Chen found that low SES during early childhood, particularly at age two, was 
associated with reduced expression of glucocorticoid receptor genes and increased expression of 
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genes related to inflammatory processes in adolescent girls (73).  The effect of early-life SES was 
not mediated by current stress, health behaviors, or BMI (73).  Also, improvements in SES from 
early to late childhood did not mitigate the association between early-life disadvantage and the 
expression of stress and immune-related genes (73).  Similar results were found by a study that 
examined the effect of early-life SES in adults.  In this study, compared to adults who grew up in 
higher-SES families, adults who grew up in low-SES families showed decreased expression of 
genes coding for cortisol receptors and increased expression of genes coding for proinflammatory 
cytokines (55).  Low early-life SES adults also displayed higher daily salivary cortisol and had a 
greater increase in IL-6 to immune challenge than adults from higher SES families (55).  These 
early SES-related differences in physiology remained after controlling for current SES and health 
behaviors (55).  Findings from these two studies support the notion that low-SES in early-
childhood is associated with lasting changes in elements of NEI network regulation at many 
levels of physiology (genetic, cell receptors, cortisol production). 
 Taken together, studies of maternal mental and psychosocial characteristics and family 
SES support the hypothesis that early-life adversity is associated with a patterned physiologic 
response by the CNS and immune system that, when repeatedly activated throughout 
development, may cause biologic changes in the activation and regulation of these systems.  Such 
changes may result in an over-active HPA axis and a poorly-regulated and inflammation-prone 
immune system.  This “defensive phenotype” (55) may put children growing up with family-level 
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Study Design and Methods 
 
3.1. Study Design and the Fetus to Five Study 
 This study used data from the Fetus to Five study.  Fetus to Five is a laboratory-based 
study investigating the influence of maternal psychosocial factors and family socioeconomic 
status (SES) on the development of cognitive, emotional and regulatory processes in children.  
The study protocol was approved by the Johns Hopkins Bloomberg School of Public Health 
Institutional Review Board in 2010 and 2012; the principal investigator was Sara Johnson, PhD 
MPH.     
Participants 
 Fetus to Five recruited mother/child pairs from March 2011 to July 2013.  There were 
two phases of subject recruitment.  Phase 1 data was collected from spring 2011 to summer 2012.  
Phase 1 participants were recruited from a pool of mothers who participated in the Fetal 
Development Study of Dr. Janet DiPietro in 2006-2007 (1).  For phase 1 participants, the Fetus to 
Five study is a five-year follow-up to the Fetal Development Study; mother/fetus pairs studied in 
the 2006/07 Fetal Development Study were recruited to be mother/child pairs in the Fetus to Five 
study.  Fetus to Five collected data from 65% of eligible mother/child pairs from the Fetal 
Development Study. This sample includes 58 mother/child pairs who came into the laboratory for 
a study visit, as well as 18 mothers who participated remotely by email or mail surveys (Figure 
3.1).  The majority of mother participants from phase 1 were middle-class (mean household 
income: $100,000-$150,000) and non-Hispanic white (82% white, 13% African American, 5% 
Asian/Pacific Islander, 4% Hispanic).  At the time of testing, the mean age of phase 1 mothers 
was 37.89 (SD= 4.62) years, and the mean age of phase 1 children was 5.35 (SD= 0.28) years.  
Slightly more than half of phase 1 children were female (59%). Table 3.1 displays demographic 
33 
 
information for the analytic sample (including participants from recruitment phases 1 and 2 for 
whom complete salivary analyte data were available).  
 Since phase 1 participants were from mostly stable middle/high-income families, phase 
2 of Fetus to Five was designed to replicate the study procedures of phase 1 using a community 
sample of five-year-old children and their mothers from lower-income families.  Phase 2 data 
collection was conducted from fall 2012 to summer 2013.  Mother/child pairs were recruited 
through fliers posted in Baltimore City (e.g., at churches, community centers, and markets) and at 
the Johns Hopkins Harriet Lane Pediatric Clinic.  Ninety-three mother/child pairs participated in 
phase 2.  Of these, three were unable to complete the study procedures (one due to language 
barriers, one due to child refusal, and one due to mother refusal; Figure 3.1).  The majority of 
mother participants from phase 2 were low-income (mean household income: $16,000-$24,999) 
and non-Hispanic African American (90% African American,  9% white, 1% Asian/Pacific 
Islander, 5% Hispanic).  At the time of testing, the mean age of phase 2 mothers was 29.64 
(SD=7.04) years, and the mean age of phase 2 children was 5.50 (SD= 0.30) years.  
Approximately half of phase 2 children were female (48%).   





Table 3.1.  Demographic information for the study sample (n=125) by phase of recruitment 
  
Phase 1 (n=45) Phase 2 (n=80) 
Frequency Percent Frequency Percent 
Child age, mean years (SD)* 5.35 (0.28) 5.50 (0.28) 
Child race* 
  White 35 78% 7 9% 
  African American 7 16% 73 91% 
  Asian/Pacific Islander 3 7% 0 0% 
Child ethnicity 
  Hispanic 1 2% 4 5% 
Child sex 
  Female 25 56% 39 49% 
Maternal age, mean years (SD)*  37.89 (4.62) 29.64 (7.04) 
Family income*          
  <$5,000 0 0% 13 16% 
  $5,000-11,999 0 0% 17 21% 
  $12,000-15,999 0 0% 8 10% 
  $16,000-24,999 0 0% 21 26% 
  $25,000-34,999 0 0% 7 9% 
  $35,000-49,999 2 4% 2 3% 
  $50,000-74,999 3 7% 7 9% 
  $75,000-99,999 3 7% 1 1% 
  $100,000-149,999 18 40% 3 4% 
  $150,000+ 19 42% 1 1% 
Maternal education* 
  < High school (HS) 0 0% 8 10% 
  HS/GED 1 2% 32 40% 
  Some college 1 2% 30 38% 
  2-year degree 4 9% 3 4% 
  4-year degree 16 36% 4 5% 
  Masters degree 8 18% 3 4% 
  Doctoral/Professional degree 15 33% 0 0% 
*Difference between phases p< .01.   
SD= Standard deviation; GED= General Equivalency Diploma.  
 
Inclusion and exclusion criteria 
To be included in the Fetus to Five study, phase 1 mothers had to have met the inclusion 
criteria for the Fetal Development Study (being a nonsmoking pregnant mother with a healthy 
singleton fetus; 1) and expressed interest in follow-up studies in 2006/07.  For phase 2, female 
biological mothers or legal guardians of five-year-old children in the Baltimore City-area were 
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eligible for enrollment as mother participants. English fluency was required for mother and child 
participants in both phases of data collection, and all children had to be five-years old.  Also, 
children in both phases were excluded if their mothers reported that they had a significant health 
condition or developmental disability that impaired cognitive, motor, or regulatory functioning 
such as cystic fibrosis, autism, or mental retardation. 
Procedures 
All study visits were conducted on the Johns Hopkins Bloomberg School of Public 
Health East Baltimore Campus.  Figure 3.2 illustrates the Fetus to Five in-lab study procedures 
for child participants. The study visit began with a free play session for the mother and child 
participants to allow the child to acclimate to the study room.  After free play, mothers completed 
a survey, and children participated in a series of behavioral and neuropsychological assessments.  
Children completed the Peabody Picture Vocabulary Test-Fourth Edition (2) and two cognitive 
challenge tasks that tested inhibitory control (the Silly Sounds Game and Pig Game; 3,4). 
Children also participated in three age-appropriate emotional challenge tasks: the Disappointing 
Gift Game, the Not Sharing Game, and Mischel’s Delay of Gratification Task (5). Study sessions 
were video and audio recorded.   
Four saliva samples were collected from both mother and child participants throughout 
the study visit (two samples were collected before emotional stressor tasks and two were 
collected after emotional stressor tasks; see Figure 3.2).  Electrophysiologic data (heart rate and 
skin conductance) were also collected from mothers and children throughout the visit. The 
procedures for phases 1 and 2 were very similar, with minor changes between phases aimed to 
increase participation and completion rates in phase 2. Differences in procedures between the 




Child emotional stressor tasks 
 Children participated in three emotional stressor tasks: the Disappointing Gift Game, the 
Not Sharing Game, and Mischel’s Delay of Gratification Task (5).  The timeline for 
administration of each task relative to the saliva measures is shown in Figure 3.2.  The 
Disappointing Gift Game assessed a child’s response to disappointment (6).  Each child ranked 
six potential gifts (including undesirable items (e.g., a sock)) from favorite to least favorite.  
Approximately 15 minutes later, the child was given his/her least favorite gift.  The child’s 
reaction to the gift was recorded (audio/video and electrophysiologic recording) for one minute. 
This task has been shown to challenge behavioral control and to elicit negative emotions (e.g., 
anger) in young children (6–10).  
The Not Sharing Game is an emotional stressor and test of emotional regulation (11,12).  
In this game, an evaluator unevenly distributed candy between herself and the child.  The child's 
thoughts about the unequal sharing were elicited four times during the game via direct 
questioning (e.g., “Wow! I have a lot more candy than you.  How do you feel about that?”). This 
task has been shown to elicit negative emotions (e.g., frustration) and to increase salivary cortisol 
in young children (12).   
The Delay of Gratification Task is an emotional stressor and test of coping abilities 
(5,11). The child was left alone in the study room with a treat of the child's choosing (either a 
marshmallow or a pretzel).  The child was told that the evaluator must briefly leave the room, and 
he/she was asked to not eat the treat while the evaluator was away.  A bell was placed in front of 
the child, and he/she was told that ringing the bell would bring the evaluator back to the room and 
allow him/her to eat the treat.  However, the child was told that if he/she waited for the evaluator 
to return on her own (without ringing the bell), he/she would be rewarded with two treats.  The 
child was left alone with the treat for eight minutes or until he/she rang the bell.  This age-
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appropriate stressor task has been shown to elicit negative emotions and correlate with inhibitory 
control measures in young children (5,10,13).    
Child anthropometry 
Child height and weight were each measured once by study staff using a wall-mounted 
yard stick and a scale. Body mass index (BMI) was calculated, and weight status categories 
(underweight and healthy weight vs. overweight and obese) were assigned to each child using the 
Centers for Disease Control and Prevention’s BMI percentile ranges by sex and age (14,15).   
Figure 3.2. Fetus to Five study protocol with elapsed time between saliva samples and stressor 
tasks for study sample (n=125)  
 
Parent Survey 
Mothers completed a survey during the study visit that included questions about 
sociodemographic and psychosocial factors for the mother, family, and child participants.  
Psychological instruments were embedded within the survey to assess the mother’s level of 
parenting stress (Parenting Stress Index (PSI; 16)), financial stress, depression (the Center for 
Epidemiological Study of Depression scale (CES-D-20; 17)), and anxiety (the State-Trait Anxiety 
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Inventory (STAI; 18)). Questions about family income and maternal education provided objective 
measures of SES.  The mother was also asked to report her marital status, smoking status 
(yes/no), and the number of times the family moved in the past five years.  Appendix A includes 
portions of the Parent Survey used in the dissertation. 
Saliva Collection and Storage 
Four in-laboratory whole saliva samples were collected using passive drool.  The timing 
of saliva samples was linked to the study tasks completed by the child and therefore determined 
by the length of time the child took to complete the tasks. Each mother synchronized her samples 
with her child’s samples (see Figure 3.2 for average timing of saliva samples and tasks).  During 
each saliva collection, participants drooled into a vial for three minutes or until 0.75 milliliters of 
fluid was collected. Saliva samples were stored at -20 degrees Celsius until assayed.   
Determination of Salivary Analytes 
Saliva assays were performed at the Center for Interdisciplinary Salivary Bioscience 
Research at the Johns Hopkins School of Nursing and the Institute for Interdisciplinary Salivary 
Bioscience Research at Arizona State University. Saliva samples were assayed following Granger 
and colleagues (19) for salivary alpha-amylase (sAA) by kinetic reaction assay. Salivary alpha-
amylase results were computed in U/mL.  For sAA, intra-assay variation (CV) computed for the 
mean of 30 replicate tests was less than 7.5%, and inter-assay variation computed for the mean of 
average duplicates for 16 separate runs was less than 6%. Cortisol was analyzed in duplicate 
using a commercially available enzyme immunoassay without modification to the manufacturer’s 
protocol (Salimetrics, Carlsbad, CA) with a range of sensitivity from .007 to 3.0 µg/dL, and intra- 
and inter-assay coefficients of variation less than 5 and 10% respectively. Salivary cortisol data 
were expressed in micrograms per deciliter (µg/dL).  
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Salivary cytokines were measured following Riis and colleagues (20) using 96-well 
format multiplex electrochemiluminescence immunoassays manufactured by Meso Scale 
Discovery (MSD, Gaithersburg, MD).  Each well was coated with capture-antibodies to IL-1β, 
IL-6, IL-8 and TNFα. Detection antibodies were coupled to SULFOTAGTM labels that emit light 
when electrochemically stimulated via carbon-coated electrodes in the bottom each microwell. 
The MSD 4-plex Multi-Spot Array assay was run following the manufacturer’s recommended 
protocol without modification. Cytokine concentrations were determined with MSD Discovery 
Workbench Software (v. 3.0.17) using curve fit models (4-PL with a weighting function option of 
1/y2). Lower limits of detection (LLD) and intra-assay coefficients of variation (CV) were: IL-1β 
(0.06 pg/mL, 4.4%), IL-6 (0.09 pg/mL, 4.8%), IL-8 (0.05 pg/mL, 2.1%) and. TNFα (0.11 pg/mL, 
6.6%). For all analytes, concentrations below the assay’s LLD were estimated by the saliva 
processing laboratory using the curve model for the plate.  
Associations between sAA and cytokine concentrations and salivary flow rate were tested 
using Spearman’s rank correlations and regression analyses with robust variance.  No consistent 
associations between flow rate and raw analyte concentrations were found, so data were not 
adjusted for salivary flow rate (21). Due to the timing of subject recruitment and saliva laboratory 
processing, the effect of batch (i.e., assay plate assignment) was confounded by phase effects in 
these data and could not be fully examined (although laboratory estimates of inter-assay CV were 
within the acceptable range).    
3.2. Study Sample  
 This study uses data from the 125 mother/child pairs that had complete salivary analyte 
data for child participants in the Fetus to Five study (Figure 3.1). This number includes 45 
mother/child pairs from phase 1 and 80 pairs from phase 2.   
Phase 1: Remote vs. On-site Participants 
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 Fetal Development Study participants from 2006/07 who were interested in participating 
in Fetus to Five in 2011/12, but were unable to participate on-site were offered remote 
participation via mail and email. No saliva data were collected for remote participants.  Eighteen 
phase 1 subjects participated remotely.  On average, on-site and remote participants for phase 1 
were similar in terms of child sex, race, ethnicity, current sickness and periodontal problems, and 
maternal age, smoking, education and marital status and family income. Remote child 
participants were older than on-site participants (t(74)=-3.43, p< .01), because the age enrollment 
criterion for children (i.e., 5 years of age) was relaxed for remote participants since no biologic 
data were collected remotely.  
Sample With and Without Full Salivary Analyte Data 
 All children who participated in complete study appointments on-site (n=148) provided 
saliva samples.  However, 23 children had incomplete salivary analyte data due to insufficient 
saliva volume for processing (n= 9), contamination during the saliva processing (n=2), or use of 
an alternate saliva collection method (salivette) that did not allow for cytokine analysis (n=12).   
There were no differences between children with (n=125) and without full salivary analyte data 
(n=23) in terms of age, sex, race, ethnicity, current sickness or periodontal problems, recent 
health, body mass index category, maternal age, smoking, education or marital status, family 
income, or the timing of study tasks relative to saliva samples. Overall, children with full analyte 
data were awake for longer when the study appointment began compared to those without full 
analyte data (t(146)=2.00, p< .05).  Differences in time since waking are important given the 
circadian pattern of salivary cortisol.  Within study phase, there were no differences between 
children with and without full analyte data for any sociodemographic or health factor, and there 
were no within-phase differences in time since waking.  
Phase 1 vs. Phase 2: Demographic and Health Characteristics 
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Phase 2 of subject recruitment was designed to diversify the phase 1 sample of stable 
middle/high socioeconomic status (SES) families.  As such, there were significant differences 
between the phases for sociodemographic variables (see Table 3.1.).  Compared to phase 1 
mothers, phase 2 mothers were younger (t(123)=7.05, p< .001), and they were less likely to be 
married (χ2(1)=73.25, p< .001) and more likely to smoke (χ2(1) =16.47, p< .001).  Phase 2 was 
majority African American, while phase 1 was majority white (χ2(1)=61.51, p< .001), however, 
participants in both phases were majority non-Hispanic.  Phase 2 mothers had less education 
(χ2(7)=85.79, p< .001) and lower family incomes (χ2(9)= 74.50, p< .001). 
Overall, there were no differences between children in phase 1 and 2 in terms of sex, 
current sickness and periodontal problems, and measures of recent health. The timing of study 
tasks relative to saliva samples was similar for phases 1 and 2. Although all children were five 
years old, phase 2 children were older than phase 1 children (t(123)= -2.95, p< .01; Table 3.1), 
and phase 2 children were also more likely to be overweight/obese than phase 1 children 
(χ2(1)=25.10, p< .001). Also, children from phase 2 were, on average, awake for longer when the 
study appointment began compared to phase 1 children (t(123)= -4.23, p< .001).   
3.3. Salivary Analyte Non-detects and Duplicate Data  
Salivary biomeasure data from children were examined in this study.  Cytokine testing 
was performed with 15% duplicates, and the average of the duplicate measures was used as the 
raw concentration.  Eight microplates were used to test child saliva samples for cytokines, and the 
LLD varied by microplate and cytokine. Of the 500 samples (4 samples each for 125 children), 
there were three non-detected samples of IL-6 and 25 of TNFα.  Non-detects were estimated by 
the laboratory using the fit curve.  Two of the non-detects were estimated as zero by the 
laboratory (one for IL-6 and one for TNFα).  All samples of IL-1β and IL-8 were measureable 
above the LLD.   
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Alpha-amylase was tested in singulate with 30 duplicate tests for intra-assay validity 
calculations (duplicate assays run on the same plate). When assayed in duplicate, the mean of the 
two values was used as the raw concentration. The LLD for alpha-amylase was 0.4 U/mL for all 
microplates. One sAA concentration was below the LLD and was estimated as zero by the 
laboratory. Cortisol was tested in duplicate (i.e., all samples measured twice). The average of the 
duplicate measures was used as the raw concentration for each sample.  The LLD for cortisol was 
0.007 µg/dL for all microplates. Thirty-eight non-detects (7.6%) were estimated by the laboratory 
for cortisol, and nineteen of these values were estimated as zero.   
3.4. Study Aim 1 Variables and Analytic Methods 
Variables 
Study aim 1 explored current salivary analyte pre-analytic data processing techniques and 
their implications for data quality, and the validity and reliability of study findings.  TNFα and 
cortisol data from the study sample of 125 five-year old children were used to demonstrate the 
impact of different pre-analytic data processing methods on analyte mean levels by sex.  Sex 
differences in mean TNFα and cortisol were compared when data were subjected to different, 
commonly used pre-analytic processing techniques. Child sex was based on maternal report.    
Exploratory Data Analysis and Missing Data 
 Salivary analyte data displayed a strong positive skew. Multiple non-linear 
transformations (inverse, cubic, inverse cubic, square, inverse square, squared-root, inverse of the 
squared-root, and natural log) were tested for each analyte.  The natural log transformation was 
applied to both analytes, because it provided the least skewed distributions (zero values were 
handled in various ways to allow for the data transformation, discussed below).  To allow for the 
comparison of results using data subjected to different pre-analytic data processing decisions, no 
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data used in study aim 1 were Winsorized, meaning outlying data points were included as 
measured. There were no missing child sex data.   
Pre-analytic Processing of Analyte Data and Statistical Analyses 
  The purpose of study aim 1 analyses was to demonstrate the impact of different pre-
analytic data processing methods on salivary analyte data and analyte mean levels by child sex.  
Therefore, the main statistical analyses for study aim 1 were pre-analytic data processing 
methods.  Analyses included comparing five methods for handling censored data (non-detects) 
and four methods for handling non-real zero values.  Sex differences in raw mean cortisol 
concentrations were compared when non-detects were: 1) dropped from the data; 2) replaced with 
half the LLD; 3) replaced with the LLD; 4) included as censored points in Tobit regression 
models with robust variance; and 5) included as censored points in quantile regression.  These 
comparisons illustrate the impact of different methods for handing censored data on group means, 
including commonly employed and simple substitution methods, as well as less commonly used 
regression models designed for censored data (Tobit models) and non-parametric modeling 
approaches (quantile regression). There are currently no universally-accepted best practices for 
handling zero values in salivary analyte data, accordingly, sex differences in mean log-
transformed TNFα and cortisol were compared when: 1) two was added as a constant to all raw 
data points to eliminate zero values; 2) 0.001 was added as constant to eliminate zero values; 3) 
zero values were replaced with 0.0001; and 4) zero values were dropped from the data.  These 
comparisons illustrate how typically-employed techniques for handling zero values in salivary 
analyte data impact analyte group means.  For these analyses, laboratory-estimates of all censored 
data were used.   




Study aim 2 tested three hypotheses regarding salivary cytokines (IL-1β, IL-6, IL-8 and 
TNFα) in five-year old children: 1) salivary cytokine activity is positively intercorrelated across a 
series of cognitive and emotional challenge tasks; 2) salivary cytokine activity is positively 
associated with oral health issues and unrelated to demographic and systemic health factors; and 
3) salivary cytokines are positively associated with ANS activity and negatively associated with 
HPA activity.  The dependent variables were the four salivary cytokines across the four saliva 
samples. 
Early data processing of salivary cytokines  
Laboratory-estimated concentrations of non-detects for IL-6 and TNFα were included in 
the data. All cytokine data distributions were very positively skewed (range across the four 
samples (skew, kurtosis) for IL-1β: 3.07-6.23, 14.68-51.50; IL-6: 3.40-6.47, 15.04-52.87; IL-8: 
2.57-4.77, 10.60-30.98; TNFα: 4.16-8.90, 24.29-88.87).  Similar to other studies using salivary 
analyte data, cytokine data were log-transformed and Winsorized to adjust for a small number of 
outliers (22). To allow for log-transformation, zero values were replaced with 0.0001.  
Winsorization was performed by cytokine and saliva sample separately for 0.6% of ILβ-1, 0.6% 
of IL-6, 0.8% of IL-8, and 1.0% of TNFα concentrations.  Individual trajectories across saliva 
samples were maintained during the Winsorization process.  All values were Winsorized within 
three standard deviations of the mean. Winsorization and transformation improved the 
distribution of the analytes (range across the four samples (skew, kurtosis) for IL-1β: 0.28-0.48, 
2.77-3.36; IL-6: 0.35-0.63, 2.88-3.34; IL-8: 0.27-0.63, 2.70-3.94; TNFα: -0.20-0.44, 3.42-3.85). 
Independent Variables 
Study aim 2 examined the relations between cytokine concentrations and activation of the 
ANS and HPA axis (indexed by sAA and cortisol, respectively), as well as demographic and 




Markers of ANS and HPA activation 
Early data processing:  Laboratory-estimates of non-detected values of sAA and cortisol were 
used.  Alpha-amylase and cortisol displayed strong positive skews (range across the four samples 
(skew, kurtosis) for sAA: 1.96-4.13, 7.95-29.52; cortisol: 2.26-12.00, 4.37-10.97), so data were 
log-transformed.  To allow for transformations, zero values of sAA and cortisol were replaced 
with 0.0001.  After transformation, sAA and cortisol data were Winsorized by analyte and 
sample.  Twenty-two cortisol values (4.4%) were Winsorized to be within 3.7 standard deviations 
of the mean.  Ten sAA values (2.0%) were Winsorized to be within three standard deviations 
from the mean. Individual trajectories were maintained during the Winsorization process. 
Winsorization and transformation improved the distribution of the analytes (range across the four 
samples (skew, kurtosis) for sAA: -0.61- -0.33, 3.28-4.56; cortisol: -1.81- -1.03, 4.72-6.55). 
Health and demographic data  
Information about health and demographic variables included in study aim 2 is shown in 
Table 3.2. Child height (inches) and weight (pounds) were used to calculate body mass index 
(weight (lb.) / [height (in)] 2 x 703), and weight status (underweight or healthy weight vs. 
overweight or obese) was assigned to each child using the Centers for Disease Control and 
Prevention’s age- and sex-specific criteria (14,23).   
Maternal smoking, child race, child medication use, child oral health problems, and child 
health were based on maternal report on the Parent Survey.  Mothers listed all prescription and 
over-the-counter medications taken by her child in the two days prior to the study visit.  Two 
dummy variables coding for use of any medication, and use of allergy and asthma medication 
were created.  Current child periodontal/dental issues were assessed with the question “Does your 
child currently have any dental problems such as cuts or sores in his or her mouth, very loose 
teeth, a tooth lost in the last 48 hours, bleeding gums while brushing, or untreated cavities?” 
(yes/no).  Child current illness was assessed with the question “Is your child currently feeling sick  
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Table 3.2.  Study aim 2 demographic, health, and timing variables 






mother “What is your child's birthday” 
Child sex 
Dichotomous:  
male, female Parent Survey 





white Parent Survey 
“How would you describe your child’s 
race? (Check all that apply)?” 
(White/Black or African 
American/Asian or Pacific Islander/ 
Native American or Alaskan 
Native/Other, please specify) 









of child height  
& weight  
Child currently sick 
Dichotomous:  
yes, no Parent Survey 
“Is your child currently feeling sick or ill 
(i.e., runny nose, fever, cough aching, 
etc.)?” (yes/no) 
Child recent health 
Dichotomous:  
excellent-good, 
fair/poor Parent Survey 
“Compared to others his or her age, 
would you say your child's health in the 
last 2 days (48 hours) has been:” 
(excellent/very good/good/fair/poor) 
Child taken any 
medicine in last two 
days 
Dichotomous:  
yes, no Parent Survey 
“Has your child taken any prescription 
or over-the-counter medications in the 
last 2 days (48 hours)?" (yes/no); If yes, 
please list the names of these 
medications:” 
Child taken allergy/ 
asthma medicine in 
last two days 
Dichotomous:  
yes, no Parent Survey 
Child current oral 
health issues 
Dichotomous:  
yes, no Parent Survey 
“Does your child currently have any 
dental problems such as cuts or sores in 
his or her mouth, very loose teeth, a 
tooth lost in the last 48 hours, bleeding 





yes, no Parent Survey “Do you smoke cigarettes?” (yes/no) 







“What time did your child wake up this 
morning? (Please write the hour, minute, 
and whether this was AM/PM)” 





notes & video 
recording of 
study session  
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or ill? (e.g., runny nose, fever, cough, aching, etc.)” (yes/no), and recent health was assessed with 
the question “Compared to others his or her age, would you say your child's health in the last two 
days (48 hours) has been: (responses: excellent; very good; good; fair; poor)”.  Recent health 
categories were dichotomized to compare children with excellent to good health to those whose 
mothers reported their health to be fair or poor.  Child race was reported by mothers and data 
were dichotomized (white vs. non-white), because of a low percentage of Asian/Pacific Islanders 
in the sample (see Table 3.1.). 
Timing data 
The impact of potential circadian patterns in cytokine levels was examined using the 
elapsed time from waking to the study appointment.  Elapsed time from waking was calculated 
using maternal report of child’s wake time and the study visit start time for each child.  A task 
timing variable, defined as the elapsed time from the Disappointing Gift Part 2 task and each 
saliva sample, was used to account for the differential timing of emotional stressor tasks across 
child participants. 
Analytic Methods 
Exploratory data analysis 
 Exploratory data analysis examined the distributions and means of all continuous 
variables and frequency distributions of all categorical variables. These analyses tested the 
normality of continuous variables and informed the dichotomization of categorical variables. 
Multiple non-linear transformations (inverse, cubic, inverse cubic, square, inverse square, 
squared-root, inverse of the squared-root, and natural log) were tested for each analyte.  The 
natural log transformation was selected for all analytes, because it provided the least skewed 




 Missingness was examined for each variable.  There were low rates of missing data for 
most variables due to incomplete survey responses or staff omissions (missingness ranged from 
0-2.4% for all variables except child age). Parent-reported child age in months was missing for 
8.8% of the sample. Missing data for age, BMI, sample and stressor times, time since waking, and 
survey data were obtained from evaluator’s notes and video recordings of study appointments 
(16% of the missing data) or imputed using mean values (84% of missing data).    
Statistical analyses 
 T-tests and Pearson correlations were used to examine differences in task timing (i.e., 
elapsed time from Part 2 of the Disappointing Gift Game to saliva samples) by age, sex and 
health factors.  Paired t-tests examined changes in sAA and cortisol across samples and 
differences between cytokine concentrations at each sample.  To test the first hypothesis (i.e., 
salivary cytokines are positively intercorrelated), intercorrelations among cytokines at each 
sample were examined using Pearson correlations and a principal components analysis.  For each 
set of t-tests and Pearson correlations, tests of statistical significance were two-sided with an 
alpha of .05, and Bonferroni-corrected alpha levels (.05/number of tests) were also examined. 
 The second hypothesis was that salivary cytokine activity is positively associated with 
oral health and unrelated to demographic and systemic health. To test this hypothesis, multilevel 
mixed models examined associations between cytokines and demographic and health factors. 
Each cytokine was modeled separately as an outcome with robust variance. Models included a 
random intercept and an autoregressive (AR-1) residual error matrix to account for the correlation 
of sample concentrations within children and correlated errors across samples. The association 
between each cytokine and each demographic and health factor was examined separately in 
models adjusted for the task timing variable. Variables associated with cytokines at p≤ .1 were 
selected as covariates in fully adjusted models for each cytokine. Sample size restrictions required 
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model parsimony to avoid overfitting, therefore, backwards stepwise regression with a retention 
threshold of p< .05 was used to create parsimonious adjusted models for each cytokine.  
  The nonlinearity of the cytokine concentrations across the study visit was examined 
using a spline knot to explore the extent and nature of task-related change in cytokine levels. 
With no a priori hypotheses about the timing of task-related change in cytokine levels, the 
appropriateness of a knot placed at sample 2 or 3 in both null and parsimonious adjusted models 
was tested.  Spline models used a parameterization describing the intercept, slope over the first 
samples (sample 1-2 or sample 1-3) and the slope over the last samples (sample 2-4 or sample 3-
4), rather than the slope over the first samples and the deviation of slope over the first vs. last 
samples. Differences between slope terms were examined using post-estimation tests, and 
significant differences suggested a task-related change in cytokine slope beginning at the spline 
knot.  For each cytokine, log likelihood estimates were used to select the most appropriate model 
(spline model with knot at sample 2, spline model with knot at sample 3, or linear model).   
 The third hypothesis was that salivary cytokines are positively associated with ANS 
activity and negatively associated with HPA activity. To test this hypothesis, sAA and cortisol 
were added separately as independent variables to the final model for each cytokine.  Based on 
literature that suggests that the NEI relations may vary by sex, the interaction between sex and 
sAA or cortisol on each cytokine was examined (24,25).   
Checks of model fit and sensitivity analyses 
 Model fit was assessed for each final model using residual plots and added variable plots 
(added variables plots were perfomed using simple linear regression that ignored the nested 
nature of the data).  Influential points were identified and models were performed without 
influential cases to test the robustness of the findings. Additional sensitivity analyses were 
performed on complete case data to test the impact of data imputation methods.  Sensitivity 
analyses also examined the interaction between each covariate and each cytokine reactivity slope 
50 
 
or overall trajectory (slope from sample 2-4 or 3-4, or overall trajectory from sample 1-4). The 
only significant effects were seen for TNFα which had a non-significant positive slope from 
sample 2-4 that was steeper for older children and less steep slope for children of smoking 
mothers.  The findings for TNFα from these models were similar to those without the covariate 
by slope interaction terms. The robustness of sAA and cortisol findings was tested by including, 
along with sAA or cortisol, all relevant and statistically significant health and demographic 
covariates for sAA and cortisol in final models.  Furthermore, to examine the nature of sAA and 
cortisol effects on cytokine levels, the individual mean and trajectory effects of sAA and cortisol 
were examined simultaneously as separate terms in each final model.  These models revealed no 
significant difference between individual mean and trajectory effects of either sAA or cortisol.  
Therefore, final models tested cytokine relations with sAA and cortisol as single combined 
effects.  
 To assess the impact of censoring in the cortisol data and the laboratory-estimated 
values used to replace the non-detects, final models were performed using a substitution method 
for cortisol non-detects (i.e., replace non-detects with half the LLD (0.0035 µg/dL)). Also, 
random effects Tobit models with bootstrapped variance were performed for each final model 
with the cytokine and cortisol variables swapped, so that cortisol was the dependent variable and 
cytokines were the independent variables (in separate models).  This approach allowed for the 
specification of a single lower limit of censoring (i.e., the natural log of the LLD of the cortisol 
assay (-4.961845)) in Tobit models.   
3.6. Study Aim 3 Variables and Analytic Methods  
Dependent Variables 
 Study aim 3 examined the role of maternal psychological well-being in modifying the 
relation between HPA and immune system activity in the oral cavity.  The dependent variable 
was cortisol concentrations at the four saliva samples. 
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Early data processing of salivary cortisol 
 Substitution methods were used to handle censored cortisol values. The 38 non-detected 
cortisol values (7.6%) were replaced with half the LLD of the cortisol assay (0.0035 µg/dL).  
Cortisol data were very positively skewed (range across the four samples (skew, kurtosis): 1.13-
2.27, 4.37-11.02).  To improve the normality of the distribution, data were log-transformed.  
Three data points from one outlier were Winsorized so that all values were within three standard 
deviations of the sample mean.  The individual’s cortisol trajectory across the study visit was 
maintained during the Winsorization process. Winsorization and transformation improved the 
distribution of the data for the full sample (range across the four samples (skew, kurtosis): -1.20- -
0.84, 3.04- 4.64). 
Independent Variables 
Study aim 3 examined the modifying role of maternal psychological well-being in the 
relation between cortisol and cytokine activity.  The main independent variables were the 
cytokine concentrations at the four saliva samples, a factor score indexing maternal distress, and 
the interaction between each cytokine and the maternal distress factor score. A factor score of 
family financial hardship was included as a covariate, so that the effect of maternal distress could 
be examined after adjusting for financial factors.  In addition, fully-adjusted models tested the 
influence of health and demographic covariates, as well as a measures of circadian rhythm and 
elapsed time between samples. Statistically significant covariates were retained in the final 
models. 
Salivary cytokines 





Maternal distress and family financial hardship 
 Maternal psychological well-being and family financial hardship were indexed by 
composite scores generated from a factor analysis of eight variables related to maternal mental 
and psychosocial health and family SES (detail follows). Table 3.3 shows the variables included 
in the factor analysis.  Family income in the last 12 months, maternal education and marital 
status, and the number of moves in the child’s life were assessed with questions on the parent 
survey.  Instruments embedded within the parent survey were used to create the other four 
variables used in the factor analysis, including: 1) maternal financial stress; 2) maternal 
depressive symptoms; 3) maternal anxiety; and 4) maternal parenting stress.  
 Maternal financial stress was measured using a six item instrument adapted from Essex 
and colleagues (26) assessing the frequency of financial stressors in mothers’ lives in the last 3 
months including difficulty paying bills, thoughts about money problems, fears of losing her 
home and job, and feelings of limited opportunities due to finances. Each item was scored on a 
five point Likert scale from “never” to “always” with higher scores indicating more financial 
stress. The sum score of the six items was used as a measure of maternal financial stress.  
 Maternal depressive symptoms in the last week were measured using the Center for 
Epidemiologic Studies Depression Scale (CES-D; 17).  The CES-D is a 20 item scale.  Each item 
is scored on a Likert scale from “rarely or none of the time” (score of 0) to “most or all of the 
time” (score of 3) with higher scores indicating more depressive symptoms. The sum CES-D 
score was used to index maternal depressive symptoms. 
 Maternal trait-anxiety was measured using the Speilberger State-Trait Anxiety 
Inventory-Form Y2 (STAI; 18). The STAI has 20 items. Responses range from “almost never” 
(score of 1) to “almost always” (score of 5) with higher scores associated with more anxiety.  The 
sum STAI score was used to index maternal anxiety.  
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Table 3.3.  Family SES and maternal mental and psychosocial health variables used in factor 
analysis for aim 3 
Variable Variable Type 
Data 
source 
Question or Instrument 
Family income Categorical:  
<$5,000- 11,999, $12,000- 





"For the past 12 months, which category 
best describes your total combined 
family income?  Include income before 
taxes and from all sources. (Ex. wages, 
rent from properties, social security, 
disability, veteran’s benefits, 
unemployment benefits, worker’s 
compensation, help from relatives, child 
support payments, alimony, etc.)" (12 





<HS, HS /GED, some 
college, 2-year college, 4-
year college, masters, 
doctoral or professional  
Parent 
Survey 
"What is the highest level of education 
you have completed?" (<HS/HS or 
GED/Some College/2-year College 
Degree/4-year College Degree/Master’s 
Degree/ Doctoral Degree/Professional 




married, not married 
Parent 
Survey 







Right-censored continuous Parent 
Survey 
"Since this child was born, how many 
times have you moved to a different 























Parenting Stress Index (Short Form) 
HS=high school; GED=general educational development degree; JD= juris doctor; MD=medical doctor. 
   
 Maternal parenting and life stress was measured using the Parenting Stress Index (PSI; 
16). Phase 1 mothers completed the PSI Long-form and phase 2 mothers completed the PSI 
Short-form. Both forms include Likert scale response-type and multiple choice questions, and 
higher scores indicate higher levels of parenting and life stress.  The correlation between total 
scores on the Long and Short-form PSI is 0.94 (16), and the PSI Short-form is a subset of Long-
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form items. Both forms of the PSI have subscales that measure different domains of parent and 
life stress; domain scores can be summed to create a total stress score for each form.  PSI Short-
form total scores were calculated for each participant to index parenting stress.  
Interaction between cytokine concentrations and early-life adversity factor score 
 The main independent variable in study aim 3 analyses was the interaction term for 
salivary cytokine concentrations by maternal distress factor score. This term represents the 
moderating effect of maternal psychological well-being on the relation between cytokine and 
cortisol activity. 
Key covariates: health, demographic and timing data 
 The health, demographic, and timing variables examined in study aim 2, except for child 
race, were used in study aim 3 as potential covariates (see Table 3.2).  Child race was not 
assessed as a potential covariate because race and SES/adversity are highly correlated in this 
sample.  In addition to these 11 covariates, interaction terms for time since waking by saliva 
sample and child sex by cytokine concentrations were included in fully-adjusted models based on 
findings from the literature suggesting a blunted cortisol response to stress in the morning vs. 
afternoon (27) and sex-related differences in salivary cytokine activity (24,25,28). 
Analytic Methods 
Exploratory data analysis 
In addition to the exploratory data analysis for salivary cytokine, demographic, health and 
timing data performed for study aim 2, the distributions and means of family SES and maternal 
mental and psychosocial health variables (Table 3.3) were examined.  These analyses examined 




 The missingness methods employed for study aim 2 were used in study aim 3 for all 
demographic, health, and timing variables. Before using family SES and maternal mental and 
psychosocial health variables, missingness was also examined for these variables. There were no 
missing data for maternal education, marital status, or the number of moves during child's life. 
Family income data were incomplete for 10.4% of the study sample. All incomplete data for 
family income were from phase 2 participants with seven missing responses and seven 
participants selecting the “Don’t know” response option.  “Don’t know” responses and missing 
data were substituted with the mean family income for phase 2 ($16,000-$24,999/year). 
Item-level missingness on instruments:  Item-level missingness for each of the instruments 
(financial stress index, CES-D, STAI, PSI) was examined and imputed before instrument sum 
scores were used in factor analyses.  Financial stress data were missing for 6.4% of the study 
sample.  While all missing data for this measure were from phase 2 participants, no participant 
was missing more than one item.  CES-D data were incomplete for 9.6% of the study sample (two 
phase 1 participants, and 10 phase 2 participants). Only one participant was missing more than 
one item on the CES-D.  STAI data were missing for 16% of the study sample (one phase 1 
participant, and 19 phase 2 participants), but only two participants were missing more than one 
item. Missing items on the financial stress index, CES-D and STAI were imputed with the mean 
score of the completed items.   
The PSI Short-form items were incomplete for 17.6% of the study sample.  A survey 
formatting error resulted in 14 phase 1 participants missing one item from one of the PSI 
subscales, and two of these participants were also missing one item from another PSI subscale.  
Eight phase 2 participants were missing items on the PSI, however only one participant was 
missing more than one item per subscale.  Missing items on the PSI were imputed with the mean 




Factor analyses: Polychoric exploratory factor analysis (EFA) was conducted with the eight 
family SES and maternal mental and psychosocial health variables (Table 3.3) using maximum 
likelihood estimation with robust standard errors, oblique (geomin) rotation, and one to four 
factors.  Continuous variables were standardized before use in the EFA and the number of times 
the child moved was specified as a continuous right-censored variable.  A two factor solution was 
selected based on information criteria, factor loadings, and residual variances (Akaike and 
Bayesian Information Criteria (AIC, BIC) and sample-size adjusted Bayesian Information 
Criteria: 1 factor= 2450.34, 2532.36, 2440.65; 2 factor= 2306.05, 2407.87, 2294.03; 3 factors= 
2303.65, 2422.44, 2289.63; 4 factors= 2311.55, 2444.49, 2295.86).  The three-factor pattern had 
low residual variances and the same loading pattern as the two-factor solution except with an 
additional third factor comprised of only one variable (moves during child’s life). The two-factor 
pattern had low residual variances for each input variable (residual variance ranged from 0.10- 
0.62), and oblique rotation resulted in two factors with correlation=0.57 (p< .001). Factor 
loadings indicated one factor represented financial hardship and the other factor represented 
maternal distress (see Table 3.4).  Factor scores, derived using the posterior mode method, 
provided a score for financial hardship and maternal distress for each child.  Higher financial 
hardship scores indicated lower family SES and higher maternal distress scores indicated poorer 
maternal psychological well- being. Financial hardship and maternal distress factor scores were 




Multilevel mixed models for cortisol:  Cortisol was modeled as an outcome using multilevel 
mixed models with robust variance, a random intercept, and a random slope to account for 
repeated sampling within individuals and varying cortisol trajectories across the study visit 
between individuals. An independent covariance and residual errors structure were specified, and 
the residual variance was modeled separately for each saliva sample to allow for unequal variance 
across samples.  Model specification was informed by examination of the model AIC/BIC 
estimates as well as theoretical considerations given the study’s reactivity paradigm and expected 
variation in cortisol stress responses across children.  
 Separate multilevel mixed models assessed the relation between cortisol and each of the 
11 health, demographic, and timing variables.  The relation between cortisol and each potential 
covariate was also assessed in separate multilevel mixed models adjusted for each cytokine.  
Statistically significant and conceptually important variables were retained for use in fully-
adjusted models.  Four separate fully-adjusted models for cortisol were performed, each with only 
one cytokine as a predictor.  Table 3.5 displays the variables included in the fully-adjusted and 
Table 3.4.  Factor loadings and parameter estimates from factor analyses with a two-factor 
solution for family SES and maternal mental and psychosocial health variables 
Variable 











Family income in last 12 months .95* .93** .00  
Maternal education .75* .82** .13  
Maternal marital status 1.04* .89** -.23  
Number of moves in child’s life .59* .61** .04  
Financial stress .51* .68** .30*  
Maternal CES-D score .08  .86* .90** 
Maternal STAI score .00  .89* .89** 
Maternal PSI score -.20*  .74* .62** 
 
EFA= exploratory factor analysis; CES-D= Center for Epidemiologic Studies Depression Scale; STAI= Speilberger 
State-Trait Anxiety Inventory-Form Y2; PSI= Parenting Stress Index- Short Form.  Bolded factor loadings indicate 
factor structure used in to generate factor scores. Factor loadings are rotated and parameter estimates are 
standardized.  





final models for each cytokine model. The main independent variables in fully-adjusted models 
were: the cytokine of interest, the maternal distress factor score, and the interaction between 
cytokine concentrations and the maternal distress factor score (Table 3.5). Health and 
demographic covariates in fully-adjusted models included: child age, sex, BMI category, current 
sickness and oral health issues, maternal smoking status, family financial hardship factor score, 
the time from child waking to appointment start time, the elapsed time from stressor task to saliva 
sample, and the interactions between time from waking and sample, and between cytokine and 
child sex1 (Table 3.5).  Four parsimonious final models were created by subjecting fully-adjusted 
models to backwards stepwise selection of covariates using a p< .05 retention criterion. The main 
independent variables were retained for use in the final models and not subjected to the selection 
procedures. 
 In addition to controlling for the family financial hardship factor score, post-hoc models 
examined the specificity of the modifying effect of maternal distress on the cytokine-cortisol 
relation by testing the significance of a cytokine by family financial hardship interaction term in 
final models with maternal distress included as a covariate. 
Checks of model fit and sensitivity analyses 
 Model fit was assessed for each final model using residual plots and added variable plots 
(added variables plots were perfomed using simple linear regression that ignored the nested 
nature of the data). Influential points were identified, and models were fit without influential 
cases to test the robustness of the findings.  The robustness of the interaction between cytokine 
concentrations and maternal distress was scrutinized by using a three-level categorical maternal 
                                                          
1 Maternal smoking status, time from waking to appointment, child current sickness and BMI category were 




distress variable instead of the continuous factor score.  The distributions of model residuals by 
interaction terms were also examined.    
Table 3.5. Variables included in fully-adjusted and final models for aim 3 










Dependent Variable:  
Cortisol  Cortisol Cortisol Cortisol Cortisol 
Main Independent Variables:  
Cytokine concentration IL-1β IL-6 IL-8 TNFα 
Maternal distress factor score      
Cytokine by maternal distress     
Covariates:  
Sample     
Child age         
Child sex     
Child sex by cytokine     
Child body mass index category        
Child currently sick     
Child current oral health issues         
Maternal smoking status         
Family financial hardship      
Time since waking     
Time since waking by sample     
Task timing         
= Included in final model 
    
    
 To assess the impact of substitution methods for censored cortisol data, final models 
were performed using an alternate substitution (i.e., the LLD (0.007 µg/dL)), as well as using 
laboratory estimates of cortisol values below the LLD (with zero values replaced with 0.0001).  
Also, random effects Tobit models with a lower limit of censoring set at the natural log of the 
LLD of the cortisol assay (-4.961845) and bootstrapped variance were performed.   
 Sensitivity analyses also tested the use of individual maternal distress and family 
financial variables in final models instead of factor scores.  The impact of imputation methods for 
missing data was also assessed in sensitivity analyses performed on complete case data. 
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Furthermore, to examine the nature of cytokine effects on cortisol levels, the individual mean and 
trajectory effects of each cytokine were examined simultaneously as separate terms in each final 
model.  These models revealed no significant difference in the individual mean and trajectory 
effects of any cytokine, therefore final models tested cortisol relations with cytokines as single 
combined effects. 
3.7. Statistical Software 
 All analyses, except factor analyses performed for aim 3, were conducted in Stata/SE 
12.1 (StataCorp LP, College Station, TX).  Factor analyses and factor score computations for aim 
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Pre-Analytic Considerations and Best Practices for Studies Involving Salivary Analyte Data 
 
4.1. Abstract 
Objective: This review discusses the methodological challenges and pitfalls in salivary analyte 
data analysis.  The paper focuses on pre-analytic data processing procedures that are essential for 
data validity and reliability, but are rarely described in the literature, including: flow-rate 
adjustments, censored data points, and data transformations.  
Methods: A review of in-laboratory and pre-analytic data processing steps is presented. 
Techniques for addressing data processing and analytic challenges drawn from current salivary 
analysis studies and literature from other fields encountering similar issues are then discussed. 
Finally, the impact of different pre-analytic methods choices on data parameters and study results 
is illustrated using sample salivary analyte data. 
Results:  A set of best practice recommendations is proposed to improve validity, reliability, 
precision, and across-study consistency in the pre-analytic phase of salivary analyte data analysis. 
Conclusions: Salivary biomeasures present exciting opportunities for advancing health research 
and interdisciplinary studies examining mechanisms linking brain, behavior, and health.  To 
maximize this potential, this paper highlights the need for researchers to discuss pre-analytic data 
processing choices and methods, and for collaboration across multiple fields to establish a set of 




4.2. Introduction  
Multidisciplinary biobehavioral research is critical to enhancing the understanding of 
health and development of children. In their strategic plans, the National Institutes of Health 
tasked investigators to advance the use and development of cross-systems biologic data for 
disease screening, diagnosis, and treatment, as well as monitoring normative development and 
aging (e.g., 1).  With a national focus on transdisciplinary biobehavioral research intensifying, a 
growing number of investigators are incorporating biologic data collection and analysis into their 
studies.   
Saliva offers a minimally-invasive, safe, accurate, time- and cost-efficient, and 
ecologically valid method for obtaining biologic data (e.g., 2). Analytes and biomarkers in oral 
fluids are advancing research on the mechanisms underlying cognitive function, behavior, 
emotional and mental disorders (e.g., 3,4), as well as the biomonitoring of environmental 
exposures and stress (5,6). Within the past 20 years, collection devices and assay reagents 
specifically designed for saliva have become commercially available and widely accessible.  With 
minimal training, research participants and patients can self-collect, handle, transport and store 
saliva specimens. Using saliva, researchers are able to collect repeated samples and assay 
multiple analytes per sample without high participant burden.  
There are methodological challenges associated with the collection, handling, transport, 
and assay of saliva as a research specimen. These challenges, and strategies to address them, are 
well-documented and extensively discussed in the literature (2).  This paper draws attention to 
more subtle challenges beginning in the early steps of sample handling and assay, as well issues 
related to pre-analytic data processing.  Pre-analytic data processing encompasses handling 
duplicate, extreme, censored and zero values; addressing kurtotic and skewed distributions; 
evaluating data transformations; and computing indicators of individual differences. Choices 
investigators make in the pre-analytic data processing phase can impact the reliability and validity 
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of the data and study findings. However, guidance about pre-analytic decision-points is sparse in 
the existing literature. 
The purpose of this paper is to review pre-analytic data processing steps, highlight 
specific challenges, and present best practices for salivary analyte data processing. This paper 
uses sample data to illustrate how variations of these practices impact the nature, interpretation 
and implications of study results. Decisions made by technicians in saliva processing laboratories 
that have the potential to impact data validity are briefly discussed. The focus, however, is on the 
choices an investigator must make after receiving analyte data from the laboratory. Basic analytic 
methods that are particularly useful for salivary analyte data analysis, such as transforming data 
and modeling group parameters, are also discussed.  
4.3. In-laboratory Saliva Processing Steps 
A basic understanding of in-laboratory sample processing helps to inform pre-analytic 
data processing decisions, as well as determinations of data quality, validity, and reliability.  
Saliva samples are typically donated and prepared in the field, transported to the laboratory under 
controlled temperatures, and then processed for the determination of analytes using high 
complexity assays (e.g., immunoassay or kinetic reaction) designed for use with oral fluid.  These 
assay protocols often employ microtiter plate technology.  Each microtiter plate has a finite 
number of microwells, and a portion of each saliva sample is placed in the microwells.  On each 
plate, some of the microwells are reserved for a series of specimens known as calibrators or 
standards. These samples have known concentrations of the analyte of interest and are used to 
construct the standard curve.  
Controls are also tested on each assay plate.  Controls are created by an external source 
and their levels reflect the lower and upper expected range of participant specimens. During 
laboratory processing, color change in each well is determined in measurement units of optical 
density.  Through comparisons with the standard curve, optical density units are converted into 
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standard units.  Assay protocols include strict criteria to ensure the consistency of liquid handling, 
the standard curve, and the reliability and precision of each assay (for more detail the reader is 
referred to 7,8).  Raw data generated by this process typically include: determinations for the 
analyte of interest (in singlet, duplicate or triplicate), a metric to indicate salivary flow rate (i.e., 
volume or volume estimated by weight, and time), and the indices of inter- and intra-assay 
precision (i.e., coefficients of variation).   
4.4. Pre-analytic Data Processing 
Once received by the investigator, the raw data are reviewed, evaluated, and prepared for 
use in statistical models.  These pre-analytic steps include: 1) examining data parameters related 
to in-laboratory saliva processing procedures; 2) examining and addressing unreliable values; and 
3) examining the distribution of the data.  Each step is discussed in detail below, and references 
are provided for further reading. Figures 4.1 and 4.4 illustrate these steps and important questions 
and decision points that arise during pre-analytic data processing.  
Step 1: Examine data parameters related to in-laboratory saliva processing procedures 
A) Evaluating the standard curve.  The shape and slope of the standard curve is critical to the 
precision, reliability and validity of salivary analyte determinations. The slope of the standard 
curve must be nearly perfectly linear to enable the precise computation of standard units from the 
microplate reader output.  The assay’s standard curve RSQ (r-squared) should be greater than 
0.999 to ensure high quality data (Figure 4.1). Values from the standard curve for the high and 
low controls must be used to verify that the curve is valid in the range expected of the study 
samples. Laboratory technicians should provide investigators with the expected and observed 
values of control samples and ensure that the observed values of control samples are within the 
expected range (Figure 4.1).  For detailed information about standard curves, the reader is 




Figure 4.1. Pre-analytic data processing steps 1 and 2: 1) Examine data parameters related to in-laboratory saliva processing procedures; and 2) 
Examine and address unreliable values
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B) Intra-assay precision.   Intra-assay precision represents how well the assay was performed 
on the samples in the hands of the assay’s operator.  The intra-assay coefficient of variation (CV) 
indexes the reliability of the assay for individual samples as well as the study as a whole.  To 
calculate the intra-assay CV, all, or a subset of, samples are run in duplicate (or triplicate). On an 
individual sample basis, the CV is used to determine whether the individual sample’s assay 
results are reliable or whether the test should be repeated.  The criterion by which investigators 
judge duplicate values as reliable is rarely reported.  Adequate reliability across an entire study is 
indexed by an intra-assay CV that is less than 5%, on average across all samples (7). When 
samples are assayed in duplicate/triplicate, the average of the concentrations should be used in the 
analysis.   
C) Inter-assay precision.  The number of unique samples that can be run on an assay plate 
varies according to the number of wells on the microplate, the percent of duplicates/triplicates 
run, and the number of wells dedicated to controls (including non-specific binding wells) and 
standards. Typically each microplate will assay 36 unknown samples in duplicate, and studies 
with more than 36 samples need multiple microplates.  Inter-assay precision is calculated across 
microplates, typically using the high and low controls tested on each microplate, as a measure of 
reliability.  Immunodiagnostic industry standards expect the inter-assay CV to be less than 15% 
(7).  With up to 15% variation in assay results accepted as normative between plates, 
investigators should ensure that all samples collected from the same participant are placed on the 
same microplate to minimize within-subject error variance. However, the impact of plate (or 
batch) on between-subject variance remains an issue.  Investigators should request plate numbers, 
and values for high and low controls in order to examine the impact of microplate assignment 
(Figure 4.1). 
D) Salivary flow rate.  Levels of analytes that move from circulation into the oral fluid or are 
secreted by the salivary glands may be influenced by salivary flow rate (e.g., alpha-amylase; 9 
secretory Immunoglobulin A; 10, and dehydroepiandrosterone-sulfate; 11).  Salivary flow rate is 
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calculated using laboratory measurements of sample volume (flow rate= sample volume/sample 
collection duration) and is expressed in units of mL/minute. It is important to determine whether 
flow rate is associated with analyte levels.  If there is an association, or if prior research illustrates 
the importance of flow rate on the analyte’s concentration, the effect of flow rate should be 
examined in the main analyses (Figure 4.1).  As an alternative to statistical covariation, a 
correction can be computed by multiplying concentration/volume by volume/minute. This 
corrected index is expressed in units of concentration/minute or units of activity/minute and is 
referred to as “output”.  Failing to account for salivary flow rate can significantly restrict the 
utility of some salivary analyte data. 
E) Lower limits of detection (LLD).  The LLD is the lowest concentration of a salivary analyte 
that the assay can reliably discriminate from zero. The reliability of determinations below an 
assay’s LLD depends on the laboratory’s procedures for setting the assay LLD and the microplate 
and reader technology.  Investigators should ask the laboratory about their procedures for setting 
assay LLDs and estimating concentrations below the LLD for each analyte. Depending on the 
reliability of laboratory estimates of values below the LLD (i.e., non-detects), the investigator can 
chose from several methods for handling these low concentrations. These methods are detailed 
below and shown in Figure 4.1.   
Step 2.  Examine and address unreliable values   
A.       Methods for handling values below the LLD.   Investigators can chose from several 
methods for handling values below the LLD, including: 1) dropping all non-detected values; 2) 
substituting non-detects with a constant (e.g., the LLD concentration, a percentage of the LLD 
concentration, or zero); 3) using non-detects in the data as they were estimated by the laboratory; 
4) including non-detects in the data and categorizing all analyte data; 5) using multiple imputation 
to fill in non-detects; and 6) using statistical methods that account for imprecise values below the 
LLD.  When choosing a method for handling censored data, the sample size, the percent of 
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censoring, the LLD concentration relative to the observed data, and laboratory procedures for 
estimating values below the LLD should all be considered. Detailed discussions and comparisons 
of these six methods (and others) are available in the literature (for reviews see 12–14). This 
report will only briefly discuss key advantages/disadvantages of methods typically employed by 
salivary analyte researchers. Interested readers are referred to the National Institute of Child 
Health and Human Development (NICHD) Epidemiology Branch (15), for more detailed 
descriptions of emerging methods for analyzing censored data.  
   The impact of different censored data methods on group parameters and how this impact 
changes by level of censoring is illustrated in Figure 4.2 using sample data. Sex differences in 
raw salivary cortisol for 125 children (61 male) are shown under the true percent of censoring 
(12%) and with censoring artificially increased to 26% using five different censored data methods 
discussed below and presented in Figure 4.1.  Figure 4.2 illustrates the impact dropping non-
detects has on sex differences in mean cortisol compared to when substitution or Tobit models are 
used.  Furthermore, the impact of these methods varies by level of censoring.  Quantile regression 
uses median values, however, and group parameters are therefore insensitive to censoring levels 
when the percent of non-detects is less than 50%.  
In the literature, the most common approaches to handling non-detects involve dropping 
or substituting censored data points, and categorizing analyte data (Figure 4.1).  Dropping 
censored data points is not generally recommended, because it introduces bias, sacrifices data, 
and decreases power (13,16,17).  Substituting non-detects with a constant (e.g., the LLD or a 
percent of the LLD) also introduces bias and inappropriately reduces variance (13,17,18).  The 
amount of bias associated with substitution methods depends on the distribution of the data, the 
level of measurement error, the percent of censored data, and the LLD relative to the observed 
concentrations (14,19–21). Substitution may be an acceptable method of handling censored data 
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when the percent of censoring is low and between-subject variance is the focus of the study 
(18,22).  
Figure 4.2. Difference between male and female mean raw cortisol (µg/dL) using five different 
methods for handling censored values in salivary analyte data with 12 and 26% censoringa 
 
Another common option is to use non-detects as estimated by the laboratory (Figure 4.1). 
Modern microplate reader software extrapolates values for samples below the LLD.  Laboratories 
often estimate values below the LLD and include them as flagged values in the data report.  It is 
important to recognize, however, that the reliability of these values depends on the assay 
technology and the quality of the laboratory procedures, and estimates may not be reliable upon 
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re-assay. Thus, laboratory estimates of these values may be no more valid than other substitutions 
(12).  
Finally, categorizing analyte data by concentration (e.g., into quartiles or quintiles) is an 
attractive method for handling non-detects, because it allows the investigator to avoid the 
problem of censored data since all non-detects are grouped into the same category.  However, 
categorization sacrifices information and may limit further statistical modeling strategies and 
complicate interpretation of model parameters (19).    
The last two approaches for handling non-detects, multiple imputation and statistical 
modeling, account for the imprecision of censored data.  Multiple imputation techniques estimate 
censored data points through regression models and substitute each non-detect with a set of 
imputed values (18,19).  Statistical models can then be performed on the imputed data, and results 
are pooled across imputations (19). Modeling of the non-detects with multiple imputation 
assumes a normal distribution of the underlying data (16). If this assumption is violated, the 
validity of the imputed data is compromised (16).   
Finally, pre-analytic data processing steps for filling in censored data can be bypassed if 
statistical analysis methods that account for imprecision below the LLD are employed.  Unlike 
the methods discussed above, these models do not replace non-detects, rather they recognize the 
censored data and incorporate the imprecision introduced by censoring into the model parameters. 
There are non-parametric and parametric modeling approaches (Figure 4.1).    
Non-parametric modeling options for non-correlated data include Kaplan-Meier methods 
and Cox and quantile regression.  Kaplan-Meier methods are particularly useful for estimating 
means in the presence of multiple LLDs (23,24). Cox and quantile regression can compute trends 
in the data and examine the influence of covariates (25,26). The reader is referred to Gillespie and 
colleagues (23) for a review of the Kaplan-Meier method, Eilers and colleagues (25) for more 
information about quantile regression, and Dinse and colleagues (26) for a review of Cox 
regression for censored biomarker data.   
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Parametric modeling approaches for continuous censored data include maximum 
likelihood estimation (MLE) and Tobit models (13,14,18).  Robust variations of MLE may be 
more appropriate for use with salivary analyte data that tend to violate these model assumptions 
of data normality and homoscedasticity (14).  Extended versions of MLE are also available for 
use with correlated data (e.g., repeated measures data; 22).  
Tobit models are regression models designed for modeling censored dependent variables 
by fixing a limit of censoring (i.e., the LLD) for the outcome (18).  Tobit models assume a normal 
distribution, homoscedasticity, and independence of observations (27).  However, Tobit model 
extensions designed to handle heteroscedasticity (28), and longitudinal and correlated data 
(29,30) are available.  Tobit models only account for censoring in the dependent variable and are 
most appropriate when there is a single, constant limit of censoring.  If there are multiple LLDs 
(e.g., if LLD varies by microplate) or if analyte data have been combined into composite 
measures (e.g., proportion change, slope, area under the curve) Tobit models may not be 
appropriate because there is no constant limit of censoring.  
B) Techniques to handle zeroes. Another important step in addressing values below the LLD is 
the handling of zero values (Figure 4.1). Zero values are below the LLD; therefore they are 
neither reliable concentrations nor true zeroes.  Zeros also complicate data transformation 
techniques that are typically necessary before performing parametric statistical tests with salivary 
analyte data. For example, to perform a log-transformation data cannot include zero values.  
Zeroes can be handled by: 1) dropping zero values from data; 2) replacing zero values with a very 
low concentration; 3) adding a constant to all data; or 4) replacing zero values with a constant 
(e.g., the LLD or half the LLD).  These options should be considered alongside the question of 
how to handle non-detects, as replacement methods should be consistent and logical across all 
values below the LLD. There is no accepted standard method for handling zero values; 
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investigators should consider the percent of zero values and evaluate the impact of zero values 
and the methods for handling them on data distributions and parameters.  
Important details must also be considered for each method for handling zero values. For 
example, if replacing zeroes with a constant, should the constant be the same across analytes or 
should it vary by analyte or plate?  If adding a constant to the data, what is an appropriate 
constant? Also, if examining multiple analytes, what constant is appropriate to add for all the data 
(as the constant must be the same for each analyte if comparisons are planned)?  These questions 
are important to keep in mind prior to data transformation, because non-linear data 
transformations (e.g., log transformation) will result in differential spacing between transformed 
values depending on their magnitude (low values are stretched out and higher values are 
compressed together).   
Figure 4.3 uses sample data to illustrate the impact of different methods for handling 
zeroes on group parameters.  Sex differences in mean salivary tumor necrosis factor-alpha 
(TNFα) and cortisol are shown using the four different methods for handling zeroes discussed 
above.  For this figure, saliva for 125 children (61 males) was assayed for TNFα and cortisol; 
non-detects were included as estimated by the laboratory and data were log-transformed. Only 
one sample of TNFα was estimated as zero by the laboratory, and ten were estimated as zero for 
cortisol. Figure 4.3 illustrates the importance of choosing an appropriate constant; the difference 
between male and female TNFα and cortisol means varies by the choice of constant (two or 
0.001).  This figure also shows the impact of dropping zeroes from the data even when there are 
few zero values.  For example, TNFα only has one zero value, however, dropping this value 




Figure 4.3.  Difference between male and female mean log-transformed TNFα (pg/mL) and 
cortisol (µg/mL) using four different methods for handling zeroes in salivary analyte dataa 
 
 
Step 3: Examine the distribution of the data (Figure 4.4) 
 Salivary analyte data typically display a strong positive skew with a disproportionate 
amount of low concentrations and a long tail of high concentrations.  Many data transformation 
techniques can be employed to correct the skew of the distribution (e.g., log-transformation, 
inverse-square root, square root), so that data can be analyzed using parametric statistical models 
(Figure 4.4).  The impact of each of these approaches should be tested for each analyte.  In 
choosing data transformation techniques, it is important to consider future analyses that may 
include more than one analyte or comparisons across analytes.  Making small compromises in 
normality and choosing a single transformation technique for all analytes will keep analytes on 
the same scale and improve interpretability. 
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Even after transforming the data, there may still be outlying data points. Outlying data 
points may be plausible data or may be due to sample contamination or laboratory processing 
errors.  To the extent possible, implausible or contaminated values should be scrutinized and 
flagged or dropped from the data.  There are many techniques available for dealing with plausible 
outliers including: 1) deleting all outliers from the data; 2) Winsorizing the outliers (31); and 3) 
keeping plausible outliers in the data and examining model fit in future analyses (Figure 4.4). 
Dropping plausible outliers reduces information and introduces bias in the data. Winsorizing the 
data, or replacing outlying data points with values equal to the most extreme plausible data point, 
will improve the data distribution and reduce variance (31).  If Winsorization techniques are 
applied, a series of questions should be addressed.  For example, it is important to consider which 
groups of data (e.g., participant groups, time points) should be Winsorized together and to set an 
acceptable range of variation from the mean. When Winsorizing longitudinal data by time point, 
individual trajectories should be taken into account; for example, if an individual’s raw value at 
time one is greater than the raw value at time two, the Winsorized value at time one should also 
be greater than the Winsorized value at time two. Dropping and Winsorizing outliers both 
introduce biases.  However, including unadjusted outliers in the data can impact model fit and 
may not provide additional information about the overall nature of the data.  See Wilcox and 









Figure 4.4. Pre-analytic data processing step 3: Examine the distribution of the data 
 
 
4.5. Beyond Pre-analytic Data Processing  
 Every decision made in the pre-analytic phase of data processing impacts the data that 
will be used in more complex statistical models to answer the specified research question.  The 
goal of pre-analytic data processing is to generate a dataset that best represents the nature of the 
data and can be used in statistical models to produce valid and reliable study findings. Common 
statistical modeling approaches for salivary analytes include modeling: within-individual change 
over time, coordination among multiple analytes, and concordance within and between subject 
groups (e.g., families, mother-child dyads).  The quality of the results of these more complex 
statistical analyses is contingent upon the validity and reliability of the raw analyte data, as well 
as pre-analytic decisions which determine the data distribution, variance, and bias, and define the 
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range of statistical approaches available to the investigator (e.g., non-parametric vs. parametric 
modeling, linear vs. ordinal regression).  A detailed discussion of complex statistical methods in 
these areas is beyond the scope of this paper. However, key methods are presented below to 
demonstrate the link between pre-analytic processing decisions and statistical model building.   
A) Within-individual analyte change 
There are many ways to examine change over time in salivary analyte data.  Discussion 
of complex methods, such as latent curve modeling (33), multilevel mixed models (34), 
generalized estimating equations for repeated measures (35) and structural equation modeling 
(36) is outside the scope of this paper.  These statistical approaches, however, are powerful 
methods that should be considered when modeling change in analytes over time.       
Comparing “responders” to “non-responders”.  Often studies aim to examine the psychological 
or health correlates of a specific analyte’s response to a stimulus (e.g., the response of salivary 
alpha-amylase to a laboratory stressor).  One common and straightforward approach is to divide 
the sample into “responders” and “non-responders” and compare these groups on a range of 
selected factors.  However, there are no established standards for distinguishing groups, and 
differences in the number of groups and cut-offs for group membership makes it difficult to 
compare results across studies. Granger and colleagues (2)  suggest that a threshold for 
meaningful change in salivary analytes should be based on twice the average inter-assay 
coefficient of variation and an absolute difference twice the LLD.  Other studies have used 
difference scores, proportion change percentiles, cluster analysis, and mean and standard 
deviation parameters to determine group cut-offs (37–39).  
When deciding how to distinguish groups of responders, it is important to consider 
thresholds used by previous researchers, as well as the distribution of the data. If the data are 
censored and data parameters are to be used as group membership thresholds, statistical modeling 
methods for parameter estimation (e.g., Kaplan-Meier, Tobit models) rather than simple 
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substitution methods may be appropriate. Statistical modeling approaches for parameter 
estimation are generally more appropriate for highly censored data, and errors in parameter 
estimation will be perpetuated if parameters (e.g., mean, standard deviation) are used as group 
cut-offs. Although methodologically simple, comparing responders and non-responders sacrifices 
information as continuous data is categorized and participants may be dropped from analyses if 
their responses do not meet group thresholds. 
Examining composite measures of change.   Another commonly used and simple approach to 
examining change in analytes over time is to use composite measures of change, such as 
proportion change, difference scores, slope, and area under the curve with respect to ground 
(AUCg) and with respect to increase (AUCi; 40).  Composite measures express concentration 
changes with a single value, thereby avoiding the complexities of modeling repeated measures 
and correlated data points. Proportion change and difference scores summarize analyte change 
across two samples. Slope measures further incorporate the elapsed time between samples.   
AUCg and AUCi are composite measures that express change in concentration over 
many samples and account for the time between samples (40). AUCg is a measure of total analyte 
output, while AUCi measures output across time with respect to the initial concentration (40).  
Pruessner and colleagues (40) standardized the formula for AUCg and AUCi to improve across-
study comparisons.  However, pre-analytic data processing steps, such as handling of non-detects 
and zeroes, and data transformations, impact the data that are used in the computation of 
composite measures and can cause variation in these measures across studies.  For example, it is 
important to keep the scale of the data in mind when calculating composite measures.  If log 
transformations were used, the data will likely contain negative values, so composite measures’ 
formulae must be modified to account for transformed data and negative values or raw data 




B) Coordination among multiple analytes 
Modern microplate technology allows investigators to assay multiple analytes per 
sample.  While this can provide a wealth of information about individual and cross-system 
functioning, simultaneous analysis of multiple analytes presents challenges in both the pre-
analytic (e.g., decisions regarding non-detects, choice of a constant, and data transformations) and 
analytic phases of data analysis.  In the analytic phase, common techniques for examining analyte 
coordination include: conducting simple correlations, principal component analysis (41), cross-
correlations (42), ratios (e.g., alpha-amylase to cortisol ratios; 43), and hierarchical linear 
modeling (44).  
C) Concordance within and between subject groups 
Common statistical strategies to model concordance between individuals fall in two 
major categories – multilevel modeling (45) and latent growth curve modeling (46).  Both 
modeling techniques operationalize the degrees of concordance by estimating the strength of the 
association between two participants’ analyte concentrations at baseline and in the rate change 
over time. Often, researchers are interested in examining factors that influence the level of 
concordance between subjects (e.g., how does stress impact cortisol concordance between 
mother/child pairs?). These questions can be addressed by including moderators in the models. In 
most cases, multilevel modeling and latent growth curve modeling tend to yield comparable 
parameter estimates (47). However, the multilevel framework has been more commonly 
employed due to its flexibility in incorporating both categorical and continuous moderators 
(48,49).  
Furthermore, researchers interested in establishing temporal precedence and 
directionality of influence between participants can use a time-lagged approach (50). A recent 
development in statistical analysis, the actor-partner interdependent model (APIM), allows 
researchers to examine the bidirectional effect of analytes between the members in a dyad (51). 
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Finally, these modeling techniques can be applied to study the concordance among multiple 
participants to paint a more colorful picture of the role of salivary analytes in family or group 
dynamics (50). Novel applications of social network analysis to salivary analyte data (e.g., 52) 
also provide new opportunities for examining associations between social relationships and 
biologic functioning within complex social groups.  
4.6. Best Practices in Pre-analytic Data Processing  
Salivary analyte data hold great promise for advancing health and development research. 
Salivary data can help elucidate mechanisms underlying mental, emotional, and behavioral 
disorders, track toxic exposures, and monitor health and growth.  However, in order to fully 
realize the role of salivary analyte data in furthering our understanding of psychology, health, and 
the interplay of experience, environments and multi-system functioning, better dissemination of 
information regarding pre-analytic data processing is needed.  Pre-analytic data processing is a 
neglected phase of data analysis for which no standard protocols are followed and limited 
information is provided in published manuscripts. Variations in pre-analytic data processing 
methods complicate across-study result comparisons and undermine the reliability and 
replicability of salivary analyte study results.  
The best practices of pre-analytic data processing likely vary by analyte, data distribution, 
censoring level, and research question.  However, establishing reporting requirements for pre-
analytic salivary analyte data processing methods, similar to the Consolidated Standards of 
Reporting Trials, would facilitate across-study comparisons and improve interpretation of the 
internal and external validity of biomeasure findings.  Explicit detailing of pre-analytic data 
processing methods in manuscripts would also provide researchers with a toolkit of pre-analytic 
data processing methods and promote consistency as well as innovation in these methods.  
Collaborations among psychology, health, biostatistics, epidemiology, and environmental 
health researchers to establish standards for pre-analytic salivary analyte data processing methods 
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would greatly advance biomarker research.  The Epidemiology Branch of the NICHD is currently 
collaborating with the Biostatistics and Bioinformatics Branch to develop methods for analyzing 
biomarker data. However, there is no standard set of practices available for health research.  
While some fields have proposed recommendations for some steps of pre-analytic data processing 
(e.g., the Environmental Protection Agency provides recommendations for censored data), these 
recommendations are not typically followed by health researchers.  Consistent data analysis 
methods across multiple areas of health research would maximize the potential of salivary analyte 














4.7. References  
1.  National Institute of Mental Health. National Institute of Mental Health Strategic Plan. 
2008.  
2.  Granger DA, Fortunato CK, Beltzer EK, Virag M, Bright MA, Out D. Focus on 
methodology: salivary bioscience and research on adolescence: an integrated perspective. 
J Adolesc [Internet]. Elsevier Ltd; 2012 Aug [cited 2013 Dec 16];35(4):1081–95. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22401843 
3.  Alink LR a, Cicchetti D, Kim J, Rogosch F a. Longitudinal associations among child 
maltreatment, social functioning, and cortisol regulation. Dev Psychol [Internet]. 2012 Jan 
[cited 2014 May 5];48(1):224–36. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3400182&tool=pmcentrez&re
ndertype=abstract 
4.  Keller PS, El-Sheikh M, Granger DA, Buckhalt JA. Interactions between salivary cortisol 
and alpha-amylase as predictors of children’s cognitive functioning and academic 
performance. Physiol Behav [Internet]. Elsevier B.V.; 2012 Feb 28 [cited 2013 Nov 
11];105(4):987–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22100627 
5.  Granger DA, Johnson SB, Szanton SL, Out D, Schumann LL. Incorporating salivary 
biomarkers into nursing research: an overview and review of best practices. Biol Res Nurs 
[Internet]. 2012 Oct [cited 2014 Mar 27];14(4):347–56. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22593229 
6.  Soo-Quee Koh D, Choon-Huat Koh G. The use of salivary biomarkers in occupational and 
environmental medicine. Occup Environ Med [Internet]. 2007 Mar [cited 2014 May 
29];64(3):202–10. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2092532&tool=pmcentrez&re
ndertype=abstract 
7.  Chard T. An introduction to radioimmunoassay and related techniques. Fourth. 
Amsterdam, Netherlands: Elsevier; 1990.  
8.  Wild D. The Immunoassay Handbook. Fourth. John R, Sheehan C, Binder S, He J, editors. 
Waltham, MA: Elsevier; 2013.  
9.  Beltzer EK, Fortunato CK, Guaderrama MM, Peckins MK, Garramone BM, Granger DA. 
Salivary flow and alpha-amylase: collection technique, duration, and oral fluid type. 
Physiol Behav [Internet]. 2010 Sep 1 [cited 2013 Nov 11];101(2):289–96. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20515701 
10.  Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic 
immunity? Ann N Y Acad Sci [Internet]. 2007 Mar [cited 2013 Nov 15];1098:288–311. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17435136 
11.  Vining R, McGinley R. The Measurement of Hormones in Saliva: Possibilities and 
Pitfalls. J Steriod Biochem. 1987;27(1-3):81–94.  
85 
 
12.  Antweiler RC, Taylor HE. Evaluation of statistical treatments of left-censored 
environmental data using coincident uncensored data sets: I. Summary statistics. Environ 
Sci Technol [Internet]. 2008 May 15;42(10):3732–8. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/18546715 
13.  Helsel DR. Fabricating data: how substituting values for nondetects can ruin results, and 
what can be done about it. Chemosphere [Internet]. 2006 Dec [cited 2014 Jan 
22];65(11):2434–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16737727 
14.  Hewett P, Ganser GH. A comparison of several methods for analyzing censored data. Ann 
Occup Hyg [Internet]. 2007 Oct [cited 2014 Feb 19];51(7):611–32. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/17940277 
15.  National Institute of Child Health and Human Development. Epidemiology Branch 
Research - Methodological Research in Epidemiology [Internet]. 2013. Available from: 
http://www.nichd.nih.gov/about/org/diphr/eb/research/Pages/limit-detection.aspx 
16.  Baccarelli A, Pfeiffer R, Consonni D, Pesatori AC, Bonzini M, Patterson DG, et al. 
Handling of dioxin measurement data in the presence of non-detectable values: overview 
of available methods and their application in the Seveso chloracne study. Chemosphere 
[Internet]. 2005 Aug [cited 2014 Mar 5];60(7):898–906. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/15992596 
17.  Cole SR, Chu H, Nie L, Schisterman EF. Estimating the odds ratio when exposure has a 
limit of detection. Int J Epidemiol [Internet]. 2009 Dec [cited 2014 Mar 29];38(6):1674–
80. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2786252&tool=pmcentrez&re
ndertype=abstract 
18.  Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, et al. Epidemiologic 
Evaluation of Measurement Data in the Presence of Detection Limits. Environ Health 
Perspect [Internet]. 2004 Sep 13 [cited 2014 Mar 29];112(17):1691–6. Available from: 
http://www.ehponline.org/ambra-doi-resolver/10.1289/ehp.7199 
19.  Uh H-W, Hartgers FC, Yazdanbakhsh M, Houwing-Duistermaat JJ. Evaluation of 
regression methods when immunological measurements are constrained by detection 
limits. BMC Immunol [Internet]. 2008 Jan [cited 2014 Feb 17];9:59. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2592244&tool=pmcentrez&re
ndertype=abstract 
20.  Schisterman EF, Vexler A, Whitcomb BW, Liu A. The limitations due to exposure 
detection limits for regression models. Am J Epidemiol [Internet]. 2006 Mar 15 [cited 
2014 Feb 20];163(4):374–83. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1408541&tool=pmcentrez&re
ndertype=abstract 
21.  Richardson DB. Effects of Exposure Measurement Error When an Exposure Variable Is 
Constrained by a Lower Limit. Am J Epidemiol [Internet]. 2003 Feb 15 [cited 2014 Mar 
29];157(4):355–63. Available from: http://aje.oupjournals.org/cgi/doi/10.1093/aje/kwf217 
86 
 
22.  Jin Y, Hein MJ, Deddens J a, Hines CJ. Analysis of lognormally distributed exposure data 
with repeated measures and values below the limit of detection using SAS. Ann Occup 
Hyg [Internet]. 2011 Jan [cited 2014 Jan 29];55(1):97–112. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/21177260 
23.  Gillespie BW, Chen Q, Reichert H, Franzblau A, Hedgeman E, Lepkowski J, et al. 
Estimating population distributions when some data are below a limit of detection by 
using a reverse Kaplan-Meier estimator. Epidemiology [Internet]. 2010 Jul [cited 2014 Jun 
4];21 Suppl 4(4):S64–70. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/20386104 
24.  Helsel DR. Summing Nondetects : Incorporating Low-Level Contaminants in Risk 
Assessment. Integr Environ Assess Manag. 2009;6(3):361–6.  
25.  Eilers PHC, Röder E, Savelkoul HFJ, van Wijk RG. Quantile regression for the statistical 
analysis of immunological data with many non-detects. BMC Immunol [Internet]. 2012 
Jan [cited 2014 Mar 5];13:37. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3447667&tool=pmcentrez&re
ndertype=abstract 
26.  Dinse GE, Jusko T a, Ho L a, Annam K, Graubard BI, Hertz-Picciotto I, et al. 
Accommodating measurements below a limit of detection: a novel application of Cox 
regression. Am J Epidemiol [Internet]. 2014 Apr 15 [cited 2014 Jun 4];179(8):1018–24. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24671072 
27.  Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of 
health status. Qual Life Res [Internet]. 2000 Jan;9(8):901–10. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/11284209 
28.  Austin P. Bayesian extensions of the Tobit model for analyzing measures of health status. 
Med Decis Making [Internet]. 2002;22(2):152–62. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/11958497 
29.  Epstein MP, Lin X, Boehnke M. A tobit variance-component method for linkage analysis 




30.  Fu P, Hughes J, Zeng G, Hanook S, Orem J, Mwanda OW, et al. A comparative 
investigation of methods for longitudinal data with limits of detection through a case 
study. Stat Methods Med Res [Internet]. 2012 Apr 13 [cited 2014 Mar 5]; Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22504231 
31.  Kruskal W, Ferguson TS, Tukey JW, Gumbel EJ. Discussion of the Papers of Messrs . 
Anscombe and Daniel. Technometrics. 1960;2(2):157–66.  
32.  Wilcox RR, Keselman HJ. Modern Regression Methods That Can Substantially Increase 
Power and Provide a More Accurate Understanding of Associations. Eur J Pers [Internet]. 





33.  Davies PT, Sturge-apple ML, Cicchetti D, Cummings EM. The Role of Child 
Adrenocortical Functioning in Pathways Between Interparental Conflict and Child 
Maladjustment. Dev Psychol. 2007;43(4):918–30.  
34.  Dmitrieva NO, Almeida DM, Dmitrieva J, Loken E, Pieper CF. A day-centered approach 
to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults. 
Psychoneuroendocrinology [Internet]. Elsevier Ltd; 2013 Oct [cited 2014 Jul 
14];38(10):2354–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23770247 
35.  Laudenslager ML, Noonan C, Jacobsen C, Goldberg J, Buchwald D, Bremner JD, et al. 
Salivary cortisol among American Indians with and without posttraumatic stress disorder 
(PTSD): gender and alcohol influences. Brain Behav Immun [Internet]. Elsevier Inc.; 
2009 Jul [cited 2014 Jul 14];23(5):658–62. Available from: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2711684&tool=pmcentrez&re
ndertype=abstract 
36.  Willoughby M, Vandergrift N, Blair C, Granger DA. A Structural Equation Modeling 
Approach for the Analysis of Cortisol Data Collected Using Pre–Post–Post Designs. 
Struct Equ Model A Multidiscip J [Internet]. 2007 Jan;14(1):125–45. Available from: 
http://www.tandfonline.com/doi/abs/10.1080/10705510709336740 
37.  Kunz-Ebrecht SR, Mohamed-Ali V, Feldman PJ, Kirschbaum C, Steptoe A. Cortisol 
responses to mild psychological stress are inversely associated with proinflammatory 
cytokines. Brain Behav Immun [Internet]. 2003 Oct [cited 2013 Dec 4];17(5):373–83. 
Available from: http://linkinghub.elsevier.com/retrieve/pii/S0889159103000291 
38.  Izawa S, Sugaya N, Kimura K, Ogawa N, Yamada KC, Shirotsuki K, et al. An increase in 
salivary interleukin-6 level following acute psychosocial stress and its biological 
correlates in healthy young adults. Biol Psychol [Internet]. Elsevier B.V.; 2013 Oct [cited 
2013 Dec 13];94(2):249–54. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23831278 
39.  Miller R, Plessow F, Kirschbaum C, Stalder T. Classification criteria for distinguishing 
cortisol responders from nonresponders to psychosocial stress: evaluation of salivary 
cortisol pulse detection in panel designs. Psychosom Med [Internet]. 2013 [cited 2014 Jul 
10];75(9):832–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24184845 
40.  Pruessner JC, Kirshbaum C, Meinlschmid G, Hellhammer DH. Two formulas for 
computation of the area under the curve represent measures of total hormone 
concentration versus time-dependent change. Psychoneuroendocrinology. 
2003;28(7):916–31.  
41.  Riis JL, Out D, Dorn LD, Beal SJ, Denson L, Pabst S, et al. Salivary cytokines in healthy 
adolescent girls: Intercorrelations, stability, and associations with serum cytokines, age, 
and pubertal stage. Dev Psychobiol [Internet]. 2013 Jul 19 [cited 2013 Dec 20];(June). 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23868603 
88 
 
42.  Engert V, Vogel S, Efanov SI, Duchesne A, Corbo V, Ali N, et al. Investigation into the 
cross-correlation of salivary cortisol and alpha-amylase responses to psychological stress. 
Psychoneuroendocrinology [Internet]. Elsevier Ltd; 2011 Oct [cited 2013 Nov 
11];36(9):1294–302. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21470780 
43.  Ali N, Pruessner JC. The salivary alpha amylase over cortisol ratio as a marker to assess 
dysregulations of the stress systems. Physiol Behav [Internet]. Elsevier Inc.; 2012 Apr 12 
[cited 2013 Nov 11];106(1):65–72. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/22019784 
44.  Laurent HK, Laurent SM, Granger DA. Salivary nerve growth factor reactivity to acute 
psychosocial stress: a new frontier for stress research. Psychosom Med [Internet]. 2013 
Oct [cited 2014 Jul 14];75(8):744–50. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24077771 
45.  Hibel LC, Trumbell JM, Mercado E. Work/non-workday differences in mother, child, and 
mother-child morning cortisol in a sample of working mothers and their children. Early 
Hum Dev [Internet]. Elsevier Ltd; 2014 Jan [cited 2014 Jul 14];90(1):1–7. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/24345420 
46.  Hibel LC, Granger DA, Blair C, Cox MJ. Intimate partner violence moderates the 
association between mother-infant adrenocortical activity across an emotional challenge. J 
Fam Psychol [Internet]. 2009 Oct [cited 2014 Mar 19];23(5):615–25. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19803598 
47.  Chou C, Bentler P, Pentz M. Comparisons of two statistical approaches to study growth 
curves: The multilevel model and the latent curve analysis. Struct Equ Model A 
Multidiscip J. 1998;5(3):247–66.  
48.  Papp LM, Pendry P, Adam EK. Mother-Adolescent Physiological Synchrony in 
Naturalistic Settings: Within-Family Cortisol Associations and Moderators. J Fam 
Psychol. 2009;23(6):882–202.  
49.  Stoel R, van Den Wittenboer G, Hox J. Analyzing longitudinal data using multilevel 
regression and latent growth curve analysis. Metodol las Ciencas del Comport. 2003;5:21–
42.  
50.  Saxbe DE, Margolin G, Spies Shapiro L, Ramos M, Rodriguez A, Iturralde E. Relative 
influences: patterns of HPA axis concordance during triadic family interaction. Health 
Psychol [Internet]. 2014 Mar;33(3):273–81. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/23914815 
51.  Atkinson L, Gonzalez A, Kashy D a, Santo Basile V, Masellis M, Pereira J, et al. Maternal 
sensitivity and infant and mother adrenocortical function across challenges. 
Psychoneuroendocrinology [Internet]. Elsevier Ltd; 2013 Dec [cited 2014 Jul 
14];38(12):2943–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24007973 
52.  Kornienko O, Clemans KH, Out D, Granger DA. Friendship network position and salivary 
cortisol levels. Soc Neurosci [Internet]. 2013 Jan [cited 2014 Jul 16];8(4):385–96. 
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23682997  
89 
 
 CHAPTER FIVE 
Salivary cytokines as a minimally-invasive measure of immune functioning 
 in young children: Correlates of individual differences and sensitivity to laboratory stress  
 
5.1. Abstract 
Background and Objective: There is growing interest in minimally-invasive measures of 
environmentally-responsive biological systems in developmental science. Contributing to that 
endeavor, this study explores the intercorrelations, correlates, and task-sensitivity of 
proinflammatory salivary cytokines in childhood. 
Methods: Saliva was sampled from 125 healthy five-year old children (49% male) across a series 
of cognitive and emotional challenge laboratory tasks. Samples were assayed for cytokines (IL-
1β, IL-6, IL-8, TNFα), and markers of hypothalamic-pituitary-adrenal (HPA) and autonomic 
nervous system (ANS) activation (salivary cortisol and alpha-amylase (sAA)).  
Results: Cytokines were positively intercorrelated and task-sensitivity varied.  Except IL-8, 
cytokines were elevated in children with oral health issues and exposure to tobacco smoke. 
Among boys, cytokines were positively related to sAA and negatively related to cortisol.   
Conclusions: The findings suggest that in healthy children, salivary cytokine levels reflect 
compartmentalized oral immune activity. Associations between ANS and HPA activity and 
cytokines in saliva may present opportunities for minimally-invasive methods to explore 




5.2. Introduction   
There is growing interest among researchers and health care professionals in the 
calibration and functioning of the neuroendocrine-immune (NEI) network and its role in child 
health and development (1–3).  Of particular importance is the impact of the early environment in 
shaping the development and regulation of the central nervous system (CNS) and the immune 
system (1).  Understanding the influence of early-life adversity and stress on NEI functioning 
may be foundational to understanding and addressing the development and progression of 
inflammatory-related diseases in later life (1,4,5). 
Key to expanding NEI research in children is the development of minimally-invasive 
biomeasures that are valid, reliable and feasible for use in a young population.  Saliva collection 
is a minimally-invasive, low-cost, and socially acceptable method of obtaining biomeasure data 
(6). Technical advances now allow us to measure in oral fluids many of the intracellular 
regulatory molecules that facilitate communication and coordination between the immune system 
(cytokines), hypothalamic-pituitary-adrenal axis (HPA; cortisol), autonomic nervous system 
(ANS; alpha-amylase), and behavior (see 7). 
Despite increasing interest in the NEI network in early child development and the 
demand for minimally-invasive biomeasures, little is known about the nature and meaning of 
individual differences in salivary cytokines in young children.  Only two studies have examined 
salivary cytokines in pre-pubertal youth, and these studies only examined interleukin-6 (8,9).  
Fundamental questions regarding salivary cytokine detection rates, variation, intercorrelations, 
stress-sensitivity, and correlations with measures of ANS and HPA activity, as well as 
associations with health and demographic factors in early childhood remain unanswered.  The 
present study begins to address several knowledge gaps by analyzing cytokines and key markers 
of the activity of the NEI network in saliva samples collected across a series of challenging 
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laboratory tasks designed to elicit negative emotions and coping behaviors in healthy young 
children. 
Conceptual Issues 
Like the CNS, the immune system is tasked with adapting the body’s internal 
environment to meet the demands and challenges of the external environment. This adaptive 
calibration of the CNS and immune system is important for both within-system and across-system 
functioning and regulation. Environmental sensitivity is particularly important during early 
childhood when both systems are undergoing developmental change (10,11).  Communication 
between the CNS and immune system is essential for establishing homeostasis and allostasis 
(1,12).  A set of shared chemical messengers (i.e., cytokines, hormones) and direct cell-to-cell 
interactions allow for the integration and reciprocal regulation of the CNS and immune system.   
Cytokines are the primary intercellular protein messengers of the immune system.  In 
addition to regulating immune processes, cytokines facilitate communication between the 
immune system and the rest of the body, and they are critical for development, growth, and 
healing.  Cells throughout the body and the CNS produce and release cytokines. Secretion of 
cytokines often involves new protein synthesis, however, some cytokines are produced and stored 
in intracellular granules for rapid release. Cytokines have multiple target cells and mechanisms of 
action; their effects are often redundant or synergistic.  There are several classes of cytokines. 
Within the interleukin subclass, interleukin-1 beta (IL-1β), interleukin-6 (IL-6) and interleukin-8 
(IL-8), and tumor necrosis factor alpha (TNFα), are the four critical signaling molecules involved 
in initiating and maintaining inflammation (13,14).   
 These cytokines also coordinate and regulate communication within the NEI network, 
and their levels are influenced by stress-related activity in the ANS and HPA axis (15).  For 
instance, activation of the ANS in response to acute stress is associated with the release of 
noradrenaline and a subsequent increase in inflammatory cytokines (15,16).  Rising levels of 
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inflammatory cytokines stimulate the HPA axis to release cortisol which then inhibits 
inflammatory cytokine production (15,17).  This negative feedback loop between the immune 
system and the CNS  is critical to regulating inflammation and maintaining health (15,18). 
Dysregulation of this feedback loop can result in chronic inflammation and excessive cytokine 
secretion which has been associated with “sickness behaviors” (e.g., depressed mood and 
decreased appetite), and autoimmune and neurologic diseases (19,20). On the other hand, 
insufficient immune functioning increases susceptibility to disease (21).   
The Present Study 
This paper represents the first systematic exploration of the nature and correlates of 
salivary cytokines in early childhood. This study examined cytokine intercorrelations and 
associations with demographic and health factors, including measures of systemic and oral health, 
for salivary IL-1β, IL-6, IL-8, and TNFα in five-year old children.  To investigate relations 
between cytokines and measures of ANS and HPA activity within the oral cavity, the associations 
between cytokines and salivary alpha-amylase (sAA) and cortisol were also examined.  Three 
hypotheses were tested.  In addition to these hypotheses, changes in cytokine levels across a 
series of cognitive and emotional challenge tasks were explored without a priori hypotheses 
regarding the direction and magnitude of cytokine change.  
Hypothesis 1. Salivary cytokine activity is positively intercorrelated across a series of cognitive 
and emotional challenge tasks. 
The salivary cytokines examined (IL-1β, IL-6, IL-8, TNFα) are proinflammatory and 
share regulatory mechanisms (22).  Findings from studies examining salivary cytokines in older 
youth suggest a coordinated immune response in the oral cavity and strong inter-cytokine 
correlations (23). It was hypothesized that the inter-cytokine associations in young children are 
similar to those observed in older youth.  Although no studies were identified that examined 
proinflammatory cytokine intercorrelations after acute stress, the cytokines examined have 
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common regulatory mechanisms mediated by the activation of the ANS and HPA axis (22). 
Therefore, cytokine levels post-stress are hypothesized to be related to the ANS and HPA axis 
stress response and highly intercorrelated.   
Hypothesis 2. Salivary cytokine activity is positively associated with oral health issues and 
unrelated to demographic and systemic health factors. 
The immune system is highly compartmentalized. Salivary cytokines are produced within 
the oral cavity to respond to local immunological threats (24).  Not surprisingly, previous studies 
show consistent positive associations between oral health problems and salivary cytokine levels 
in older youth and adults (25–31). Systemic health and demographic factors, however, are largely 
unrelated to levels of salivary cytokines (23,32–34). It was hypothesized that cytokine levels in 
the saliva of healthy young children follow the same patterns as observed in older youth and 
adults.    
Hypothesis 3.  Salivary cytokines are positively associated with ANS activity and negatively 
associated with HPA activity. 
The immune system and the ANS and HPA axis are reciprocally regulated (15).  
Although not widely studied, two investigations reported negative associations between IL-6 and 
HPA activity in the oral cavity in adults (35,36).  Izawa and colleagues (35) also found that 
salivary IL-6 was positively associated with ANS activity in adults participating in an acute stress 
task.  
 Numerous studies reveal that salivary cortisol and sAA provide important information 
regarding HPA and ANS activation in response to stress (37–40).  The mechanisms underlying 
cytokine stress-reactivity in saliva are not well understood, and reactivity may reflect both 
immune system as well as ANS and HPA processes.  Coordination between the psychobiology of 
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stress and salivary cytokines could open up new opportunities for developmental studies linking 
brain, behavior, immunity and health. 
Cytokine change in response to challenge. 
 While changes in cytokine levels across the study visit may be partially driven by CNS 
activity in response to the challenge tasks, little is known about the nature and magnitude of 
stress-related change in salivary cytokines. Limited previous research suggests that salivary 
cytokines may be associated with negative emotional states. Three studies found increases in oral  
IL-6 in adults after social stressor tasks (35,41,42). Higher levels of salivary IL-6 are also 
associated with negative emotions and mental states (9,33,36). In addition, salivary IL-1β has 
been associated with the activation of brain areas involved in emotional processing in adults (43).  
Little research, however, has focused on salivary cytokine associations with cognitive stress. 
There is also limited research in children. A small study of 8-9 year olds found an increase in 
salivary IL-6 in girls and a decrease in IL-6 in boys after two stressor tasks (one cognitive and 
one emotional; 8).  Given the limited information regarding the nature of acute cognitive and 
emotional stress-related change in salivary cytokines in young children, the changes in cytokine 
concentrations across the study visit were explored without specific a priori hypotheses.   
5.3. Materials and Methods 
Participants 
Participants were recruited from a pool of mothers who participated in a fetal 
development study conducted from 2006 to 2007 and from the local community in Baltimore, 
Maryland.  Mother-child pairs were recruited from March 2011 to July 2013.  Enrollment in the 
fetal development study in 2006-2007 was limited to relatively low-risk non-smoking women 
with healthy, singleton pregnancies (additional eligibility criteria are described in 44).  Mothers 
from the fetal development study were self-referred and mostly well-educated, married and white 
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(44).  To increase the diversity of the sample, mother-child pairs were also recruited from 
Baltimore City through community postings and fliers.  To be enrolled in the current study, 
children had to be five years old, and mothers and children had to be fluent in English.  Children 
with significant health conditions or developmental disabilities that impaired cognitive, motor, or 
regulatory functioning were excluded.  Community enrollment accounted for 64% of the sample.  
Data were collected from 151 mother-child dyads.  Of these pairs, three were unable to 
complete the study protocol, and 23 children had insufficient salivary data. The current 
investigation analyzed data from the 125 children with complete saliva data for all samples. 
Children with (n=125) and without (n=23) complete saliva data were similar with respect to age, 
sex, recent health, current sickness, oral health, and body mass index (BMI).  Approximately half 
the sample was male, about a third was white, and the majority was in good health (Table 5.1).  
On the day of the study about 19% were sick (e.g., runny nose or cough), and approximately 22% 
used an over-the-counter or prescription medication in the two days prior (Table 5.1). Also, a 
considerable proportion of the sample had oral health issues (including bleeding gums and very 
loose teeth), or were exposed to tobacco smoke (Table 5.1).  
Procedures 
The Johns Hopkins Bloomberg School of Public Health Institutional Review Board 
approved the study protocol. Mothers provided written informed consent. Figure 5.1 shows the 
study protocol for children. The 90 minute study visit began with a free play session for the 
mother and child participants to allow the child to acclimate to the study room.  After free play, 
mothers completed a survey, and children participated in a series of behavioral and 
neuropsychological assessments.  Children completed the Peabody Picture Vocabulary Test- 
Fourth Edition (45) and two cognitive challenge tasks that tested inhibitory control (the Silly 
Sounds Game and Pig Game; 46,47). Children also participated in three age-appropriate 
emotional challenge tasks: the Disappointing Gift Game, the Not Sharing Game, and Mischel’s 
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Delay of Gratification Task (48) (described in detail below).  Four saliva samples were collected 
from children throughout the study visit (two samples before the emotional challenge tasks and 
two after these tasks). The majority (88%) of study appointments were conducted in the 
afternoon, and the elapsed time from child waking to study appointment was not associated with 
age, sex or health (except overweight and obese children were awake for longer when the 
appointment began compared to underweight and children of a healthy weight (t(123)= -3.95, p< 
.01)).   
Emotional challenge tasks: The Disappointing Gift Game assessed the child’s response to 
disappointment (49).  During Part 1 of this game, the child ranked six potential gifts (including 
undesirable items (e.g., a sock)) from favorite to least favorite.  Part 2 of this game occurred 
approximately 15 minutes later when the child was given his/her least favorite gift.  After 
receiving the gift, two study evaluators asked the child a series of questions that required the child 
to confront his/her disappointment, as well as the evaluators’ authority (e.g., “Did you get a 
Table 5.1. Demographic and health characteristics of the sample of 125 five-year old children 
Demographic Characteristics 
Age, mean years (SD) 5.45 (0.29) 
  Frequency Percent 
Male 61 49% 
Race     
White 42 34% 
African American 80 64% 
Asian/Pacific Islander 3 2% 
Health Characteristics 
Overweight/ Obesea 44 35% 
Fair/ Poor Health in Last 2 Days 9 7% 
Currently Sick with Cold or Feverb 24 19% 
Taken Any Medicine in Last 2 Days 28 22% 
Taken Allergy/ Asthma Medicine in Last 2 Days 20 16% 
Current Oral Health Issues 14 11% 
Mother Smokes 28 22% 
aWeight status (underweight or healthy weight vs. overweight or obese) assigned using the Centers for Disease 
Control and Prevention’s percentile ranges by sex and age.  
bCurrent sickness assessed with the question: “Is your child currently feeling sick or ill? (e.g., runny nose, fever, 
cough, aching, etc.)”.   




prize? Is this the prize you wanted?”).  This task has been shown to challenge behavioral control 
and to elicit negative emotions (e.g., anger) in young children (49–53).  
The Not Sharing Game is an emotional stressor and test of emotional regulation (54,55).  
In this game, an evaluator unevenly distributed candy between herself and the child.  Throughout 
this task, the evaluator asked the child a series of questions to elicit his/her feelings about the 
game and about the evaluator’s behavior.  This task has been shown to elicit negative emotions 
(e.g., frustration) and to increase salivary cortisol in young children (54).   
The Delay of Gratification Task is an emotional stressor and test of coping abilities 
(48,55). The child was left alone in the study room with either a marshmallow or a pretzel.  The 
child was told that the evaluator must briefly leave the room, and he/she was asked to not eat the 
treat while the evaluator was away. The child was told that if he/she waited for the evaluator to 
return on her own (i.e., without ringing a bell that would summon the evaluator), he/she would be 
receive two treats.  The child was left alone with the treat for eight minutes or until he/she rang 
the bell.  This task has been shown to elicit negative emotions and correlate with inhibitory 
control measures in young children (48,53,56).    
Health and demographic data: An evaluator measured children’s height and weight.  Children 
were classified as underweight or healthy weight versus overweight or obese based on the Centers 
for Disease Control and Prevention age- and sex-specific standards (57,58).  Maternal smoking, 
children’s medication use in the last 48 hours, and children’s oral health issues, race/ethnicity, 
and recent health were based on maternal report. Dummy variables were created for the child’s 
use of any medication, and use of allergy or asthma medication. Current child oral health issues, 
based on mother-reported cuts or sores in the mouth, very loose/recently lost teeth, bleeding gums 
while brushing, or untreated cavities, were coded as yes/no.  Child race/ethnicity was reported by 
mothers and data were dichotomized (white versus non-white) because of low percentages of 
Asian/Pacific Islanders and Native Americans/Alaskan Natives in the sample (Table 5.1). Child 
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current illness and recent health were assessed with the questions “Is your child currently feeling 
sick or ill? (e.g., runny nose, fever, cough, aching, etc.)” (yes/no), and “Compared to others his or 
her age, would you say your child's health in the last two days (48 hours) has been: (responses: 
excellent; very good; good; fair; poor).” Responses were dichotomized into excellent/good health 
versus fair/poor health.   
Timing data: To assess the impact of circadian patterns on cytokine concentrations, a time since 
waking variable was created using maternal report of child’s wake time and the study visit start 
time. A task timing variable was also created that indexed the elapsed time between Part 2 of the 
Disappointing Gift Game and each saliva sample. The task timing variable was used to adjust for 
the differential timing of emotional challenge tasks across children. Figure 5.1 shows the timing 
of the tasks and samples; the timing of the saliva samples was unrelated to age, sex and health 
variables. 
Salivary Analyte Data 
Following Granger and colleagues (59), whole unstimulated saliva was collected by 
passive drool into a 2 mL cyrogenic vial for three minutes or until 0.75 milliliters of fluid was 
collected. Saliva samples were stored at -20 degrees Celsius until assayed. Saliva samples were 
assayed following Granger and colleagues (39) for sAA by kinetic reaction assay. Salivary alpha-
amylase results were determined in U/mL.  For sAA, intra-assay variation computed for the mean 
of 30 replicate tests was less than 7.5%, and inter-assay variation computed for the mean of 
average duplicates for 16 separate runs was less than 6%. Cortisol was analyzed in duplicate 
using a commercially available enzyme immunoassay without modification to the manufacturer’s 
protocol (Salimetrics, Carlsbad, CA) with a range of sensitivity from .007 to 3.0 µg/dL. Intra- and 
inter-assay coefficients of variation for cortisol were less than 5 and 10% respectively.  
Salivary cytokines were measured following Riis and colleagues (23) using a 4-plex 96-
well format electrochemiluminescence immunoassay manufactured by Meso Scale Discovery 
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(MSD, Gaithersburg, MD). Each well of each 96-well plate was coated with capture-antibodies to 
IL-1β, IL-6, IL-8 and TNFα. Detection antibodies were coupled to SULFOTAGTM labels that 
emit light when electrochemically stimulated via carbon-coated electrodes in the bottom each 
microwell. The 4-plex Multi-Spot Array assay was run following the manufacturer’s 
recommended protocol without modification. Cytokine concentrations were determined with 
MSD Discovery Workbench Software (v. 3.0.17) using curve fit models (4-PL with a weighting 
function option of 1/y2). Lower limits of detection (LLD) and intra-assay coefficients of variation 
were as follows: IL-1β (0.06 pg/mL, 4.4%), IL-6 (0.09 pg/mL, 4.8%), IL-8 (0.05 pg/mL, 2.1%), 
and TNFα (0.11 pg/mL, 6.6%). The detection rates for the four salivary cytokines ranged from 
95-100% in the 500 saliva samples (125 children with four samples each).  Only three saliva 
samples for IL-6 and 25 samples for TNFα had concentrations below the assays’ lower limit of 
detection.  
For all analytes, concentrations below the assay’s LLD were estimated using the curve 
model for the plate. All biomeasure data distributions were very skewed (range across the four 
samples (skew, kurtosis) for IL-1β: 3.07- 6.23, 14.68- 51.50; IL-6: 3.40- 6.47, 15.04- 52.87; IL-8: 
2.57- 4.77, 10.60- 30.98; TNFα: 4.16- 8.90, 24.29- 88.87; sAA: 1.96- 4.13, 7.95- 29.52; cortisol: 
2.26- 12.00, 4.37- 10.97).   
Statistical Analyses 
Salivary analyte data were log-transformed and Winsorized to improve the normality of 
the distributions (60). Winsorization was performed by analyte and saliva sample separately.  
During Winsorization, ≤1% of each cytokine’s concentrations, 2% of sAA concentrations, and 
4% of cortisol concentrations were changed.  Individual trajectories across saliva samples were 
maintained for all analytes during the Winsorization process, so Winsorization thresholds varied 
slightly by analyte; cytokine and sAA values were brought within three standard deviations of the 
mean, and cortisol values were brought within 3.7 standard deviations.   
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Winsorization and transformation improved the distribution of the analytes (range across 
the four samples (skew, kurtosis) for IL-1β: 0.28-0.48, 2.77-3.36; IL-6: 0.35-0.63, 2.88-3.34; IL-
8: 0.27-0.63, 2.70-3.94; TNFα: -0.20-0.44, 3.42-3.85; sAA: -0.61- -0.33, 3.28-4.56; cortisol:         
-1.81- -1.03, 4.72-6.55). No consistent associations between flow rate and raw sAA and cytokine 
concentrations were found, so, following recommendations by Granger and colleagues (7), data 
were not adjusted for salivary flow rate. First, the raw data were explored, then log-transformed 
and Winsorized data were used in all statistical analyses. 
T-tests and Pearson correlations were used to examine differences in task timing (i.e., 
elapsed time from Part 2 of the Disappointing Gift Game to saliva samples) by age, sex and 
health factors.  Paired t-tests examined changes in sAA and cortisol across samples and 
differences between cytokine concentrations at each sample.  To test the first hypothesis, 
intercorrelations among cytokines at each sample were examined using Pearson correlations and a 
principal components analysis.  For each set of t-tests and Pearson correlations, tests of statistical 
significance were two-sided with an alpha of .05, and Bonferroni-corrected alpha levels 
(.05/number of tests) were also examined. 
To test the second hypothesis, multilevel mixed models examined associations between 
cytokines and demographic and health factors. Each cytokine was modeled separately as an 
outcome with robust variance. Models included a random intercept and an autoregressive (AR-1) 
residual error matrix to account for the correlation of sample concentrations within subjects and 
correlated errors across samples. The association between each cytokine and each demographic 
and health factor was examined separately in models adjusted for the task timing variable. 
Variables associated with cytokines at p≤ .1 were selected as covariates in fully adjusted models 
for each cytokine. Backwards stepwise regression with a retention threshold of p< .05 was used to 
create parsimonious adjusted models for each cytokine.  
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Furthermore, to explore the extent and nature of task-related change in cytokine levels, 
the nonlinearity of cytokine trajectories across the study visit was examined using a spline knot. 
With no a priori hypotheses about the timing of task-related change in cytokine levels, the 
appropriateness of a knot placed at sample 2 or 3 was tested in both null and parsimonious 
adjusted models.  Spline models used a parameterization describing the intercept, the slope over 
the first samples (sample 1-2 or sample 1-3), and the slope over the last samples (sample 2-4 or 
sample 3-4), rather than the slope over the first samples and the deviation of slope over the first 
vs. last samples. Differences between slope terms were examined using post-estimation tests, and 
significant differences suggested a change in cytokine slope beginning at the spline knot. For 
each cytokine, likelihood-ratio estimates were used to select the most appropriate model (spline 
model with knot at sample 2, spline model with knot at sample 3, or linear model).   
To test the third hypothesis, sAA and cortisol were added separately as independent 
variables to the final model for each cytokine. Based on literature that suggests that NEI relations 
may vary by sex, the interaction between sex and sAA or cortisol on each cytokine was also 
examined (61,62).   
Missing data were less than 2.5% for all variables except child age. Child age in months 
was missing for 8.8% of the sample (although all children were five years old). Missing data for 
age, BMI, sample and task timing, time since waking, and survey data were imputed. Evaluator 
notes were used to obtain 16% of missing data, and the remaining missing data were imputed 
using mean values. Sensitivity analyses performed on complete case data demonstrated that this 
imputation did not substantively impact the findings (estimates and p-values). Statistical analyses 






Salivary Cytokine Concentrations 
The descriptive statistics for raw concentrations of each cytokine by saliva sample are 
shown in Table 5.2. Overall, IL-1β and IL-8 were present at much higher concentrations than IL-
6 and TNFα.  For each saliva sample, levels of IL-8 were the highest, followed by IL-1β, IL-6 
and TNFα (t(123)= 47.42-74.45,  p< .008 for all). Analyte levels were highly variable across 
participants but were quite stable across the study protocol with significant positive correlations 
across samples for each analyte at the Bonferroni-corrected alpha level (IL-1β r’s(123)= .74-.88; 
IL-6 r’s(123)= .81-.92; IL-8 r’s(123)= .61-.81; TNFα r’s(123)= .67-.86; sAA r’s(123)= .80 -.91; 
cortisol r’s(123)= .59 -.84, p< .008 for all). 
Table 5.2.  Descriptive statistics for raw salivary cytokine data in five-year old children across 
a 90-minute study visit with challenge tasks (pg/mL; n=125)a 
 Sample 1 Sample 2 Sample 3 Sample 4 
IL-1β 
Mean (SD) 212.12 (417.50) 182.62 (367.75) 136.77 (174.03) 90.68 (117.10) 
Minimum - 
Maximum 13.54 - 3908.97 10.72 - 3401.80 9.58 - 1242.97 3.39 - 762.47 
IL-6 
Mean (SD) 16.70 (34.50) 16.36 (39.70) 14.23 (39.42) 16.01 (45.13) 
Minimum - 
Maximum 0.00 - 203.46 0.10 - 253.51 0.19 - 349.51 0.32 - 416.10 
IL-8 
Mean (SD) 769.52 (772.13) 732.65 (998.32) 631.04 (593.65) 495.08 (712.39) 
Minimum - 
Maximum 92.10 - 4660.69 48.13 - 7368.48 97.05 - 4306.81 61.58 - 5841.91 
TNFα 
Mean (SD) 4.18 (8.55) 3.86 (13.90) 2.47 (3.55) 2.26 (3.85) 
Minimum - 
Maximum 0.01 - 71.92 0.10 - 145.68 0.02 - 26.82 0.00 - 26.39 







ANS and HPA Activty 
Alpha-amylase and cortisol concentrations changed across the study visit.  Alpha-
amylase was stable from sample 1 to sample 3, and concentrations increased after sample 3 (mean 
sample 3 concentration= 114.02 U/mL, mean sample 4 concentration= 125.47 U/mL, sample 3 
vs. sample 4: (t(124)= -3.00, p< .01)).  In contrast, cortisol concentrations declined from sample 1 
to 3 and then remained stable overall for the rest of the visit (mean sample 1 concentration= 0.09 
µg/dL, mean sample 2 concentration= 0.08 µg/dL, sample 1 vs. sample 2: t(124)= 2.46, p< .05; 
mean sample 3 concentration= 0.07 µg/dL, sample 2 vs. sample 3: t(124)= 2.76, p< .01)).  For 
both analytes, differences across the study visit were significant at the Bonferroni-corrected 
significance level (corrected α= .017).  Using a 10% threshold for meaningful change (7), 44% of 
children showed a meaningful increase in cortisol after sample 3 and 40% showed a decrease.  
Most children (60%) exhibited a meaningful increase in sAA after sample 2 and only 18% 
exhibited a decrease.   
Hypothesis 1: Cytokine Intercorrelations  
Table 5.3 shows the intercorrelations between cytokines at each saliva sample.  All 
cytokines were significantly and positively correlated with each other at each sample (r’s(123)= 
.54- .77, p< .008 for all; see Table 5.3). Principal components analysis suggested that a single 
component explained 72-77% of the variance in cytokine concentrations at each sample. 
Intercorrelations among the cytokines at each sample remained significant after accounting for 







Table 5.3.  Correlations between salivary cytokines at each saliva sample (n=125)a 
Sample 1 
  IL-1β IL-6 IL-8 
IL-1β       
IL-6 0.70*     
IL-8 0.69* 0.64*   
TNFα 0.73* 0.71* 0.62* 
Sample 2 
IL-1β       
IL-6 0.70*     
IL-8 0.77* 0.64*   
TNFα 0.73* 0.70* 0.61* 
Sample 3 
IL-1β       
IL-6 0.63*     
IL-8 0.67* 0.64*   
TNFα 0.62* 0.66* 0.54* 
Sample 4 
IL-1β       
IL-6 0.72*     
IL-8 0.75* 0.71*   
TNFα 0.65* 0.71* 0.64* 
a IL-1β= interleukin-1 beta; IL-6= interleukin-6; IL-8= interleukin-8; TNFα= tumor necrosis factor 
alpha. *p<.008 (Bonferroni-corrected significance level) 
 
 
Model Construction for Hypotheses 2 and 3 
Multilevel mixed models were used to address hypotheses 2 and 3.  A separate model 
was constructed for each cytokine using backward stepwise regression of demographic and health 
covariates. The nonlinearity of change across the study visit was also tested for each cytokine 
during the model-building process by evaluating the appropriateness of a spline knot placed at 
sample 2 or sample 3.  Final models included the health and demographic covariates listed in 
Tables 5.4-5.7. Likelihood-ratio tests indicated that the change in IL-1β, IL-8, and TNFα was not 
linear across the study visit. The final models for IL-1β and IL-8 had spline knots at sample 3 
indicating a significantly steeper decline in cytokine levels after sample 3 (Tables 5.4 and 5.6).  
The final model for TNFα had a significant spline knot at sample 2; TNFα declined from sample 
1 to sample 2 and then remained stable for the rest of the study visit (Table 5.7).  Results from 
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spline models and likelihood-ratio tests indicated that the change in IL-6 across the study visit 
was linear, so IL-6 was modeled linearly in the final model.  There was no significant change in 
IL-6 across the study visit (Table 5.5).   
Hypothesis 2: Associations between Salivary Cytokines and Demographic and Health Factors 
The results from final models for each cytokine are shown in Tables 5.4-5.7.  IL-1β and 
IL-6 were higher in children with current oral health issues compared to those without oral health 
issues (Table 5.4 and 5.5, respectively).  TNFα was higher in children with smoking mothers than 
those with non-smoking mothers (Table 5.7).  IL-6 was also positively associated with time since 
waking and age (Table 5.5).  IL-8 was the only cytokine not related to any demographic or health 
variable.   
Table 5.4. Results from final mixed models of log-transformed IL-1β (n=125) 
IL-1β 
Fixed Effects Parameter SE p 
Intercept 4.77 0.14 <.001 
Task Timing 0.00 0.01 .48 
Sample 1-3 -0.13 0.04 <.001 
Sample 3-4  -0.58a 0.15 <.001 
Current Oral Health Issues 0.59 0.18 <.01 
Random Effects Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.68 0.12 0.49-0.96 
Residual: AR(1)  
Rho 0.51 0.09 0.32-0.66 
Within-subject Variance 0.30 0.06 0.20-0.45 
SE= robust standard error; CI= confidence interval. 








Table 5.5.  Results from final mixed models of log-transformed IL-6 (n=125) 
IL-6 
Fixed Effects Parameter SE p 
Intercept 1.41 0.13 <.001 
Task Timing 0.00 0.00 .29 
Sample  -0.07 0.04 .11 
Current Oral Health Issues 1.03 0.39 <.01 
Age  0.10 0.04 <.01 
Time Since Waking 0.10 0.04 <.05 
Random Effects Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 1.48 0.21 1.12-1.97 
Residual: AR(1)  
Rho 0.36 0.09 0.16-0.53 
Within-subject Variance 0.39 0.08 0.26-0.60 
SE= robust standard error; CI= confidence interval. 
 
 
Table 5.6.  Results from final mixed models of log-transformed IL-8 (n=125) 
IL-8  
Fixed Effects Parameter SE p 
Intercept 6.32 0.13 <.001 
Task Timing 0.00 0.01 .77 
Sample 1-3 -0.06 0.03 .08 
Sample 3-4 -0.34a 0.16 <.05 
Random Effects Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.41 0.07 0.30-0.58 
Residual: AR(1)  
Rho 0.27 0.11 0.05-0.46 
Within-subject Variance 0.23 0.04 0.17-0.32 
SE= robust standard error; CI= confidence interval. 









Table 5.7.  Results from final mixed models of log-transformed TNFα (n=125) 
TNFα  
Fixed Effects Parameter SE p 
Intercept 0.54 0.19 <.01 
Task Timing -0.02 0.01 <.05 
Sample 1-2 -0.23 0.06 <.001 
Sample 2-4  0.10a 0.11 .36 
Maternal Smoking 0.52 0.22 <.05 
Random Effects Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.85 0.13 0.62-1.16 
Residual: AR(1)  
Rho 0.36 0.12 0.12-0.57 
Within-subject Variance 0.48 0.10 0.32-0.74 
SE= robust standard error; CI= confidence interval. 
aDifference between slopes from sample 1-2 and 2-4: β= 0.33, z= 2.66, p< .01.  
 
Hypothesis 3: Associations between Salivary Cytokines and ANS and HPA Activity 
 To examine the association between cytokine levels and ANS and HPA activity, sAA and 
cortisol were added separately as independent variables in final models for each cytokine (results 
shown in Appendix B Supplemental Tables S.5.1- S.5.4). Alpha-amylase was positively 
associated with IL-1β (β=0.16, z=2.16, p<.05) and TNFα (although this association was only 
marginal, β=.16, z=1.82, p=.07).  No significant relations were found between sAA and IL-6 and 
IL-8. Cortisol was not associated with any cytokine. 
 To examine sex differences in the relation between ANS or HPA activity and cytokine 
levels, the significance of sex by sAA or sex by cortisol interactions was tested in each final 
cytokine model. The interaction between sAA and sex was significant for IL-1β, IL-8 and TNFα 
(IL-1β: β= -0.40, z= -2.82, p< .01; IL-8: β= -0.30, z= -2.51, p<.05; TNFα: β= -0.49, z= -2.62,  
p<.01), and it was marginally significant for IL-6 (β= -0.44, z= -1.96, p= .05). These interactions 
indicated significant positive relations between cytokines and sAA among boys (effect of sAA on 
IL-1β: β= 0.43, z= 4.39, p <.001; IL-6: β=0.46, z= 2.68, p <.01; IL-8: β=0.30, z= 3.53, p <.001; 
TNFα: β=0.49, z= 3.45, p <.01), and less positive relations among girls.  The interaction between 
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cortisol and sex was also significant for every cytokine (IL-1β: β= 0.25, z= 2.69, p< .01; IL-6 β = 
0.33, z= 2.46, p< .05; IL-8: β = 0.25, z= 3.50, p< .001; TNFα: β = 0.30, z= 2.69, p< .01). These 
interactions indicated significant inverse relations between cytokines and cortisol among boys 
(effect of cortisol on IL-1β: β = -0.17, z= -3.24, p< .01; IL-6: β = -0.25, z= -2.81, p< .01; IL-8: β = 
-0.20, z= -3.68, p< .001; TNFα: β = -.26, z= -2.76, p< .01), and weaker inverse relations between 
cytokines and cortisol among girls.   
 To better understand the role of sex in moderating cytokine-CNS relations, the effects of 
sAA and cortisol were examined separately in sex-stratified final models for each cytokine.  The 
results from stratified models are shown in Appendix B Supplemental Tables S.5.5- S.5.8. 
Among boys, sAA was positively associated with each cytokine (IL-1β: β= 0.43, z= 4.62, p< 
.001; IL-6: β= 0.53, z= 3.87, p< .001; IL-8: β= 0.32, z= 3.66, p< .001; TNFα: β= 0.46, z= 3.33, p< 
.01) and cortisol was negatively associated with each cytokine (IL-1β: β= -0.17, z= -4.28, p< 
.001; IL-6: β= -0.27, z= -4.74, p< .001; IL-8: β= -0.21, z= -5.16, p< .001; TNFα: β= -0.26,          
z= -4.34, p< .001).  Among girls, there were no significant associations between cytokines and 
sAA or cortisol (Appendix B Supplemental Tables S.5.5- S.5.8).   
 Stratified analyses also revealed sex-specific cytokine trajectories across the study visit.  
The pattern of change in IL-1β and IL-8 observed in the whole sample was also seen among boys 
and girls separately, however the decreases in slopes at sample 3 were only significant among 
boys (difference between slopes from sample 1-3 and 3-4 for IL-1β with sAA: β= -0.54, z= -3.68, 
p<.001, with cortisol: β= -0.53, z= -3.63, p<.001; for IL-8 with sAA: β= -0.36, z= -2.11, p<.05, 
with cortisol: β= -0.35, z= -2.18, p<.05; Appendix B Supplemental Tables S.5.5 and S.5.7).  Also, 
IL-6 declined across the study visit in boys, but was stable across the visit for girls (for boys, IL-6 
slope with sAA: β= -0.16, z= -2.65, p<.01, with cortisol: β= -0.15, z= -2.56, p<.05; Appendix B 
Supplemental Table S.5.6).  The pattern of change in TNFα observed in the whole sample was 
also seen among boys and girls separately, however the change in slope at sample 2 was only 
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significant in girls (difference between slopes from sample 1-2 and 2-4 with sAA: β= 0.42, z= 
2.19, p<.05, with cortisol: β= 0.43, z= 2.22, p<.05; Appendix B Supplemental Table S.5.8).  
5.5. Discussion 
 The findings provide new information regarding salivary cytokine detectability, 
concentrations, task-sensitivity, and associations with demographic and health factors, as well as 
with measures of ANS and HPA activation in five-year old children. IL-1β, IL-6, IL-8 and TNFα 
all had high rates of detection and strong across-sample correlations suggesting that cytokine 
measurements were reliable and relatively stable within-individual. The findings also provide 
information about the constitution of saliva in young children. Consistent with findings from 
studies of adolescents and adults (23,26,28,63), levels of IL-1β and IL-8 were higher than levels 
of IL-6 and TNFα in this sample. Relative levels of cytokines were consistent across the saliva 
samples with IL-8 present at the highest concentrations, followed by IL-1β, IL-6 and TNFα. IL-
1β and IL-8 are important for the migration and activation of neutrophils, which are the most 
prevalent phagocytic immune cell in the mouth (64–66).  Despite varying concentrations, the 
cytokines were significantly positively intercorrelated at each saliva sampling time point. These 
findings support the first hypothesis; they add to findings from studies in older participants and 
suggest strongly coordinated immune processes within the oral cavity (23,67).  
Associations between Salivary Cytokines and Demographic and Health Factors 
 It was hypothesized that salivary cytokines are positively associated with factors related to 
oral health and unrelated to demographic and systemic health factors.  This hypothesis was 
largely supported. Children with oral health issues had higher levels of IL-1β and IL-6 and 
children exposed to tobacco smoke had higher levels of TNFα.  Previous studies have found 
elevated levels of salivary markers of inflammation in adults with gingivitis and periodontal 
disease (25–28), and in adolescents with dental caries (29). The current findings extend these 
associations to young children who typically have low rates of clinically diagnosed periodontal 
111 
 
conditions but may have high rates of loose or missing teeth and dental caries.  Exposure to 
tobacco smoke is a risk factor for periodontal disease in adults (30,68) and adolescents (31), and 
second-hand smoke exposure has been linked to elevated levels of salivary IL-1β in adults (30). 
The current finding that maternal smoking is positively associated with inflammatory cytokine 
levels in children extends our understanding of the effects of tobacco smoke exposure on child 
health. Future studies should examine the utility of salivary cytokines as early indicators of 
inflammatory processes involved in oral disease. 
 Unlike oral health factors, systemic health and demographic factors including sex, race, 
medication use, BMI, current sickness and recent health were unrelated to salivary cytokine 
levels.  Although the sample size was substantial, only a small group of children had fair or poor 
health.  Therefore, the heterogeneity and size of the sample may not have been sufficient to detect 
associations with recent health. The positive association observed between IL-6 and time since 
waking is consistent with findings of diurnal patterns of salivary IL-6 in adults with increasing 
concentrations beginning in the afternoon and peaking late at night (69).  Despite the narrow age 
range of the sample, older children showed higher levels of IL-6. The two other studies of 
salivary cytokines in children (with age ranges from 8 to 12 years) found no age or puberty-
related differences in IL-6 (8,9).  In a study of adolescent girls, age and puberty were related to 
salivary cytokine levels, however there were inverse associations in this older sample (23). Early 
childhood is a period of complex neurologic and immunologic development (1), therefore the 
positive associations between age and IL-6 found in the current study may represent 
developmental differences in neuro-immune processes specific to this developmental stage.   
 Overall, the finding that cytokines were largely unrelated to demographic and health 
characteristics, but were significantly elevated in children with oral health issues and those 
exposed to tobacco smoke supports the notion that salivary cytokines in young healthy children 
may not be representative of systemic inflammation, but rather reflect local immune processes of 
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the oral cavity. Although no saliva samples in the study were visually contaminated with blood, 
future investigations should examine whether blood contamination may confound the relation 
between salivary cytokines and oral health among children (7). Also, future studies of cytokine 
serum-saliva correlations could help explain the cytokine associations observed in this study and 
provide direct evidence regarding the level of compartmentalization of oral immune processes.  
Salivary cytokines may be more closely coordinated with serum levels during physiological states 
characterized as hyper-inflammatory (e.g., burns); studies to address this possibility seem like a 
worthwhile next step. 
Associations between Salivary Cytokines and ANS and HPA Activity 
 The hypothesis that cytokine activity is positively associated with ANS and negatively 
associated with HPA activity was partially supported.  Surprisingly, these relations varied by sex.  
Among boys, cytokines were positively associated with sAA and negatively associated with 
cortisol.  Among girls, however, there were no significant associations between ANS or HPA 
activity and any cytokine. Similar sex differences in NEI relations have been reported by studies 
of serum cytokines in adults (61,62,70,71). In these studies, men exhibited an increased 
sensitivity of inflammatory cytokines to the inhibitory effects of cortisol after a socioemotional 
stressor task, while women exhibited either no change or a decrease in sensitivity (61,62,71). 
These differences in cortisol sensitivity were associated with sex differences in cytokine levels 
across the stressor tasks with men showing a decrease in cytokines and women showing either no 
change or and increase (61,62).  In the current study, similar sex-specific patterns of change were 
observed as boys exhibited declining cytokine trajectories and girl exhibited flatter trajectories 
across the visit.  
 This is the first study to demonstrate these sex differences in NEI relations in children and 
using salivary markers of HPA and immune activity. The findings suggest that sexual 
differentiation in CNS-immune relations are mediated, at least in part, by mechanisms 
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independent of pubertal development; for example, intrauterine sex hormones may impact HPA 
axis development and regulation (72), and sex differences in maternal-fetal relations, placental 
function, and neuroendocrine-neuroimmune interactions may have lasting effects on NEI 
relations (73). The findings may help explain those of El-Sheikh and colleagues (8) who found 
stress-related increases in salivary IL-6 in girls and decreases in boys. Although El-Sheikh and 
colleagues (8) did not measure sAA or cortisol, the current findings suggest that sex-related 
changes in IL-6 may have be influenced by relations with ANS or HPA activity. The findings 
also extend sex-specific NEI relations beyond the HPA axis to include measures of ANS 
activation and suggest that similar sex differences may exist in HPA- and ANS-immune relations. 
While additional research is needed to examine whether NEI relations in saliva reflect systemic 
NEI functioning, evidence of relations between CNS and immune activity in the oral cavity that 
mirror those found in serum demonstrates great potential for advancing the field of 
developmental psychoneuroimmunology and addresses the fundamental question of whether 
minimally-invasive methods can be used to examine NEI functioning.   
Salivary Cytokine Task-sensitivity   
 Changes in cytokine levels across a series of cognitive and emotional challenge tasks were 
examined without a priori hypotheses regarding the nature, timing, and magnitude of task-related 
change in cytokine concentrations. The expected diurnal pattern of proinflammatory cytokine 
levels is an important context for interpreting these findings. While little is known about salivary 
cytokines in particular, the diurnal pattern of proinflammatory cytokines is influenced by cortisol, 
therefore, diurnal processes should exert positive change in cytokine levels across the study visit 
(69,74). The majority of the cytokines, however, declined across the visit.  
  Among boys, IL-1β, IL-6, and IL-8 declined across all four saliva samples, suggesting 
sensitivity to the study environment or tasks. Furthermore, IL-1β and IL-8 exhibited a marked 
decline in slope immediately after the emotional challenge tasks indicating potentially increased 
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sensitivity to the socioemotional stressors and the CNS response elicited by these tasks.  In 
contrast, TNFα declined across the cognitive tasks and remained stable across the emotional 
tasks, suggesting sensitivity to the cognitive tasks. Among girls, cytokine trajectories were flatter, 
which may indicate less-specific and reduced sensitivity to the tasks. Interestingly, despite a lack 
of association between cytokine and CNS activation in girls, cytokines did not show diurnal 
increases across the visit, but rather exhibited declining or stable trajectories. Further research is 
needed to understand the diurnal patterns of salivary cytokines and the mechanisms underlying 
task-specific cytokine change in young children. 
 The interpretation of cytokine trajectories is complicated by aspects of the study protocol, 
including the timing, order, and nature of the tasks, and the potential influence of unmeasured 
factors. The time between study tasks and saliva samples depended on the speed at which the 
child completed the tasks, and therefore varied across children. Given these differences in elapsed 
time from task to sample and the lack of information regarding salivary cytokine reactivity and 
recovery times, concentration changes are considered a cumulative response to all tasks rather 
than a specific response to one task. It is also important to note that increases in salivary 
cytokines often require new protein synthesis, and the time between the study tasks and saliva 
samples may not have been long enough to allow for the examination of task-related increases in 
cytokine concentrations.   
 Isolating cytokine task-specific change is also complicated by the order and types of tasks 
administered.  While cognitive challenge tasks engage ANS activation (39,40,75), tasks involving 
emotional and social evaluative threat are typically needed to initiate an HPA stress response 
(76).  This study used emotional challenge tasks shown to be effective stressors for young 
children (49,54,56).  These tasks are commonly used with this age group and include elements of 
social evaluative pressure. The emotional challenge tasks required the children to interact, and 
confront or disagree with, an adult authority figure (the research evaluator). The varied cortisol 
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response observed in the current study is typical for studies of the HPA response in children (76), 
and the observed increases in sAA indicate ANS activation in response to the emotional tasks.  
This increases confidence that the emotional challenge tasks employed were appropriate 
socioemotional stressors for this age group.  The extent of stress associated with the cognitive 
challenge tasks, however, is unclear (as cortisol levels declined across these tasks and sAA levels 
remained stable). Any CNS or cytokine response to the cognitive tasks likely influenced the 
subsequent response to the emotional challenge tasks. Future research is needed to delineate 
cytokine resting trajectories and sensitivity to specific types of stress.   
 This study represents the first examination of cross-system relations between salivary 
cytokines and measures of ANS and HPA activation. While this provides novel information 
regarding the coordinated response to stress in the oral cavity, it is important to recognize the 
potential influence of other unmeasured salivary analytes when interpreting cytokine task-
sensitivity. Trueba and colleagues (77) found that adults exhibit an increase in many anti-
inflammatory salivary proteins after acute socioemotional stress.  Additional research on the 
stress-related release of other anti-inflammatory proteins, the time course of their release, and the 
sensitivity of salivary cytokines to these proteins is important to illuminating the task-sensitivity 
of salivary cytokines and their associations with measures of ANS and HPA activity.  
5.6. Conclusion  
 These results provide unique information regarding the concentrations of salivary 
cytokines in young children and the interplay of these immunologic analytes with markers of 
ANS and HPA activity across a series of challenge tasks.  Confidence in the findings is bolstered 
by the tight controls afforded by laboratory-based sampling and repeated measures within 
individuals. The findings suggest that oral immune processes are highly coordinated.  Consistent 
associations between some cytokines and oral health variables suggest that local oral immune 
processes are distinct from the systemic immune system.  The NEI relations observed in this 
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study were similar to systemic NEI relations.  Therefore, levels of some salivary cytokines may 
provide insight into child oral health, and salivary cytokines may be used with ANS and CNS 
biomarkers to provide information regarding neuroendocrine-immune functioning. These findings 
present exciting opportunities for studying mechanisms linking brain, immunity and behavior, as 
well as the calibration of across-systems connections during early development and the impact 
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Maternal Distress and Child Neuroendocrine-Immune Regulation 
 
6.1. Abstract 
Background and Objectives: Early-life adversity may cause dysregulation in the 
neuroendocrine-immune network through repeated activation of the stress response, thereby 
increasing disease risk. It was hypothesized that, regardless of family socioeconomic status, 
maternal psychological well-being moderates neuroendocrine-immune relations in children. 
Methods: Five-year old children (n=125) and their mothers participated in a laboratory study. 
Children engaged in emotional stressor tasks and provided four saliva samples. Mothers 
completed a survey and psychological assessments. Saliva was assayed for markers of immune 
function (cytokines: IL-1β, IL-6, IL-8, TNFα) and hypothalamic-pituitary-adrenal activity 
(cortisol). A composite score for depressive symptoms, anxiety, and parenting stress 
characterized maternal distress. Multilevel mixed models for cortisol examined cortisol’s 
relations with cytokine levels, maternal distress, and the interaction between cytokines and 
maternal distress.  Models were adjusted for family socioeconomic status.    
Results: Significant cytokine by maternal distress interactions indicated that as maternal distress 
increased, expected inverse cytokine-cortisol relations within children became weaker for IL-1β, 
IL-6, and TNFα (β’s=0.13-0.21, SE’s=0.05-0.06, p< .05 for all). Sex-stratified models revealed 
that these interactions were only significant among girls (β’s=0.18-0.27, SE’s=0.07, p< .01 for 
all). Among boys, there were inverse cytokine-cortisol relations for all cytokines (β’s=-0.18-            
-0.34, SE’s=0.05-0.08, p< .01 for all), and, while in the same direction as observed among girls, 
the cytokine by maternal distress interactions were non-significant.  
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Conclusions: Maternal distress influences child neuroendocrine-immune functioning by altering 
the sensitivity of inflammatory immune processes to cortisol’s inhibitory effects. This 




Early-life adversity contributes to poorer mental and physical health throughout life (1–
3).  Increasingly, pediatricians are expected to play a role in identifying and preventing early-life 
adversity (4–6).  Developing effective interventions requires advanced understanding of the 
mechanisms that link adversity to disease.  Repeated activation of the stress response, as a 
consequence of childhood adversity, may disrupt the critical balance required for healthy 
neuroendocrine-immune (NEI) network function.  Such disruptions may render the body 
vulnerable to imbalanced NEI activity, and increase disease risk later in life. For example, 
adversity may make inflammatory immune processes less sensitive to inhibitory signals from the 
central nervous system (i.e., cortisol), thereby increasing risk for chronic inflammation (7).  
Previous research suggests, however, that the negative effects of adversity on health may be 
buffered by a supportive caregiver (8–10).  Better understanding of the role caregivers play in 
moderating stress-related damage within the NEI network may illuminate a link between early-
life adversity and health, which, in turn, may contribute to more effective screening tools and 
interventions.   
This study uses salivary biomeasures to examine whether the coordination between 
hypothalamic-pituitary-adrenal (HPA) axis and immune system functioning varies by level of 
maternal distress in five-year old children from diverse socioeconomic backgrounds. This paper 
addresses two gaps in current knowledge. First, unlike prior studies that do not adequately parse 
financial and psychosocial aspects of adversity (11), this paper used several markers of maternal 
psychological well-being and socioeconomic status (SES) to separate the effects of caregivers 
from SES. Second, rather than examining a single biologic system, this paper assessed relations 
between the HPA and immune systems to gain a nuanced understanding of the biologic 
consequences of early-life adversity. It was hypothesized that maternal psychological well-being 
moderates HPA-immune system relations regardless of SES.       
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6.3. Methods   
This study used data from the Fetus to Five study (12,13). 
Participants 
Mother-child pairs were recruited from 2011 to 2013 as reported previously (12,13). 
Approximately a third of the sample (58 mother-child pairs) was recruited from mothers who 
participated in a fetal development study in 2006-2007.  Enrollment in the fetal development 
study was limited to low-risk, healthy women (13).  To increase the diversity of the sample, an 
additional 93 participant pairs were enrolled from Baltimore, Maryland using flyers in libraries, 
schools, and grocery stores.  English fluency was required, and child participants had to be five-
years old.  Mother-child pairs were excluded if mothers reported that the child had a health or 
developmental condition impairing cognitive, motor, or regulatory functioning.   
Procedures 
 The Johns Hopkins Bloomberg School of Public Health Institutional Review Board 
approved the study protocol.  Mothers provided written consent.  During a 90-minute study visit, 
five-year old children (mean=5.45 years, SD=0.29) completed neuropsychological and behavioral 
assessments and participated in emotional stressor tasks.  Four saliva samples were collected from 
children; two before and two after the stressor tasks.  Mothers provided sociodemographic and 
child health information, and completed a battery of psychological assessments.    
Emotional stressor tasks:  Children participated in three age-appropriate emotional stressor tasks 
including: the Disappointing Gift Game, the Not Sharing Game, and Mischel’s Delay of 
Gratification Task (14).  These tasks elicit negative emotions (e.g., anger and frustration) and 
challenge behavioral and emotional regulation (14–21).  The Not Sharing Game also elicits an 
increase in salivary cortisol in young children (20).  Detailed descriptions of the tasks were 
previously published (12). 
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Family sociodemographic data:  Sociodemographic data included: family income, maternal 
education, marital status, and the number of moves during the child’s life.  Financial stress was 
measured using a six-item instrument adapted from Essex and colleagues (22) assessing the 
frequency of financial stressors in the last three months (e.g., difficulty paying bills, fears of 
losing home/job). (Table 6.1) 
Maternal psychological measures:  Maternal psychological well-being was measured using three 
commonly-used, validated instruments. Maternal depressive symptoms in the last week were 
measured using the Center for Epidemiologic Studies Depression Scale (CESD-20; 23).  Trait-
anxiety was assessed using the Speilberger State-Trait Anxiety Inventory-Form Y2 (STAI; 24). 
Maternal parenting and life stress were measured using the Parenting Stress Index-Short Form 
(PSI; 25). (Table 6.1) 
Key covariates:  Salivary biomarkers can be affected by illness and contamination with blood.  
Thus, mothers provided information on whether children were experiencing symptoms of illness 
as well as whether they had loose or recently shed teeth or had other dental issues. Information 
about other potential confounders of cortisol and cytokine concentrations, including child age, 
sex, and maternal smoking status (smoking/non-smoking), was based on maternal report.  
 Body mass index (BMI) was determined using evaluators’ measurements of children's 
height and weight (26).  Weight status (underweight or healthy weight vs. overweight or obese) 
was assigned using the Centers for Disease Control and Prevention’s BMI percentile ranks by age 
and sex (27). 
The impact of diurnal patterns in cortisol was examined using elapsed time from mother 
reports of child waking to study appointment. To account for the differential timing of stressor 
tasks relative to saliva samples across children, a task timing variable, defined as the time 
between the beginning of the stressor tasks and each sample, was calculated.  
129 
 
Biomeasure data:  Whole saliva was collected using passive drool. Children pooled saliva in their 
mouths and drooled it into a collection vial. Samples were stored at -20 degrees Celsius until 
assayed.  Saliva was assayed for cortisol, a marker of HPA activity, and for four proinflammatory 
cytokines: interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis 
factor alpha (TNFα). 
Table 6.1.  Family sociodemographic and maternal psychological characteristics (n=125) 
Sociodemographic Characteristicsa    
 Frequency Percent 
Family income in last 12 months     
<$5,000-$11,999 30 24% 
$12,000-$24,999 29 23% 
$25,000-$49,999 11 9% 
$50,000-$99,999 14 11% 
≥$100,000 41 33% 
Maternal education     
<High school (HS) 8 6% 
HS degree/General Equivalency Diploma  33 26% 
Some college 31 25% 
2-year degree 7 6% 
4-year degree 20 16% 
Masters degree 11 9% 
Doctoral/professional degree 15 12% 
Maternal marital status      
Married 56 45% 
Moves during child's life     
0 35 28% 
1 38 30% 
2 17 14% 
3 21 17% 
4 7 6% 
5 2 2% 
6+ 5 4% 
Maternal financial stress (mean (SD), range)b 14.62 (6.87) 6-30 
Maternal Psychological Characteristicsc   
 Mean (SD) Range 
Maternal depressive symptomsd 13.62 (10.91) 0-47 
Maternal anxietye 37.39 (9.62) 20-62 
Maternal parenting and life stressf 67.67 (17.26) 36-113 
SD= Standard deviation. aVariables included in financial hardship factor. bCronbach’s α=.91 for this sample of 125 
mothers. cVariables included in maternal distress factor. Correlation between measures: depressive symptoms with 
anxiety: Spearman’s rho=.84; depressive symptoms with stress: Spearman’s rho=.53; anxiety with stress: Spearman’s rho=.60 
(p<.001 for all). dCronbach’s α=.90 for this sample of 125 mothers. 
e
Cronbach’s α=.85 for this sample of 125 mothers. 
f




Determination of Salivary Analytes  
Saliva assays were performed at the Center for Interdisciplinary Salivary Bioscience 
Research at the Johns Hopkins School of Nursing.  Cortisol was analyzed in duplicate using a 
commercially available enzyme immunoassay (Salimetrics, Carlsbad, CA). Cortisol assay 
sensitivity ranged from 0.007 to 3.0 µg/dL.  The intra-assay coefficient of variation (CV) was less 
than 5%, and the inter-assay CV was less than 10%. Eight percent of cortisol concentrations were 
below the lower limit of detection (LLD); these values were substituted with half the LLD 
(0.0035 µg/dL).   
Salivary cytokines were measured following Riis and colleagues (28) using multiplex 
electrochemiluminescence immunoassays by Meso Scale Discovery (Gaithersburg, MD).  MSD 
4-plex Multi-Spot Array assays were run following the manufacturer’s protocol. Cytokine 
concentrations (pg/mL) were determined with MSD Discovery Workbench Software (v. 3.0.17) 
using curve fit models (4-PL with a weighting function option of 1/y2). Lower limits of detection 
and intra-assay CVs were: IL-1β: 0.06 pg/mL, 4.4%; IL-6: 0.09 pg/mL, 4.8%; IL-8: 0.05 pg/mL, 
2.1%; and TNFα: 0.11 pg/mL, 6.6%.  All IL-1β and IL-8 concentrations were measureable above 
the LLD.  A small number of non-detects for IL-6 (<1%) and TNFα (5%) were replaced with 
laboratory-estimated concentrations.  Associations between cytokine concentrations and flow rate 
were tested using Spearman’s rank correlations and regression analyses with robust variance. No 
consistent relations were found, so data were not adjusted for salivary flow rate.  
All analyte data were positively skewed.  Data were log-transformed and Winsorized (29) 
(by analyte and sample) to improve the normality of the distributions.  For each analyte, ≤1% of 
concentrations were Winsorized, and all values were brought within three standard deviations of 





Factor analyses: The first step in data analysis was to determine whether the eight SES indicators 
and maternal psychological scale scores (Table 6.1) could be combined into distinct measures. 
This was achieved by polychoric exploratory factor analysis using maximum likelihood 
estimation with robust standard errors, oblique rotation, and one to four factors.  A two factor 
solution was selected based on information criteria, factor loadings, and residual variances; one 
factor represented financial hardship and one represented maternal distress (Tables 6.1, 6.2). 
Oblique rotation resulted in two factors with correlation=0.57 (p< .001).  Greater financial 
hardship was associated with greater maternal distress. Factor scores, derived using the posterior 
mode method, provided a score for financial hardship and maternal distress for each child.    
Table 6.2.  Factor loadings and parameter estimates from factor analyses with a two-factor 















Family income in last 12 months .95* .93** .00  
Maternal education .75* .82** .13  
Maternal marital status 1.04* .89** -.23  
Moves during child’s life .59* .61** .04  
Maternal financial stressb .51* .68** .30*  
Maternal depressive symptomsc .08  .86* .90** 
Maternal anxietyd .00  .89* .89** 
Maternal parenting and life 
stresse 
-.20*  .74* .62** 
 
aTwo-factor solution selected using information criteria, factor loadings and residual variances of solutions with one 
to four factors. Akaike and Bayesian Information Criteria and sample-size adjusted Bayesian Information Criteria: 1 
factor= 2450.34, 2532.36, 2440.65; 2 factors= 2306.05, 2407.87, 2294.03; 3 factors= 2303.65, 2422.44, 2289.63; 4 
factors= 2311.55, 2444.49, 2295.86. The two-factor solution had low residual variances (residual variance ranged 
from 0.10- 0.62). The three-factor solution had low residual variances with the same loading pattern as the two-
factor solution except with an additional third factor comprised of only one variable (moves during child’s life). 
bMeasured with the Financial Stress Index. cMeasured with Center for Epidemiologic Studies Depression Scale. 
dMeasured with  Speilberger State-Trait Anxiety Inventory-Form Y2.  eMeasured with Parenting Stress Index-Short 
Form.  
Bolded factor loadings indicate factor structure used in to generate factor scores. Factor loadings are rotated and 
parameter estimates are standardized. *p< .05, **p< .001. 
 
Multilevel Mixed Models: The next step was to examine the effect of cytokine concentrations, 
maternal distress, and cytokine by maternal distress interactions on cortisol values. Cortisol was 
132 
 
modeled as an outcome using multilevel mixed models with a random intercept and a random 
slope to account for repeated sampling within individuals and varying cortisol trajectories across 
the visit between individuals.  Robust variance and an independent covariance and residual errors 
structure were specified.  Residual variance was modeled separately for each saliva sample to 
allow for unequal variance across samples.  
 First, bivariate analyses explored relations between cortisol and each independent 
variable. Next, four separate fully-adjusted models for cortisol were performed, each with only 
one cytokine predictor.  The independent variables in fully-adjusted models included: the 
cytokine of interest, maternal distress score, cytokine by maternal distress interaction, all key 
covariates, and the financial hardship score. Fully-adjusted models also included a time since 
waking by saliva sample interaction term based on literature showing blunted cortisol responses 
to acute stress in the morning vs. afternoon (30).  Sex differences in cytokine-cortisol relations in 
these data were reported previously (12), so a sex by cytokine interaction term was also included 
in fully-adjusted models.  The main independent variables of interest in fully-adjusted models 
were the cytokine of interest, maternal distress score, and cytokine by maternal distress 
interaction.  Four parsimonious final models were created by subjecting fully-adjusted models to 
backwards stepwise selection of covariates using a p< .05 retention criterion.  The main 
independent variables were retained for final models and not subjected to the backwards stepwise 
selection.  Model fit was assessed for each final model using residual and added variable plots. 
 In addition to including financial hardship as a covariate, post-hoc models examined the 
specificity of the moderating effect of maternal distress on cytokine-cortisol relations by testing 
the significance of cytokine by financial hardship interaction terms in final models with maternal 
distress included as a covariate.   
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 All analyses, except factor analyses, were conducted in Stata/SE 12.1 (StataCorp LP, 
College Station, TX).  Factor analyses were conducted in MPlus Version 7.11 (Muthen and 
Muthen, Los Angeles, CA). 
Missingness: There were no missing data for maternal education, marital status, or the number of 
moves. Family income data were missing or classified as “don’t know” for 10% of the sample. 
Incomplete responses were imputed with the mean response for the sample group (e.g., fetal 
development follow-up or community participants). Item-level missingness for the financial 
stress index, CES-D, STAI and PSI ranged from 10-18%, but only six participants were missing 
more than one item per instrument. Thus, item-level missingness was imputed with the mean of 
the completed items in the scale (or subscale for PSI). 
There were low rates of missingness for most demographic, health and timing data (0-
<3% for all variables except child age).  Parent-reported child age in months was missing for 9% 
of the sample (although all children were five-years old). Missing demographic, health, and 
timing data were obtained using evaluator’s notes (14%) or imputed with mean values (86%). 
Sensitivity Analyses: Sensitivity analyses performed on complete case data assessed the impact of 
missingness imputations. Also, the impact of substitution methods for cortisol non-detects was 
examined by testing an alternate substitution and using random effects Tobit models. Results 
from these sensitivity analyses (estimates, p-values) did not significantly differ from the reported 
results. 
6.4. Results  
Data were collected from 151 mother-child pairs.  Three children were unable to 
complete the appointment, and 23 children had insufficient salivary data.  Analyses were 
performed on the remaining 125 pairs. Sociodemographic and health measures did not differ 
between children with and without full salivary data.  Approximately half the children in the 
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sample were female, and slightly more than a third were overweight (Table 6.3).  On average, 
children were awake for seven hours when the study appointment began (Table 6.3).  A wide 
range of SES families were represented in the sample; annual incomes ranged from less than 
$5000 to greater than $100,000 (Table 6.1).  There was also a wide range of maternal 
psychological distress in the sample (assessed using the CES-D, STAI and PSI; Table 6.1). 
 
Multilevel Mixed Models for Cortisol 
Backward stepwise selection of covariates:  Seven covariates were retained in each of the four 
final models (sample, child sex, sex by cytokine, current illness, financial hardship, time since 
waking, time since waking by sample). In addition to these covariates, child BMI category was 
significantly associated with cortisol in models with TNFα as the main cytokine predictor. Thus, 
BMI was included in this final model.  
Final model results for covariates:  Results from the final models are displayed in Table 6.4.  
Cortisol decreased across the study visit in all models, and as time since waking increased, the 
decline in cortisol across the visit became steeper. Cortisol was higher in sick children compared 
to healthy children.  Also, there were significant inverse relations between family financial 
hardship and cortisol indicating that as financial hardship increased, cortisol levels decreased. In 
the model with TNFα as a main predictor, overweight and obese children had lower cortisol 
levels than underweight children and children of a healthy weight. There were no sex differences 
in cortisol at mean cytokine levels in any model, however, there was a significant interaction 
Table 6.3.   Demographic and health characteristics (n=125)a 
  Frequency Percent 
Child age, mean years (SD) 5.45 (0.29) 
Female 64 51% 
Current illness 24 19% 
Current periodontal/dental issues 14 11% 
Mother smokes 28 22% 
Child overweight or obese 44 35% 
Time from waking to study appointment, mean hours (SD) 7.05 (2.41) 
SD=Standard deviation.  aMissing data were <3% for all variables except child age. Although all children were 
five years old, age in months was missing for 9% of the sample.  Missing data were imputed with mean values. 
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between sex and cytokine in every model indicating stronger inverse relations between cytokine 
and cortisol concentrations in boys compared to girls.   
Neuroendocrine-immune relations and moderation by maternal distress: IL-6 and IL-8 were 
inversely associated with cortisol (Table 6.4). While there was no main effect of maternal distress 
on cortisol in any model, there were significant interactions between cytokines and maternal 
distress for IL-1β, IL-6 and TNFα (Table 6.4).  Inverse relations between cortisol and IL-1β, IL-6 
and TNFα became less strong with increasing maternal distress (Figure 6.1).    
Post-hoc analyses tested the specificity of cytokine by maternal distress interaction 
effects on cortisol by examining the significance of cytokine by financial hardship interaction 
terms in final models with maternal distress included as a covariate. The cytokine by financial 
hardship interaction was not significantly associated with cortisol for IL-6, IL-8 and TNFα. The 
interaction between IL-1β and financial hardship was significantly positively associated with 
cortisol (β=0.03, z=2.42, p< .01) indicating that the inverse relation between IL-1β and cortisol 
became less strong as financial hardship increased, similar to the relation for maternal distress.  
The role of child sex:  There were significant sex by cytokine interactions in every model 
indicating stronger inverse cytokine-cortisol relations in boys than girls (Table 6.4). To explore 
sex-specific relations, stratified analyses for each final model were performed using a 
homogeneous independent residual structure and regular (not robust) variance given the smaller 
sample sizes.  
Cytokine-cortisol relations varied by sex with significant inverse relations between 
cortisol and all cytokines among boys, but not girls (Table 6.5).  Among girls, IL-1β, IL-6 and IL-
8 were positively related to cortisol, although these relations were only marginally significant 
(Table 6.6).  Similarly, cytokine by maternal distress interactions varied by sex for IL-1β, IL-6 
and TNFα with significant positive interactions among girls, but not boys (although t-tests of 
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Table 6.4. Adjusted relations between cortisol, cytokines, and maternal distress among five-year old children using multilevel mixed models 
(n=125) 
  Cytokine Main  
Independent Variable:  
IL-1β  
Cytokine Main  
Independent Variable:  
IL-6  
Cytokine Main  
Independent Variable:  
IL-8  
Cytokine Main  
Independent Variable:  
TNFα 
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept -3.00 0.13 <.001 -3.00 0.13 <.001 -2.97 0.13 <.001 -2.88 0.13 <.001 
Main Independent Variables:                          
Cytokine concentration -0.13 0.10 .19 -0.15 0.07 <.05 -0.27 0.12 <.05 -0.11 0.09 .22 
Maternal distress 0.04 0.13 .76 0.04 0.13 .75 0.07 0.13 .57 0.07 0.13 .59 
Cytokine*maternal distress 0.21 0.05 <.001 0.14 0.06 <.05 0.13 0.08 .09 0.13 0.05 <.05 
Covariates:                          
Sample -0.10 0.03 <.01 -0.12 0.02 <.001 -0.13 0.03 <.001 -0.11 0.03 <.001 
Child sex (female) -0.09 0.15 .56 -0.06 0.15 .69 -0.08 0.15 .58 -0.07 0.14 .64 
Child sex*cytokine 0.27 0.12 <.05 0.28 0.11 <.05 0.40 0.15 <.01 0.20 0.10 <.05 
Child overweight or obesea - - - - - - - - - -0.38 0.18 <.05 
Child currently sick 0.46 0.16 <.01 0.44 0.15 <.01 0.47 0.16 <.01 0.51 0.16 <.01 
Family financial hardship  -0.08 0.02 <.01 -0.08 0.02 <.01 -0.08 0.02 <.001 -0.07 0.02 <.01 
Time since waking -0.05 0.03 .12 -0.03 0.03 .30 -0.05 0.03 .11 -0.03 0.03 .29 
Time since waking*sample -0.02 0.01 <.05 -0.02 0.01 <.01 -0.02 0.01 <.01 -0.02 0.01 <.05 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Variance(intercept) 0.60 0.10 0.44-0.82 0.60 0.10 0.43-0.84 0.59 0.10 0.43-0.81 0.58 0.09 0.42-0.78 
Variance(sample) 0.02 0.02 0.01-0.09 0.02 0.02 0.00-0.10 0.02 0.02 0.01-0.09 0.02 0.02 0.01-0.09 
Residual variance                         
Sample 1 0.16 0.07 0.07-0.36 0.17 0.07 0.08-0.36 0.17 0.07 0.07-0.38 0.16 0.07 0.07-0.36 
Sample 2 0.13 0.05 0.06-0.28 0.13 0.05 0.06-0.29 0.14 0.06 0.06-0.31 0.14 0.05 0.06-0.30 
Sample 3 0.28 0.10 0.13-0.58 0.26 0.10 0.13-0.54 0.27 0.09 0.14-0.54 0.28 0.10 0.14-0.55 
Sample 4 0.43 0.12 0.25-0.75 0.42 0.13 0.23-0.76 0.41 0.12 0.24-0.72 0.42 0.12 0.23-0.75 
SE= robust standard error; CI= confidence interval. 
aChild body mass index category was only significantly associated with cortisol in models with TNFα, so body mass index category was only retained in the final model with 
TNFα  as the cytokine main independent variable.  
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model coefficients revealed no significant differences between the interaction effects for boys and 
girls; Table 6.6).  Among girls, as maternal distress increased, the positive cytokine-cortisol 
relations became stronger, mirroring the relations in the full sample. Again, the specificity of 
cytokine by maternal distress interactions were tested in boys and girls separately in post-hoc 
analyses.  No significant cytokine by financial hardship interactions were found among boys.  
Among girls, the only significant cytokine by financial hardship interaction was seen for IL-1β 
(β=0.03, z=2.43, p< .05) and the direction of this effect was the same as that observed in the full 
sample. 
Figure 6.1. Interaction between salivary cytokines and maternal distress on estimated mean log-
transformed salivary cortisol in five-year old children (n=125)a 
aCortisol and cytokines are Winsorized and log-transformed. Cytokines are centered. Models were adjusted for 
significant child health and demographic factors and family socioeconomic status. Maternal distress categorized using 
tertiles.  
 
Sensitivity analyses:  Two sets of sensitivity analyses assessed the robustness of the cytokine by 
maternal distress interactions on cortisol.  First, the maternal distress variable was categorized, 
and the significance of interactions between cytokines and a three-level maternal distress variable 
was assessed.  Findings from these models were similar to those reported above (p-values and 
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estimates).  Second, influential data points were excluded from the final models. In these models, 
the cytokine by maternal distress interaction findings were similar to those reported above for IL-
1β, IL-6 and IL-8.  However, the TNFα by maternal distress interaction was only marginally  
significant when influential data points were excluded from analyses of the full sample and of 
girls (in full sample: β=0.09, z=1.74, p< .08; in girls only: β=0.15, z=1.76, p< .08). 
6.5. Discussion 
Moderating Role of Maternal Distress on Neuroendocrine-immune Relations 
Findings from this study provide insight into the sensitivity of child NEI relations to 
adversity.  In the sample of young children from varied SES families, relations between 
inflammatory immune and HPA activity (measured by cortisol) in saliva varied by maternal 
distress.  Regardless of SES, as maternal distress increased, inverse relations between cytokine 
and cortisol activity in children became weaker. Systemically, cortisol regulates inflammation by 
inhibiting the activity of inflammatory cytokines (31). This regulatory mechanism is important 
for preventing excessive and potentially dangerous inflammation (31,32). The findings suggest 
that maternal distress is associated with less efficient regulation of inflammatory mechanisms in 
children.  These findings are consistent with the notion that adversity can result in a “defensive 
phenotype” characterized by an over-active inflammatory response (7,33). While potentially 
adaptive in the short-term, prolonged up-regulation of inflammatory mechanisms damages cells 
and increases disease risk (32).  
Interestingly, the significant interactions between cytokines and maternal distress were 
driven by significant interactions among girls.  While cytokine by maternal distress interactions 
observed among boys were in the same direction as those in girls and there were no significant 
differences in interaction effects by sex, all interaction terms were non-significant among boys.  
These sex differences may be related to sex differences in cytokine-cortisol relations.  As 
previously reported (12), there were inverse relations between cortisol and every cytokine for
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Table 6.5.  Adjusted relations between cortisol, cytokines, and maternal distress among five-year old boys using multilevel mixed models (n=61) 
  Cytokine Main  
Independent Variable:  
IL-1β  
Cytokine Main  
Independent Variable:  
IL-6  
Cytokine Main  
Independent Variable:  
IL-8  
 Cytokine Main  
Independent Variable:  
TNFα  
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept -2.97 0.13 <.001 -2.99 0.13 <.001 -2.96 0.13 <.001 -2.93 0.16 <.001 
Main Independent Variables:                          
    Cytokine concentration -0.23 0.08 <.01 -0.21 0.05 <.001 -0.34 0.08 <.001 -0.18 0.06 <.01 
Maternal distress 0.28 0.18 0.11 0.27 0.18 .13 0.29 0.17 .09 0.32 0.17 .07 
Cytokine*maternal      
distress 
0.11 0.09 0.22 0.11 0.07 .11 0.11 0.10 .25 0.08 0.07 .29 
Covariates:                          
Sample -0.15 0.04 <.001 -0.12 0.04 <.01 -0.17 0.04 <.001 -0.13 0.04 <.001 
Child overweight or obesea - - - - - - - - - -0.22 0.26 .41 
Child currently sick 0.39 0.28 0.18 0.43 0.28 .13 0.46 0.28 .10 0.53 0.28 .06 
    Family financial  hardship  -0.08 0.04 <.05 -0.07 0.04 .06 -0.09 0.04 <.05 -0.08 0.04 <.05 
Time since waking -0.07 0.05 0.16 -0.04 0.05 .44 -0.07 0.05 .14 -0.06 0.05 .25 
Time since waking 
*sample 
-0.03 0.01 <.05 -0.03 0.01 <.05 -0.03 0.01 <.05 -0.03 0.01 <.05 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Variance(intercept) 0.76 0.15 0.52-1.11 0.77 0.15 0.52-1.13 0.73 0.14 0.50-1.07 0.74 0.15 0.50-1.09 
Variance(sample) 0.03 0.01 0.01-0.08 0.04 0.01 0.02-0.08 0.03 0.01 0.01-0.07 0.04 0.01 0.02-0.08 
Residual variance 0.22 0.03 0.17-0.28 0.20 0.03 0.16-0.26 0.21 0.03 0.16-0.27 0.21 0.03 0.16-0.27 
SE= standard error; CI= confidence interval. 




Table 6.6.  Adjusted relations between cortisol, cytokines, and maternal distress among five-year old girls using multilevel mixed 
models (n=64) 
  Cytokine Main  
Independent Variable:  
IL-1β  
Cytokine Main  
Independent Variable:  
IL-6  
Cytokine Main  
Independent Variable:  
IL-8  
 Cytokine Main  
Independent Variable:  
TNFα  
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept -3.09 0.09 <.001 -3.06 0.09 <.001 -3.04 0.10 <.001 -2.90 0.11 <.001 
Main Independent Variables:                          
Cytokine concentration 0.11 0.06 .07 0.09 0.05 .06 0.12 0.07 .07 0.06 0.05 .25 
Maternal distress -0.21 0.12 .08 -0.21 0.13 .10 -0.15 0.13 .26 -0.19 0.13 .13 
Cytokine*maternal distress 0.27 0.07 <.001 0.20 0.07 <.01 0.12 0.09 .20 0.18 0.07 <.01 
Covariates:                          
Sample -0.07 0.04 .06 -0.11 0.04 <.01 -0.10 0.04 <.01 -0.10 0.04 <.01 
Child overweight or obesea -  -  -  -  -  -  -  -  -  -0.49 0.19 <.05 
Child currently sick 0.45 0.21 <.05 0.41 0.22 .07 0.42 0.23 .06 0.41 0.22 .06 
Family financial hardship  -0.07 0.02 <.01 -0.07 0.02 <.01 -0.07 0.03 <.05 -0.05 0.02 <.05 
Time since waking -0.02 0.04 .58 -0.01 0.04 .86 -0.02 0.04 .59 0.00 0.04 .90 
Time since waking*sample -0.02 0.01 .14 -0.03 0.01 .08 -0.02 0.02 .10 -0.02 0.02 .16 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Variance (intercept) 0.35 0.07 0.23-0.52 0.37 0.08 0.24-0.56 0.39 0.08 0.26-0.59 0.35 0.07 0.23-0.53 
Variance (sample) 0.03 0.10 0.10-0.08 0.03 0.01 0.01-0.08 0.03 0.02 0.01-0.08 0.03 0.02 0.01-0.08 
Residual variance 0.24 0.03 0.19-0.31 0.25 0.03 0.20-0.32 0.25 0.03 0.20-0.32 0.25 0.03 0.20-0.32 
SE= standard error; CI= confidence interval. 
aChild body mass index category only retained in the final model with TNFα as the cytokine main independent variable. 
141 
 
boys but not girls.  Among girls, cytokines were positively associated with cortisol (although 
relations were non-significant).  Similar sex differences in serum cytokine-cortisol relations have 
been reported in adults (34–37). These studies suggest that inflammatory cytokines in males show 
increased sensitivity to the inhibitory effects of cortisol after acute stress, while the same 
cytokines in females show no change or decreased sensitivity (35–37).  These differences may 
make females more vulnerable to the moderating effect of maternal distress on NEI regulation.  If 
cytokines are predisposed to exhibit decreased sensitivity to cortisol, the desensitization of 
inflammatory mechanisms associated with adversity may be magnified or observed at lower 
levels of adversity or earlier in the lifecourse among females.   
The cytokine by maternal distress interaction was significant for every cytokine except 
IL-8.  Previous investigations of these same data found that, of all four cytokines, IL-8 was 
present at the highest concentrations and was the only cytokine not associated with any 
demographic or health factor (12).  Further investigation is needed to fully understand salivary 
IL-8 and its sensitivity to demographic, health and psychosocial health factors. Future studies 
should also examine the robustness of the TNFα-maternal distress interaction as this relation was 
only marginally significant when influential cases were excluded.  
Cortisol Relations with Covariates 
Results from this study are also consistent with previous findings regarding salivary 
cortisol activity in young children. The observed decline in cortisol across the study visit and the 
impact of time since waking on this decline are consistent with the known diurnal pattern of 
salivary cortisol (38).  Also, the increased cortisol levels found among children with a cold/fever 
on the day of the visit reflect the body’s response to infection or injury which is typically 
characterized by elevations in cortisol (39).  Finally, overweight and obese children had lower 
cortisol than underweight children and those of a healthy weight.  The relation between cortisol 
and BMI in children is unclear with studies showing both increases and decreases in cortisol after 
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a weight gain (40,41). In the current study, overweight and obese children were more likely to be 
from lower SES families with more maternal distress.  The observed relation between cortisol and 
BMI may have been confounded by family SES and maternal distress.  Furthermore, cortisol and 
BMI were only significantly related in models that included TNFα, and stratified analyses 
revealed significant relations only among girls. Further research is needed to fully understand the 
relation between BMI and NEI network activity, as well as the influence of SES, early-life 
adversity and sex on these relations. 
  Family financial hardship was inversely associated with cortisol, indicating that as 
financial hardship increased cortisol levels decreased.  These results are consistent with studies 
showing blunted physiologic stress responses among low-SES children (42,43).  SES-related 
differences in cortisol likely reflect a combination of psychosocial and environmental effects. 
While the models accounted for the distinct effects of maternal distress, other unmeasured SES-
related factors likely contributed to the financial hardship relations observed in this study. 
Importantly, the moderating effect of maternal distress on cytokine-cortisol relations was 
significant after adjusting for financial hardship. Also, financial hardship did not moderate NEI 
relations for IL-6, IL-8 or TNFα. The only cytokine-cortisol relation moderated by financial 
hardship was the IL-1β-cortisol relation, and this interaction was in the same direction as 
cytokine-maternal distress interactions. Additional research is needed to fully understand the role 
of financial, psychosocial, and environmental factors in modifying NEI relations in children. 
However, these results suggest that maternal psychological well-being plays a unique role in 
moderating child NEI relations and these effects cannot be explained by SES.      
There are several strengths to the study.  First, the sample size is large and includes 
children with diverse SES backgrounds.  Also, several aspects of SES were measured and 
included as covariates.  The discrete effect of maternal psychological well-being was examined 
using validated instruments. The findings are further strengthened by repeated within-subject 
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sampling and tightly controlled laboratory procedures.  Finally, the use of salivary biomeasures 
represents a novel approach to studying the effects of adversity which allowed for the 
examination of several measures of NEI activity. By examining immune system and HPA activity 
simultaneously, the findings provide a new, more complex understanding of the physiologic 
effects of adversity. This study demonstrates the potential of using minimally-invasive methods 
to study, detect, and treat the physiologic effects of early-life adversity.   
Despite the strengths, limitations regarding the study design and sample warrant 
discussion.  While the acute stress response was not the focus of this investigation, the findings 
likely reflect acute stress-related activity within the NEI network.  Stress-related change in 
cortisol concentrations across the study visit were examined in a previous study (12).  The acute 
stress response of cortisol varied across children with about 44% of children showing an increase 
and 40% showing a decrease in cortisol after the stressor tasks (12). These changes in post-
stressor cortisol, however, did not significantly impact the linearity of cortisol across the visit, 
and preliminary analyses assessing the need for non-linear modeling of cortisol were not 
significant.  The linear trajectory of cortisol observed across the study visit may be partially due 
to the differential timing of stressor tasks and saliva samples in the study protocol. While the 
order of study tasks was the same for each participant, the timing of saliva samples relative to the 
stressor tasks depended on the speed at which the child completed the tasks.  Therefore, task-
related changes in analytes are considered cumulative responses to all tasks. Variation in cortisol 
trajectories after an acute stressor is typical for young children (44), and, in the current study, a 
random slope was included in statistical models to account for varying cortisol trajectories across 
the study visit.  The effect of task timing on cortisol was also examined and there were non-
significant relations in every model.   
The study sample included a wide range of SES families.  However, income and maternal 
education were not evenly distributed. There were large percentages of low- and high-income 
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families and few middle-income families. Studies with equal representation across socioeconomic 
strata are needed to fully understand the effects of SES on NEI relations among children. Also, a 
maternal distress factor score was used to examine the combined effect of various dimensions of 
functioning without overloading models with covariates.  This approach limits the clinical 
significance of the findings as accepted cut-offs for individual instruments are not distinguished.  
Finally, longitudinal studies are needed to clarify the direction of the observed relations and the 
meaning of altered NEI relations in saliva for health and disease risk.  Additional research of 
salivary cytokines, including serum-saliva studies, is also needed to increase our understanding of 
the meaning and interpretation of salivary cytokines in healthy children. 
6.6. Conclusion 
 This study advances understanding of potential mechanisms linking early-life adversity 
and later life disease, as well as aids in the identification of adversity risk factors.  While prior 
studies reported significant relations between maternal mental health and altered HPA activity in 
children (22,45,46), this is the first study examining the moderating effect of maternal distress on 
cross-system NEI relations. The findings suggest that maternal distress can impact child NEI 
functioning by altering the sensitivity of inflammatory immune processes to the inhibitory effects 
of cortisol. This desensitization may increase risk for chronic inflammation and disease (1).   
The findings support the use of maternal mental health screenings for identifying children 
at risk of toxic stress, regardless of socioeconomic status. Pediatricians play an increasing role in 
identifying, preventing, and treating toxic stress in children (5,47), and maternal depression 
screening programs have been successfully integrated into some pediatric care sites (48).  The 
findings support these and other efforts that facilitate the early detection and treatment of at-risk 
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Conclusions and Implications of the Study 
 
7.1. Conclusions 
 The key findings from this dissertation suggest that salivary biomeasures of the immune 
system and CNS can be used to study neuroendocrine-immune (NEI) activity and sensitivity to 
environmental factors in children.  Furthering this line of research, the findings demonstrate the 
role of mothers in child NEI functioning.  Changes in NEI relations associated with maternal 
distress were suggestive of a poorly regulated inflammatory response. These disruptions in NEI 
regulation may increase the child’s risk of developing inflammatory diseases.  The studies 
included in this dissertation are the first to use salivary data to examine cross-system NEI 
functioning in children. The findings offer new opportunities for advancing the study of stress, 
adversity, health, and development in public health research. 
 The dissertation’s three study aims laid the foundation for these main findings.  This 
chapter reviews the findings associated with each study aim.  The results are discussed in the 
context of the existing literature, and important strengths and limitations of each study are 
presented.  The implications of the study findings for public health research, programs, and 
policies are presented in the final section of the chapter. 
Study Aim 1 Conclusions and Discussion 
 Study aim 1 explored current salivary analyte data analysis methods and the implications 
of these methods on data quality and the validity and reliability of study findings.  This aim 
focused on pre-analytic data processing as a neglected phase of data analysis that has significant 
consequences for data quality.  The review revealed that many practices commonly employed by 
salivary bioscience investigators are not endorsed by experts who encounter similar issues in 
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other fields (e.g., with serum data analysis in environmental and occupational health).  The 
review also identified areas of data processing and analysis for which clear standard protocols are 
needed.  Advantages and disadvantages of a variety of pre-analytic data processing techniques 
were discussed, and the impact of these techniques on parameter estimates was illustrated using 
sample data. The review called for standardization and disclosure of pre-analytic data processing 
procedures in all published manuscripts.  By identifying and addressing the limitations of current 
salivary analyte analysis methods, this review helps advance the field of salivary bioscience and 
maximize the potential of salivary analyte data in public health research. 
Study Aim 2 Conclusions and Discussion 
 Study aim 2 examined the nature and correlates of salivary cytokines in five-year old 
children.  It examined cytokine intercorrelations, and relations with demographic and health 
characteristics, as well as relations with autonomic nervous system (ANS) and hypothalamic-
pituitary-adrenal (HPA) axis activity.  The findings revealed new information about the 
measurement and characteristics of salivary cytokines.  Cytokines were reliably measured in the 
saliva of young children.  High inter-cytokine correlations were found at each saliva sampling 
point.  These findings are consistent with studies of salivary cytokines in older participants and 
suggest highly coordinated inflammatory immune processes within saliva (1,2).   
 Analyses assessing associations between salivary cytokines and health and demographic 
factors revealed positive associations between cytokines and poor oral health factors (periodontal 
issues, maternal smoking) and no overall association between cytokines and systemic health and 
demographic factors.  While the sample size is large for a biomeasure study of children, there 
were few children with fair/poor health. The heterogeneity and size of the sample may not have 
been adequate to find differences in cytokines levels by recent health.  The results, however, are 
consistent with studies of adults and adolescents that link elevated levels of salivary markers of 
inflammation with gingivitis, periodontal disease, dental carries and second-hand smoke (3–10). 
152 
 
While additional research is needed (e.g., comparing cytokine levels in serum and saliva), these 
results suggest that immune system activity is compartmentalized and salivary cytokines may 
reflect local oral, rather than systemic health. The results also confirmed previous findings of a 
diurnal pattern in interleukin-6 (IL-6; 11) and found evidence of age-related changes in IL-6.   
 Changes in salivary cytokine concentrations associated with acute stress were examined 
in this study without a priori hypotheses regarding the nature and magnitude of stress-related 
change.  Interleukin-1 beta (IL-1β) and interleukin-8 (IL-8) showed stress-related declines in 
concentrations with a time lag similar to cortisol.  Tumor necrosis factor alpha (TNFα) showed no 
overall change in slope after the emotional stressor tasks and IL-6 showed a steady declining (but 
non-significant) trajectory across the entire study visit.   
Interpreting the meaning of changes in analytes across the study visit is complicated by 
the order and timing of the stressor tasks used in the study and the limited information available 
about salivary cytokine task-sensitivity and associations with other unmeasured salivary analytes 
released in response to the study tasks. Additional research on salivary cytokine sensitivity to 
tasks, stress, and other salivary proteins (12), and the time course of these changes is needed to 
fully understand the nature of salivary cytokine environmental sensitivity.  Furthermore, cytokine 
trajectories varied by sex; compared to boys, girls exhibited flatter cytokine trajectories across the 
visit. These differences may be due to sex differences in immune responses or in cytokine-
cortisol and cytokine-alpha-amylase relations.  
 Among boys, cytokines were significantly positively related to alpha-amylase (sAA) and 
inversely related to cortisol.  These relations were all not significant among girls. These findings 
are consistent with adult studies using serum biomeasures of immune and HPA activity (13–16) 
and they extend these findings to include immune-ANS relations. The sex differences observed in 
this study suggest that sexual differentiation of NEI relations begins before puberty (e.g., through 
intrauterine sex hormones and genetic factors) and that these differences are measurable in saliva.   
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 The results from this study provide unique information regarding the concentrations and 
correlates of salivary cytokines in young children, and the interplay of these immunologic 
analytes with markers of ANS and HPA activity across a series of stressor tasks.  The findings 
demonstrate the feasibility and reliability of collecting and measuring salivary cytokine data in a 
young population.  Furthermore, they demonstrate the potential of using salivary biomeasures to 
study NEI functioning and the mechanisms linking brain, immunity and behavior during 
development.  
Study Aim 3 Conclusions and Discussion 
 Building on the results of study aim 2, study aim 3 examined the role of early-life 
adversity in moderating the relation between HPA and immune system activity in the oral cavity 
in five-year old children. Results from this study revealed significant interactions between 
maternal distress and salivary cytokines on cortisol indicating that, regardless of family 
socioeconomic status (SES), as maternal distress increased, the expected inverse relation between 
cytokines and cortisol became weaker.  Systemically, cortisol plays an essential role in reducing 
inflammation and preventing excessive and dangerously prolonged inflammatory processes (17).  
The observed effects suggest that poor maternal mental and psychosocial health may be 
associated with less efficient regulation of child inflammatory processes by the inhibitory effects 
of cortisol, which may place the child at risk of developing inflammatory diseases.  These 
findings are consistent with the notion that early-life adversity can result in a “defensive 
phonotype” (18,19) characterized by a hyperactive inflammatory response.   
 Sex-stratified analyses revealed significant maternal distress-cytokine interactions within 
the sample were driven by relations among girls.  While no significant maternal distress-cytokine 
interactions were observed among boys, the interactions were in the same direction as those 
observed among girls and there were no significant sex differences in the interaction effects.  
These results may be related to sex-specific differences in cytokine-cortisol relations; as 
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demonstrated in study aim 2, boys exhibited inverse cytokine-cortisol relations for all cytokines, 
while these relations among girls were generally positive.  These differences may make females 
more vulnerable to the moderating effect of maternal distress on NEI relations.  If cytokines are 
predisposed to exhibit decreased sensitivity to regulatory signals from cortisol, the desensitization 
of inflammatory mechanisms associated with early-life adversity may be magnified and observed 
at lower levels of adversity or earlier in the life course among females.  
 The cytokine by maternal distress interaction was significant for every cytokine except 
IL-8.  Of all four cytokines, IL-8 was present at the highest concentrations and was the only 
cytokine not associated with any demographic or health factor. Further investigation is needed to 
fully understand salivary IL-8 and its sensitivity to demographic, health and psychosocial health 
factors. Future studies should also examine the robustness of the TNFα by maternal distress 
interaction as this relation was only marginally significant when influential cases were excluded. 
 Importantly, maternal distress by cytokine interactions were significant after adjusting for 
family SES. Consistent with prior studies examining the effect of SES on the acute stress 
response in children, family SES was inversely associated cortisol in this study (20,21).  
However, unlike maternal distress, family SES did not interact with IL-6 or TNFα to affect 
cortisol.  The only exception was the significant interaction observed between IL-1β and family 
SES.  This interaction was in the same direction as the maternal distress-cytokine interactions. 
While, additional research on the effects environmental, financial, and psychosocial factors on 
NEI functioning in young children is needed, these results suggest maternal mental and 
psychosocial health may play a unique and important role in moderating child NEI relations and 
that these effects cannot be explained by SES.  
 Many strengths of the study sample and design make this investigation a valuable 
contribution to the literature.  The study used a large sample of children from a wide range of 
SES backgrounds.  Unlike earlier studies (22), this study used several markers of family SES and 
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maternal mental and psychosocial health.  Maternal distress was indexed using three validated 
psychological instruments.  This multidimensional measurement of SES and adversity allowed 
for the examination of the distinct effects of SES and maternal distress on child physiologic 
functioning, within the constraints imposed by the measures. The use of salivary biomeasures is 
also an important strength of the study; it allowed for the simultaneous examination of activity 
within the immune system and HPA axis and provided a new and more complex understanding of 
the physiologic effects of early-life adversity.  
 Despite these strengths, limitations regarding the study protocol and sample warrant 
discussion. While the acute stress response was not the focus of this investigation, the NEI 
activity examined likely reflects stress-related changes in cytokine and cortisol concentrations. 
Preliminary analyses assessing the need for non-linear modeling of cortisol were all not 
significant, perhaps due to the variable time from stressor tasks to saliva samples. The task timing 
variable was included in saturated models, but no significant relations were found between task 
timing and cortisol.  Therefore, task timing was not included in final models and cortisol was 
modeled linearly with a random slope to account for varying cortisol trajectories across the study 
visit. Future studies with more precise timing between stressor tasks and saliva samples should 
examine the nature of NEI relations at baseline and post-stressor in children.  These studies will 
help clarify the sensitivity of NEI relations in saliva to environmental factors.    
There were also limitations regarding the study sample. While a wide range of SES 
families were represented, family income and maternal education were not evenly distributed 
throughout the sample.  There was a large percentage of low- and high-income families and few 
middle-income families. Future studies with a more equal representation across socioeconomic 
strata are needed to understand the effects of SES on NEI relations among children.  Similarly, 
scores on the financial stress index and Center for Epidemiologic Studies Depression Scale (CES-
D) were positively skewed, and robust estimation procedures were employed to handle the non-
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normal distributions.  Maternal distress was indexed by a factor score representing depressive 
symptoms, anxiety, and parenting stress, allowing for the examination of multidimensional 
maternal functioning without overloading models with covariates.  This approach, however, 
limits the clinical significance of the findings as accepted cut-offs for individual instruments are 
not distinguished.  Practically, maternal distress factors are typically correlated and the current 
findings demonstrate the importance of maternal mental and psychosocial functioning at all 
levels.  Finally, longitudinal studies are needed to clarify the direction of the observed relations 
and the meaning of altered NEI relations in saliva for health and disease risk, and additional 
research of salivary cytokines is needed to increase our understanding of the meaning and 
interpretation of salivary cytokines in healthy children. 
 The study findings address two important gaps in the early-life adversity literature.  First, 
they illuminate a potential link between early-life adversity and disease.  Second, by 
demonstrating the effect caregivers may have on child inflammatory regulation, this study aids in 
the identification of early-life adversity risk factors and supports efforts to increase early 
detection and treatment of at-risk mothers to protect maternal as well as child health and well-
being.   
7.2. Implications for Public Health Research  
 The findings from this dissertation have clear implications for public health research.  In 
particular, they present opportunities for advancing salivary analyte research and the study of SES 
and health.   
Salivary Analyte Research 
This study advances salivary bioscience for public health researchers in two ways.  First, 
the methodological review in study aim 1 provides a set of best practices for future salivary 
analyte researchers. The review also calls for the standardization and disclosure of analysis 
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methods to facilitate across-study comparisons and meta-analyses. While current best practices 
are presented, further research is needed to establish comprehensive data analysis protocols, 
accepted methodology, and reporting requirements. Public health researchers are well-suited to 
lead the way in advancing salivary biomeasure analysis methods; collaborations across a range of 
health sciences researchers (e.g., epidemiology, occupational and environmental health sciences, 
and biostatistics) are needed to develop universal analytic standards.  Study aim 1 begins this 
effort by calling attention to inconsistencies in analytic strategies and the impact these differences 
may have on study findings.  
In addition to advancing salivary bioscience methods, this dissertation includes the first 
systematic examination of new salivary immune markers (cytokines) in young children and 
demonstrates the utility of these markers in studying environmental impacts on health.  The 
results lay the foundation for future studies investigating the utility of salivary cytokines as 
measures of oral disease, and indicators of exposure to toxins and acute stress. Future research 
should continue to examine relations between salivary cytokines and biomarkers from other 
physiologic systems (e.g., HPA, ANS, metabolic system) and the meaning of these relations for 
overall health.  Furthermore, research comparing serum and salivary cytokines, and studies 
conducted with unhealthy participants will help clarify the meaning of immune activity in the oral 
cavity.  While additional research is needed, the finding that interactions between immune, ANS, 
and HPA activity in saliva mirrors those found in serum, presents exciting opportunities for 
studying NEI functioning and the biologic impact of adversity in children and on a large scale. 
Future studies investigating these biomarkers, and others, will advance the use of biologic data 
for identifying and treating early-life adversity in children. 
Population-level biomarker data play an increasingly important role in policy-making; 
biologic data can help garner public and political support and can be used to objectively reframe 
social problems and identify effective policy and program solutions. Just as brain science was 
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used to reframe mental health and substance abuse issues to allow for passage of the Mental 
Health Parity Act, findings from biomarker studies could help reframe issues regarding the effect 
of early-life adversity on child health and development.  By expanding knowledge of the 
physiologic effects of early-life adversity and helping identify specific mechanisms by which 
adversity affects health, biomarker research can be used to increase support for and innovation in 
early childhood programs.  Salivary biomarkers provide a minimally-invasive, low cost, and 
socially-acceptable method for obtaining biologic data from populations of all ages on a large-
scale.  By helping advance salivary biomarker research toward the population-level study of 
environmental impacts on health, the dissertation helps further the use of biologic data in public 
health policy and practice.   
Socioeconomic Status and Health Research 
The findings from study aim 3 also have implications for the study of SES and health.  
The relation between low-SES and poor health is well established.  However, many studies of this 
relation are limited by the confounding of psychosocial and financial aspects of SES, and by the 
examination of biomeasures from one physiologic system in isolation (22). Study aim 3 addressed 
these limitations.  First, the findings showed the distinct contributions of financial and 
psychosocial factors on child physiologic functioning. While correlated, maternal distress and 
SES influenced HPA and immune system functioning in distinct ways.  Future studies should 
continue to examine the separate effects of financial and psychosocial factors on health in order 
to gain a better understanding of the mechanisms underlying SES and health relations.   
Second, findings from study aim 3 also demonstrate the potential of salivary biomarkers 
for expanding the study of SES and health to include biologic data from multiple physiologic 
systems.  This shift towards a multisystem, integrative approach to studying health, development, 
and environmental impacts on physiology has been highlighted by clinical and public health 
professionals as an important step in advancing knowledge and promoting well-being (23,24). 
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The findings from study aim 3 illustrate the importance of examining cross-system functioning; 
while there were no main effects of maternal distress on cortisol, maternal distress played an 
important role in NEI network relations. Future research should examine biomarkers from 
multiple systems and the interactions between them to gain a more detailed understanding of 
physiologic functioning and the impact of environmental factors on health.  Furthermore, 
longitudinal studies are needed to examine the directionality of the observed effects and the 
meaning and consequences of changes in NEI relations in saliva during childhood.  Questions 
regarding associations between NEI regulation measured in saliva and current health and disease, 
as well as later-life disease risk are important for advancing the study of early-life adversity using 
salivary biomarkers.  Finally, results from study aim 3, and others (25–30), suggest sex 
differences in biologic sensitivity to early-life adversity. This presents exciting opportunities for 
future studies examining these differences and the mechanisms underlying them.  
7.3. Implications for Programs and Policies 
 The finding that maternal mental and psychosocial health moderates child NEI relations 
adds to a large body of research indicating the critical role of caregivers on child health (e.g., 30–
35). The findings endorse the use of family and community-based programs and policies that 
support caregivers and promote child health and well-being.  These approaches include: maternal-
child interventions, maternal depression screening programs, integrated care, and financial and 
policy reforms.    
Maternal-Child Interventions 
 Poor maternal mental health is associated with impaired parenting behaviors and 
disruptions in maternal-child relations (36).  Rather than treating maternal health problems in 
isolation, comprehensive interventions for mother-child dyads that focus on improving maternal-
child relations and increasing maternal capacity and social support have sustained impacts on 
maternal, as well child and family outcomes (32,37).  Two popular early intervention programs 
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providing integrated services to mothers and their children include home visiting programs and 
other Early Head Start programs.   
Home visiting: Home visiting programs serve pregnant and parenting mothers with young 
children (38). They are a growing component of early intervention plans for high-risk families 
with recent support stemming from dedicated funds provided by the Patient Protection and 
Affordable Care Act (PPACA) of 2010 (38).  While program effects vary by approach and 
population, home visiting programs have been shown to increase family stability, positive 
parenting behaviors, and utilization of health and education services, as well as improve child 
behavior and cognitive outcomes, and reduce maternal stress, psychological problems, and 
depression (39–43). Programs successful in improving maternal mental health have adopted 
several different approaches, including mother-child relationship-based therapy (39), connecting 
families to community-based and medical services (39,40,42), cognitive behavioral therapy 
(36,44) and parent training (43).   
In addition to connecting clients with mental health resources in the community, home 
visiting programs can embed mental health workers within the program to better identify and treat 
maternal mental health issues and improve the link between home visiting and clinical care (36).  
Specific mental health curricula and training for home visiting staff, as well as program 
monitoring and evaluation are essential to ensuring home visiting programs provide effective 
support for maternal mental health (45). Continued support of evidence-based programs for 
improving maternal mental health and reducing parenting stress is needed.  
Early Head Start:  Early Head Start (EHS) is a community-based program serving low-SES 
families with pregnant women, infants or toddlers (46).  EHS provides home visiting, center-
based, and mixed model (both home and center-based) services (46).  EHS has been shown to 
decrease maternal depressive symptoms by promoting child cognitive and behavior development, 
improving parenting behaviors and reducing family conflict and parenting stress (47,48).  Like 
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other home visiting programs, EHS programs can further target maternal mental health by 
embedding maternal depression strategies within the EHS framework.  For example, Boston’s 
EHS program implemented the Family Connections project to strengthen staff understanding and 
treatment capacity for maternal depression and anxiety (36).  Also, EHS programs can include 
peer support groups, such as Sister Circles (36) and group-based parent training programs shown 
to be effective in reducing maternal depression, anxiety and stress (49). 
Maternal Depression Screening Programs and Integrated Care 
 The programs discussed thus far serve mostly low-income, high-risk women and their 
families.  While maternal depressive symptoms are higher in disadvantaged populations, rates 
among all pregnant and parenting women may reach up to 25% (36). Given the elevated risk of 
depression among mothers from all social strata, and the current finding that maternal distress 
impacts child NEI relations regardless of family SES, programs to identify and treat maternal 
mental health problems must extend beyond those implemented with high-risk families.  Maternal 
depression screening programs embedded within pediatrician offices are one approach for 
monitoring and treating women across all socioeconomic strata.  While these programs have been 
successful in identifying and referring mothers with depressive symptoms to specialized care 
(50,51), their ability to improve outcomes for mothers is unclear (52,53). 
The American Academy of Pediatrics recommends screening for post-partum depression 
as part of standard well child care (54). However, recently, pediatricians have been called upon to 
increase their role in identifying and treating maternal mental health issues (55,56).  Challenges to 
expanding pediatrician-based maternal mental health programs include, a lack of training among 
pediatricians in maternal mental health issues, limited knowledge of community resources, and 
reimbursement for parent services.  To address pediatrician training, education programs can 
improve pediatricians’ self-efficacy and knowledge about identifying and treating maternal 
depression (57).   
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Beyond building pediatrician capacity and increasing pediatrician screenings and 
referrals for maternal mental health issues, integrated models of physical and mental health care 
are an increasingly important and effective approach to treating mental health conditions 
(36,52,58). Funds allocated to the creation of patient-centered medical homes through the 
PPACA could be used to support the creation of these integrated healthcare sites for families 
throughout the US (59).  Family medicine and patient-centered medical homes are two examples 
of integrated care, however the level of care and care coordination varies by site; one study found 
only 40% of patient-centered medical homes had behavioral health professionals onsite and only 
half used evidenced-based approaches for mental/behavioral health problems (60).   
Better integration of physical and mental health care could be achieved by the adoption of 
the Collaborative Care (CC) model.  This model is a cost-saving, evidenced-based approach to 
care integration that has demonstrated effectiveness in treating depression, improving physical 
and social functioning, and increasing quality of life (52,58).  This approach uses primary care 
physicians, care management staff, and psychiatric consultants to provide mental/behavioral 
health screenings, brief interventions, mental health treatment and referrals, and to proactively 
track and monitor patients (52).   
A  key component of the CC model is the use of care management staff to facilitate 
communication among physicians, psychiatric consultants, and patients (52).  The use of a care 
management team addresses several of the barriers typically faced when integrating physical and 
mental health care including, communication problems between physical and mental health 
providers, a shortage of mental health providers, and problems delegating new patient navigation 
and tracking responsibilities (61,62).   
The PPACA expanded coverage of mental health treatment and mandates no-cost 
depression screening, however reimbursement for services from integrated care models and for 
multidimensional treatments (e.g., mother-child interventions) remains a significant barrier to 
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providing these services (52,59,60).  Replacing fee-for-service with capitated or case-rate 
reimbursement approaches, as well as adding incentive-based payments, could aid in the adoption 
of integrated care models (52) and increase the provision of comprehensive mother-child services 
to families from all socioeconomic strata. 
Financial and Policy Reforms 
 While the findings from this study suggest maternal mental and psychosocial health may 
have a unique influence on child health, there was also evidence of family financial stain 
influencing child HPA activity and, to a lesser extent, NEI relations. Given these findings and the 
interrelated nature of financial hardship and maternal distress, interventions that aim to increase 
family financial security warrant discussion.  These programs and policies can alleviate caregiver 
stress and provide flexibly with time and energy which can improve maternal mental health and 
maternal-child relations.    
Programs that provide direct financial support can promote maternal mental health. The 
Earned Income Tax Credit (EITC) provides payments to low-income working Americans. A 
recent study found that, in addition to increasing employment and social mobility, increases in 
EITC payments were associated with improved self-reported health, fewer poor mental health 
days, and decreases in concentrations of biomarkers of cardiovascular disease, obesity and 
inflammation among mothers with two or more children (63). Community outreach to increase 
EITC enrollment among low-income families could help maximize these benefits.  
 Temporary Assistance for Needy Families (TANF) is another source of financial support 
for low-income families. TANF provides block grants to states for the provision of cash 
assistance, child care support, and welfare programs (64).  TANF cash assistance levels, however, 
are very low; benefit levels are not enough to bring families above half the Federal Poverty Line 
in any state (65).  Increasing cash assistance levels and implementing TANF reforms, such as 
easing work requirements for parents of young children and increasing the time allowed in mental 
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health and substance abuse programs, could support maternal-child relations and maternal health 
in this vulnerable population (66).  The impact of these reforms, however, may be hindered by the 
low benefit levels currently provided by TANF.   
Beyond providing direct financial support, several programs and policies can be 
promoted to support family stability and maternal mental health.  For example, food insecurity 
and child care are significant stressors that place mothers at risk of poor mental health (67,68).  
Continued support of the Women, Infants and Children and Supplemental Nutrition Assistance 
Programs, as well as child care subsidies could help alleviate these stressors and their toll on 
maternal mental health.  Furthermore, efforts to increase the minimum wage and provide paid 
parental leave are important options for helping support family financial stability and ease 
parental stress.  
Community-focused Approaches 
While the focus of this dissertation was the role of mothers and families in child well-
being, it is important to remember that families are embedded within communities. Building 
community capacity supports caregiver, child, and family health and could help increase the 
effectiveness of the individual and family-based intervention’s discussed above (53,69).  For 
example, safe, clean and accessible community spaces (e.g., parks, recreation/child care centers) 
can provide time for mother-child interactions, as well as increase opportunities for social 
interactions among mothers (69). Mothers with greater social support and strong social networks 
have lower rates of mental health problems, including postpartum depression (70,71).  
Supportive community networks can also increase the impact of health messaging 
campaigns and increase maternal knowledge of community resources and health behaviors (53).  
In addition, safe and well-cared for neighborhoods are associated with better mental health and 
these community-level factors can support the effectiveness of maternal mental/behavioral health 
treatments and increase the odds of recovery (71–73).  While the home visiting and clinical 
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approaches discussed above can provide social support and help link mothers with community 
resources, efforts to promote communitywide social cohesion and support systems for mothers 
can augment these individual/family-based approaches and help lay the foundation for maternal 
and child well-being (53,69).   
7.4. Concluding Remarks 
 Nearly half of all American children live in low-income families, and one of every five 
children live in families with incomes below the Federal Poverty Line (74). While children 
growing up in low-SES families face several challenges, a supportive and attentive caregiver can 
buffer them from the negative impacts of early-life adversity that may otherwise increase their 
risk of poor mental and physical health later in life.  Unfortunately, maternal mental health 
problems are common in low-income populations with estimates of maternal depressive 
symptoms reaching nearly 60% (36).  Targeted improvements in maternal mental health, social 
support, and capacity can promote healthy child development and may protect the child’s life-
long health.  The work included in this dissertation aims to promote a new line of research into 
the effects of early-life adversity using multisystem salivary biomeasures to examine physiologic 
functioning in children.  Advancing this research may help identify, prevent and treat the 
physiologic effects of early-life adversity during childhood, and promote life-long health and 
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Fetus to Five Study Parent Survey Items and Instruments 
 
A.1. Parent Survey Items 
Demographic and Health Characteristics 
Child sex (Phase 2 only) 
Your child’s gender:  
 Male  
 Female  
 
Child race 
How would you describe your child’s race? (Check all that apply) 
 White  
 Black or African American  
 Asian or Pacific Islander   
 Native American or Alaskan Native  
 Other, please specify: ____________________________________________ 
 
Child ethnicity 
How would you describe your child’s ethnicity? 
 Hispanic/Latino  
 Not Hispanic/Latino  
 
Child current sickness 




Child recent health 
Compared to others his or her age, would you say your child's health in the last 2 days has been: 
 Excellent 







Child taken any medication in the last two days 
Has your child taken any prescription or over-the-counter medications in the last 2 days? 
 Yes 
 No 
If yes, please list the names of these medications:  
Medication 1:  _______________________ 
Medication 2:  _______________________ 
Medication 3:  _______________________ 
Medication 4:  _______________________ 
 
Child current periodontal or dental issues 
Does your child currently have any dental problems such as cuts or sores in his or her mouth, 





Maternal smoking status 
Do you smoke cigarettes? 





Your age: _____________________years 
 
 
 Question for Timing Data 
Wake time 
What time did your child wake up this morning? (Write the hour : minute, and circle whether this 








Socioeconomic Status and Adversity Items 
Family income 
For the past 12 months, which category best describes your total combined family income?  
Include income before taxes and from all sources. (Ex. wages, rent from properties, social 
security, disability, veteran’s benefits, unemployment benefits, worker’s compensation, help from 
relatives, child support payments, alimony, etc.)  
 Less than $5,000  
 $5,000 to $11,999  
 $12,000 through $15,999  
 $16,000 through $24,999  
 $25,000 through $34,999  
 $35,000 through $49,999  
 $50,000 through $74,999  
 $75,000 through $99,999  
 $100,000 through $150,000  
 150,000 and greater  
 Don’t know  
How much, all together, do you and the others in your family earn in one month 
before taxes are taken out?__________________ (Phase 2 only) 
 
Maternal education 
What is the highest level of education you have completed? (Check one) 
 Less than High School  
 High School / GED 
 Some College 
 2-year College Degree 
 4-year College Degree 
 Master’s Degree 
 Doctoral Degree 
 Professional Degree (JD, MD) 
 
Maternal marital status 
What is your current marital status? 
 Single, never married  
 Married  
 Divorced  
 Separated  
 Widowed  







Number of moves during child’s life 





 4  
 5 
 6 or more 
 
 
A.2. Parent Survey Instruments 
Financial Stress Index 
In the last 3 months, how often have you: 
 Never Rarely Sometimes Often Always 
Had difficulty making your monthly 
payments? 
□ □ □ □ □ 
Thought about your money 
problems? 
□ □ □ □ □ 
Had difficulty paying your bills? □ □ □ □ □ 
Feared you might lose your home 
due to lack of money? 
□ □ □ □ □ 
Feared you might be laid off? □ □ □ □ □ 
Felt your opportunities were limited 
due to lack of finances? 
□ □ □ □ □ 
 
 
Center for Epidemiologic Studies Depression Scale 
Below is a list of feelings and behaviors. Please tell us how often you have felt or behaved this 
way during the past week. 






Some or a 









Most or all 
of the time 
(5-7 days) 
1. I was bothered by things that 
usually don’t bother me. 
□ □ □ □ 
2. I did not feel like eating; my 
appetite was poor. 
□ □ □ □ 
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3. I felt that I could not shake off the 
blues even with help from my 
family or friends. 
□ □ □ □ 
4. I felt I was just as good as other 
people. 
□ □ □ □ 
5. I had trouble keeping my mind on 
what I was doing. 
□ □ □ □ 
6. I felt depressed. □ □ □ □ 
7. I felt that everything I did was an 
effort. 
□ □ □ □ 
8. I felt hopeful about the future. □ □ □ □ 
9. I thought my life had been a 
failure. 
□ □ □ □ 
10. I felt fearful. □ □ □ □ 
11. My sleep was restless. □ □ □ □ 
12. I was happy. □ □ □ □ 
13. I talked less than usual. □ □ □ □ 
14. I felt lonely. □ □ □ □ 
15. People were unfriendly. □ □ □ □ 
16. I enjoyed life. □ □ □ □ 
17. I had crying spells. □ □ □ □ 
18. I felt sad. □ □ □ □ 
19. I felt that people dislike me. □ □ □ □ 
20. I could not get “going.” □ □ □ □ 
 
 
State-Trait Anxiety Inventory 
A number of statements which people have used to describe themselves are given below. Read 
each statement and then check the appropriate box to the right of the statement to indicate how 
you generally feel. There are no right or wrong answers. Do not spend too much time on any one 
statement, but give the answer which seems to describe how you generally feel.  
 
Almost 
Never Sometimes Often 
Almost 
Always 
1. I feel pleasant. □ □ □ □ 
2. I feel nervous and restless. □ □ □ □ 
3. I feel satisfied with myself. □ □ □ □ 
4. I wish I could be as happy as others seem 
to be. 
□ □ □ □ 
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5. I feel like a failure. □ □ □ □ 
6. I feel rested. □ □ □ □ 
7. I am “calm, cool, and collected.” □ □ □ □ 
8. I feel that difficulties are piling up so that I 
cannot overcome them. 
□ □ □ □ 
9. I worry too much over something that 
really doesn’t matter. 
□ □ □ □ 
10. I am happy. □ □ □ □ 
11. I have disturbing thoughts. □ □ □ □ 
12. I lack self-confidence. □ □ □ □ 
13. I feel secure. □ □ □ □ 
14. I make decisions easily. □ □ □ □ 
15. I feel inadequate. □ □ □ □ 
16. I am content. □ □ □ □ 
17. Some unimportant thought runs through 
my mind and bothers me. 
□ □ □ □ 
18. I take disappointments so keenly that I 
can’t put them out of my mind. 
□ □ □ □ 
19. I am a steady person. □ □ □ □ 
20. I get in a state of tension or turmoil as I 
think over my recent concerns and 
interests. 
□ □ □ □ 
 
 
Parenting Stress Index (Short-Form) 
The next group of questions focuses on your experience as a parent. Since every child is different, 
answer based on your experience as a parent of this child. 
Read each statement carefully. For each statement, focus on the child you brought here today. 
Circle the response that best represents your opinion. While you may not find a response that 
exactly states your feelings, please circle the response that comes closest to describing how you 









































1. I often have the feeling that I cannot handle things very well.  SA A NS D SD 
2. I find myself giving up more of my life to meet my children’s 
needs than I ever expected. 
SA A NS D SD 
3. I feel trapped by my responsibilities as a parent. SA A NS D SD 
4. Since having this child, I have been unable to do new and 
different things. 
SA A NS D SD 
5. Since having a child, I feel that I am almost never able to do 
things that I like to do. 
SA A NS D SD 
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6. I am unhappy with the last purchase of clothing I made for 
myself. 
SA A NS D SD 
7. There are quite a few things that bother me about my life. SA A NS D SD 
8. Having a child has caused more problems than I expected in 
my relationship with my spouse (or male/female friend). 
SA A NS D SD 
9. I feel alone and without friends. SA A NS D SD 
10. When I go to a party, I usually expect not to enjoy myself. SA A NS D SD 
11. I am not as interested in people as I used to be. SA A NS D SD 
12. I don’t enjoy things as I used to. SA A NS D SD 
13. My child rarely does things for me that make me feel good. SA A NS D SD 
14. Sometimes I feel my child doesn’t like me and doesn’t want to 
be close to me. 
SA A NS D SD 
15. My child smiles at me much less than I expected. SA A NS D SD 
16. When I do things for my child, I get the feeling that my efforts 
are not appreciated very much. 
SA A NS D SD 
17. When playing, my child doesn’t often giggle or laugh. SA A NS D SD 
18. My child doesn’t seem to learn as quickly as most children. SA A NS D SD 
19. My child doesn’t seem to smile as much as most children. SA A NS D SD 
20. My child is not able to do as much as I expected. SA A NS D SD 
21. It takes a long time and it is very hard for my child to get used 
to new things. 
SA A NS D SD 
 
For number 22, check one statement from the 5 choices. 
22. I feel that I am: 
 not very good at being a parent. 
 a person who has some trouble being a parent. 
 an average parent. 
 a better than average parent. 
 a very good parent. 
 
Answer based on your experience as a parent of this child. Circle the response that best represents 









































23. I expected to have closer and warmer feelings for my child than 
I do and this bothers me.  
SA A NS D SD 
24. Sometimes my child does things that bother me just to be 
mean. 
SA A NS D SD 
25. My child seems to cry or fuss more often than most children. SA A NS D SD 
26. My child generally wakes up in a bad mood. SA A NS D SD 
27. I feel that my child is very moody and easily upset. SA A NS D SD 
28. My child does a few things which bother me a great deal. SA A NS D SD 
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29. My child reacts very strongly when something happens that my 
child doesn’t like. 
SA A NS D SD 
30. My child gets upset easily over the smallest thing. SA A NS D SD 
31. My child’s sleeping or eating schedule was much harder to 
establish than I expected. 
SA A NS D SD 
 
 
For number 32, check one statement from the 5 choices. 
32. I have found that getting my child to do something or stop doing something is: 
 much harder than I expected. 
 somewhat harder than I expected. 
 about as hard as I expected. 
 somewhat easier than I expected. 
 much easier than I expected. 
 
For number 33, choose your response from the choices. 
33. Think carefully and count the number of things which your child does that bother you.  







Answer based on your experience as a parent of this child. Circle the response that best represents 









































34. There are some things my child does that really bother me a lot.  SA A NS D SD 
35. My child turned out to be more of a problem than I had 
expected. 
SA A NS D SD 


























Table S.5.1.  Adjusted relations between IL-1β and alpha-amylase (model 1) and cortisol (model 2) in the full samplea 
 IL-1β Model 1 (n=125) IL-1β Model 2 (n=125) 
Fixed Effects Parameter SE p Parameter SE p 
Intercept 4.78 0.13 <.001 4.78 0.15 <.001 
Task Timing 0.00 0.01 .58 0.00 0.01 .71 
Sample 1-3 -0.13 0.03 <.001 -0.13 0.04 <.01 
Sample 3-4  -0.58b 0.14 <.001 -0.58c 0.15  <.001 
Current Oral Health Issues 0.58 0.18 <.01 0.58 0.19 <.01 
Alpha-amylase 0.16 0.07 <.05    
Cortisol    -0.03 0.06 .66 
Random Effects Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.70 0.12 0.51-0.97 0.68 0.12 0.48-0.95 
Residual: AR(1)  
Rho 0.48 0.08 0.30-0.62 0.51 0.08 0.33-0.65 
Within-subject Variance 0.28 0.06 0.18-0.42 0.30 0.06 0.20-0.45 
SE= robust standard error; CI= confidence interval. 
aIL-1β, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-3 and 3-4: β= -0.45, z= -3.45, p< .01. 




Table S.5.2.  Adjusted relations between IL-6 and alpha-amylase (model 1) and cortisol (model 2) in the full samplea 
 IL-6 Model 1 (n=125) IL-6 Model 2 (n=125) 
Fixed Effects Parameter SE p Parameter SE p 
Intercept 1.41 0.13 <.001 1.42 0.13 <.001 
Task Timing 0.00 0.00 .40 0.00 0.00 .28 
Sample  -0.07 0.04 .08 -0.08 0.05 .09 
Current Oral Health Issues 1.02 0.38 <.01 1.02 0.39 <.01 
Age  0.10 0.04 <.01 0.09 0.04 <.01 
Time Since Waking 0.10 0.04 <.05 0.10 0.04 <.05 
Alpha-amylase 0.16 0.10 .11    
Cortisol    -0.06 0.09 .48 
Random Effects Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 1.50 0.22 1.13-1.99 1.48 0.21 1.11-1.95 
Residual: AR(1)  
Rho 0.33 0.09 0.14-0.50 0.36 0.09 0.17-0.52 
Within-subject Variance 0.38 0.08 0.24-0.58 0.39 0.09 0.26-0.60 
SE= robust standard error; CI= confidence interval. 




Table S.5.3.  Adjusted relations between IL-8 and alpha-amylase (model 1) and cortisol (model 2) in the full samplea 
 IL-8 Model 1 (n=125) IL-8 Model 2 (n=125) 
Fixed Effects Parameter SE p Parameter SE p 
Intercept 6.32 0.13 <.001 6.35 0.14 <.001 
Task Timing 0.10 1.51 .13 0.00 0.01 .79 
Sample 1-3 -0.06 0.03 .07 -0.07 0.04 .06 
Sample 3-4  -0.34b 0.16 <.05 -0.35c 0.16 <.05 
Alpha-amylase 0.10 0.07 .13    
Cortisol    -0.05 0.05 .29 
Random Effects Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.41 0.07 0.30-0.57 0.41 0.07 0.29-0.58 
Residual: AR(1)  
Rho 0.25 0.11 0.04-0.45 0.27 0.10 0.06-0.46 
Within-subject Variance 0.23 0.04 0.16-0.32 0.23 0.04 0.16-0.33 
SE= robust standard error; CI= confidence interval. 
aIL-8, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-3 and 3-4: β= -0.28, z= -1.91, p= .06. 












Table S.5.4.  Adjusted relations between TNFα and alpha-amylase (model 1) and cortisol (model 2) in the full samplea 
 TNFα Model 1 (n=125) TNFα Model 2 (n=125) 
Fixed Effects Parameter SE P Parameter SE p 
Intercept 0.55 0.18 <.01 0.59 0.20 <.01 
Task Timing -0.02 0.01 <.05 -0.02 0.01 <.05 
Sample 1-2 -0.24 0.06 <.001 -0.24 0.06 <.001 
Sample 2-4  0.10b 0.11 .34 0.08c 0.11 .50 
Maternal Smoking 0.49 0.22 <.05 0.48 0.22 <.05 
Alpha-amylase 0.16 0.09 .07    
Cortisol    -0.09 0.07 .19 
Random Effects Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.85 0.13 0.62-1.15 0.83 0.14 0.60-1.15 
Residual: AR(1)  
Rho 0.34 0.12 0.10-0.55 0.38 0.12 0.13-0.58 
Within-subject Variance 0.47 0.10 0.31-0.71 0.49 0.11 0.32-0.76 
SE= robust standard error; CI= confidence interval. 
aTNFα, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-2 and 2-4: β= 0.34, z= 2.69, p< .01. 











Table S.5.5.  Adjusted relations between IL-1β and alpha-amylase and cortisol in boys (models 1 and 2) and girls (models 3 and 
4) separatelya 
 IL-1β Model 1  
Boys (n=61) 
IL-1β Model 2  
Boys (n=61) 
IL-1β Model 3  
Girls (n=64) 
IL-1β Model 4  
Girls (n=64) 
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept 4.72 0.17 <.001 4.70 0.17 <.001 4.87 0.20 <.001 4.84 0.02 <.001 
Task Timing 0.01 0.01 .11 0.01 0.01 .16 0.00 0.01 .83 0.00 0.01 .86 
Sample 1-3 -0.16 0.04 <.001 -0.15 0.04 <.001 -0.12 0.06 <.05 -0.11 0.06 .07 
Sample 3-4  -0.70 b 0.16 <.001 -0.68c 0.16 <.001 -0.47d 0.25 .06 -0.47e 0.24 .06 
Current Oral Health 
Issues 
0.52 0.39 .19 0.63 0.40 .12 0.55 0.32 .08 0.59 0.32 .06 
Alpha-amylase 0.43 0.09 <.001    0.01 0.08 .85    
Cortisol    -0.17 0.04 <.001    0.08 0.04 .07 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.76 0.15 0.51-1.12 0.79 0.16 0.53-1.17 0.50 0.16 0.27-0.92 0.49 0.15 0.27-0.90 
Residual: AR(1)  
Rho 0.36 0.14 0.07-0.59 0.40 0.14 0.09-0.64 0.54 0.13 0.24-0.74 0.55 0.13 0.25-0.75 
Within-subject 
Variance 
0.16 0.03 0.11-0.24 0.17 0.04 0.11-0.26 0.39 0.11 0.23-0.67 0.39 0.11 0.23-0.68 
SE= standard error; CI= confidence interval. 
aIL-1β, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-3 and 3-4: β= -0.54, z= -3.68, p<.001. 
cDifference between slopes from sample 1-3 and 3-4: β= -0.53, z= -3.63, p<.001. 
dDifference between slopes from sample 1-3 and 3-4: β= -0.35, z= -1.57, p= .12. 








Table S.5.6.  Adjusted relations between IL-6 and alpha-amylase and cortisol in boys (models 1 and 2) and girls (models 3 and 4) 
separatelya 
 IL-6 Model 1 
Boys (n=61) 
IL-6 Model 2 
Boys (n=61) 
IL-6 Model 3  
Girls (n=64) 
IL-6 Model 4  
Girls (n=64) 
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept 1.38 0.18 <.001 1.41 0.18 <.001 1.41 0.16 <.001 1.40 0.16 <.001 
Task Timing 0.01 0.00 .19 0.01 0.00 .26 0.00 0.01 .58 0.00 0.01 .61 
Sample  -0.16 0.06 <.01 -0.15 0.06 <.05 -0.03 0.07 .62 -0.02 0.07 .81 
Current Oral Health 
Issues 
0.71 0.58 .22 0.79 0.59 .18 1.40 0.43 <.01 1.44 0.43 <.01 
Age  0.05 0.05 .32 0.06 0.05 .20 0.11 0.04 <.05 0.11 0.04 <.05 
Time Since Waking 0.20 0.07 <.01 0.17 0.07 <.05 -0.01 0.06 .92 0.00 0.06 .96 
Alpha-amylase 0.53 0.14 <.001    0.00 0.10 .98    
Cortisol    -0.27 0.06 <.001    0.09 0.05 .09 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 1.60 0.31 1.09-2.34 1.65 0.32 1.13-2.42 1.11 0.25 0.72-1.72 1.12 0.24 0.73-1.72 
Residual: AR(1)  
Rho 0.25 0.12 0.01-0.46 0.29 0.12 0.04-0.51 0.42 0.14 0.12-0.65 0.41 0.14 0.11-0.64 
Within-subject 
Variance 
0.31 0.05 0.23-0.42 0.31 0.05 0.22-0.43 0.44 0.10 0.28-0.69 0.43 0.09 0.28-0.66 
SE= standard error; CI= confidence interval. 









Table S.5.7.  Adjusted relations between IL-8 and alpha-amylase and cortisol in boys (models 1 and 2) and girls (models 3 and 4) 
separatelya 
 IL-8 Model 1 
Boys (n=61) 
IL-8 Model 2 
Boys (n=61) 
IL-8 Model 3  
Girls (n=64) 
IL-8 Model 4  
Girls (n=64) 
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept 6.37 0.15 <.001 6.40 0.15 <.001 6.31 0.19 <.001 6.28 0.19 <.001 
Task Timing 0.00 0.01 .65 0.00 0.01 .72 -0.01 0.01 .50 -0.01 0.01 .48 
Sample 1-3 -0.12 0.05 <.05 -0.12 0.05 <.05 -0.03 0.06 .59 -0.02 0.06 .77 
Sample 3-4  -0.47 b 0.18 <.05 -0.47c 0.18 <.01 -0.23d 0.25 .37 -0.21e 0.25 .40 
Alpha-amylase 0.32 0.09 <.001    0.00 0.07 .95    
Cortisol    -0.21 0.04 <.001    0.07 0.04 .10 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.37 0.08 0.24-0.56 0.38 0.08 0.25-0.58 0.40 0.10 0.25-0.64 0.38 0.09 0.24-0.62 
Residual: AR(1)  
Rho 0.19 0.13 -0.06-0.42 0.23 0.13 -0.03-0.47 0.31 0.14 0.02-0.55 0.30 0.14 0.14-0.54 
Within-subject 
Variance 
0.18 0.03 0.13-0.24 0.17 0.03 0.13-0.24 0.27 0.51 0.19-0.39 0.27 0.05 0.19-0.39 
SE= standard error; CI= confidence interval. 
aIL-8, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-3 and 3-4: β= -0.36, z= -2.11, p<.05. 
cDifference between slopes from sample 1-3 and 3-4: β= -0.35, z= -2.18, p<.05. 
dDifference between slopes from sample 1-3 and 3-4: β= -0.19, z= -0.87, p>.20. 









Table S.5.8.  Adjusted relations between TNFα and alpha-amylase and cortisol in boys (models 1 and 2) and girls (models 3 and 4) 
separatelya 
 TNFα Model 1  
Boys (n=61) 
TNFα Model 2  
Boys (n=61) 
TNFα Model 3  
Girls (n=64) 
TNFα Model 4  
Girls (n=64) 
Fixed Effects Parameter SE p Parameter SE p Parameter SE p Parameter SE p 
Intercept 0.48 0.23 <.05 0.47 0.23 <.05 0.70 0.21 <.01 0.69 0.22 <.01 
Task Timing -0.01 0.01 .25 -0.01 0.01 .18 -0.02 0.01 <.05 -0.02 0.01 <.01 
Sample 1-2 -0.24 0.10 <.05 -0.25 0.10 <.05 -0.25 0.09 <.01 -0.24 0.10 <.05 
Sample 2-4  -0.01b 0.14 .93 0.00c 0.13 .98 0.17d 0.14 .23 0.18e 0.14 .21 
Maternal Smoking 0.67 0.33 <.05 0.92 0.33 <.01 0.13 0.28 .63 0.15 0.28 .59 
Alpha-amylase 0.46 0.14 <.01    0.01 0.09 .90    
Cortisol    -0.26 0.06 <.001    0.03 0.05 .58 
Random Effects Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI Estimate SE 95% CI 
Intercept:  
Variance(Intercept) 0.84 0.19 0.54-1.30 0.88 0.21 0.55-1.41 0.71 0.16 0.45-1.12 0.72 0.16 0.46-1.13 
Residual: AR(1)  
Rho 0.32 0.12 0.08-0.53 0.43 0.12 0.17-0.64 0.33 0.13 0.06-0.55 0.33 0.13 0.06-0.55 
Within-subject 
Variance 
0.47 0.08 0.33-0.65 0.50 0.10 0.34-0.75 0.45 0.08 0.32-0.63 0.44 0.08 0.31-0.63 
SE= standard error; CI= confidence interval. 
aTNFα, alpha-amylase, and cortisol were log-transformed and Winsorized. 
bDifference between slopes from sample 1-2 and 2-4: β= 0.23, z= 1.20, p> .20. 
cDifference between slopes from sample 1-2 and 2-4: β= 0.24, z= 1.37, p= .17. 
dDifference between slopes from sample 1-2 and 2-4: β= 0.42, z= 2.19, p< .05. 
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